
<html lang="en"     class="pb-page"  data-request-id="9cfc9ec6-53c4-4d8a-81cc-eb06f3526e4d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-23;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c01732"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches" /></meta><meta name="dc.Creator" content="Hai-Yun  Xiao" /></meta><meta name="dc.Creator" content="Ning  Li" /></meta><meta name="dc.Creator" content="James J.-W.  Duan" /></meta><meta name="dc.Creator" content="Bin  Jiang" /></meta><meta name="dc.Creator" content="Zhonghui  Lu" /></meta><meta name="dc.Creator" content="Khehyong  Ngu" /></meta><meta name="dc.Creator" content="Joseph  Tino" /></meta><meta name="dc.Creator" content="Lisa M.  Kopcho" /></meta><meta name="dc.Creator" content="Hao  Lu" /></meta><meta name="dc.Creator" content="Jing  Chen" /></meta><meta name="dc.Creator" content="Andrew J.  Tebben" /></meta><meta name="dc.Creator" content="Steven  Sheriff" /></meta><meta name="dc.Creator" content="ChiehYing Y.  Chang" /></meta><meta name="dc.Creator" content="Joseph  Yanchunas, Jr." /></meta><meta name="dc.Creator" content="Deepa  Calambur" /></meta><meta name="dc.Creator" content="Mian  Gao" /></meta><meta name="dc.Creator" content="David J.  Shuster" /></meta><meta name="dc.Creator" content="Vojkan  Susulic" /></meta><meta name="dc.Creator" content="Jenny H.  Xie" /></meta><meta name="dc.Creator" content="Victor R.  Guarino" /></meta><meta name="dc.Creator" content="Dauh-Rurng  Wu" /></meta><meta name="dc.Creator" content="Kurt R.  Gregor" /></meta><meta name="dc.Creator" content="Christine B.  Goldstine" /></meta><meta name="dc.Creator" content="John  Hynes, Jr." /></meta><meta name="dc.Creator" content="John E.  Macor" /></meta><meta name="dc.Creator" content="Luisa  Salter-Cid" /></meta><meta name="dc.Creator" content="James R.  Burke" /></meta><meta name="dc.Creator" content="Patrick J.  Shaw" /></meta><meta name="dc.Creator" content="T. G. Murali  Dhar" /></meta><meta name="dc.Description" content="Scaffold hopping and structure-based drug design were employed to identify substituted 4-aminoquinolines and 4-aminonaphthyridines as potent, small molecule inhibitors of tumor necrosis factor alph..." /></meta><meta name="Description" content="Scaffold hopping and structure-based drug design were employed to identify substituted 4-aminoquinolines and 4-aminonaphthyridines as potent, small molecule inhibitors of tumor necrosis factor alph..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 1, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01732" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01732" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01732" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01732" /></link>
        
    
    

<title>Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01732" /></meta><meta property="og:title" content="Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0024.jpeg" /></meta><meta property="og:description" content="Scaffold hopping and structure-based drug design were employed to identify substituted 4-aminoquinolines and 4-aminonaphthyridines as potent, small molecule inhibitors of tumor necrosis factor alpha (TNFα). Structure–activity relationships in both the quinoline and naphthyridine series leading to the identification of compound 42 with excellent potency and pharmacokinetic profile are discussed. X-ray co-crystal structure analysis and ultracentrifugation experiments clearly demonstrate that these inhibitors distort the TNFα trimer upon binding, leading to aberrant signaling when the trimer binds to TNF receptor 1 (TNFR1). Pharmacokinetic–pharmacodynamic activity of compound 42 in a TNF-induced IL-6 mouse model and in vivo activity in a collagen antibody-induced arthritis model, where it showed biologic-like in vivo efficacy, will be discussed." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01732"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01732">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01732&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01732&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01732&amp;href=/doi/10.1021/acs.jmedchem.0c01732" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 15050-15071</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01514" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jmv063i023_1436009" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Hai-Yun Xiao</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hai-Yun Xiao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#076f666e7e7269297f6e666847656a742964686a"><span class="__cf_email__" data-cfemail="6f070e06161a014117060e002f0d021c410c0002">[email protected]</span></a>. Phone: 609-252-6469.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hai-Yun++Xiao">Hai-Yun Xiao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ning Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ning Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ning++Li">Ning Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">James J.-W. Duan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James J.-W. Duan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James+J.-W.++Duan">James J.-W. Duan</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2730-9924" title="Orcid link">http://orcid.org/0000-0003-2730-9924</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bin Jiang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bin Jiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bin++Jiang">Bin Jiang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhonghui Lu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhonghui Lu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhonghui++Lu">Zhonghui Lu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Khehyong Ngu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Khehyong Ngu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Khehyong++Ngu">Khehyong Ngu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joseph Tino</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joseph Tino</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Tino">Joseph Tino</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lisa M. Kopcho</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lisa M. Kopcho</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lisa+M.++Kopcho">Lisa M. Kopcho</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hao Lu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hao Lu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hao++Lu">Hao Lu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jing Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jing Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jing++Chen">Jing Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrew J. Tebben</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew J. Tebben</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+J.++Tebben">Andrew J. Tebben</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Steven Sheriff</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Steven Sheriff</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Sheriff">Steven Sheriff</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">ChiehYing Y. Chang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">ChiehYing Y. Chang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=ChiehYing+Y.++Chang">ChiehYing Y. Chang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joseph Yanchunas Jr.</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joseph Yanchunas, Jr.</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Yanchunas%2C++Jr.">Joseph Yanchunas, Jr.</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Deepa Calambur</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Deepa Calambur</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Deepa++Calambur">Deepa Calambur</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mian Gao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mian Gao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mian++Gao">Mian Gao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David J. Shuster</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David J. Shuster</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Shuster">David J. Shuster</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vojkan Susulic</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vojkan Susulic</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vojkan++Susulic">Vojkan Susulic</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jenny H. Xie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jenny H. Xie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jenny+H.++Xie">Jenny H. Xie</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Victor R. Guarino</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Victor R. Guarino</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Victor+R.++Guarino">Victor R. Guarino</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dauh-Rurng Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dauh-Rurng Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dauh-Rurng++Wu">Dauh-Rurng Wu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kurt R. Gregor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kurt R. Gregor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kurt+R.++Gregor">Kurt R. Gregor</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christine B. Goldstine</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christine B. Goldstine</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christine+B.++Goldstine">Christine B. Goldstine</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John Hynes Jr.</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John Hynes, Jr.</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John++Hynes%2C++Jr.">John Hynes, Jr.</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0490-5179" title="Orcid link">http://orcid.org/0000-0002-0490-5179</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John E. Macor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John E. Macor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+E.++Macor">John E. Macor</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Luisa Salter-Cid</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Luisa Salter-Cid</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Luisa++Salter-Cid">Luisa Salter-Cid</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">James R. Burke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James R. Burke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James+R.++Burke">James R. Burke</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Patrick J. Shaw</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Patrick J. Shaw</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+J.++Shaw">Patrick J. Shaw</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">T. G. Murali Dhar</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">T. G. Murali Dhar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#b8d5cdcad9d4d196dcd0d9caf8dad5cb96dbd7d5"><span class="__cf_email__" data-cfemail="7518000714191c5b111d1407351718065b161a18">[email protected]</span></a>. Phone: 609-252-4158.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=T.+G.+Murali++Dhar">T. G. Murali Dhar</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0738-1021" title="Orcid link">http://orcid.org/0000-0003-0738-1021</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01732&amp;href=/doi/10.1021%2Facs.jmedchem.0c01732" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 15050–15071</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 1, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 October 2020</li><li><span class="item_label"><b>Published</b> online</span>1 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 December 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01732" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01732</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D15050%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHai-Yun%2BXiao%252C%2BNing%2BLi%252C%2BJames%2BJ.-W.%2BDuan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D23%26contentID%3Dacs.jmedchem.0c01732%26title%3DBiologic-like%2BIn%2BVivo%2BEfficacy%2Bwith%2BSmall%2BMolecule%2BInhibitors%2Bof%2BTNF%25CE%25B1%2BIdentified%2BUsing%2BScaffold%2BHopping%2Band%2BStructure-Based%2BDrug%2BDesign%2BApproaches%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D15071%26publicationDate%3DDecember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01732"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1949</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01732" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hai-Yun&quot;,&quot;last_name&quot;:&quot;Xiao&quot;},{&quot;first_name&quot;:&quot;Ning&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;J.-W. Duan&quot;},{&quot;first_name&quot;:&quot;Bin&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Zhonghui&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Khehyong&quot;,&quot;last_name&quot;:&quot;Ngu&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Tino&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;M. Kopcho&quot;},{&quot;first_name&quot;:&quot;Hao&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Jing&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;J. Tebben&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Sheriff&quot;},{&quot;first_name&quot;:&quot;ChiehYing&quot;,&quot;last_name&quot;:&quot;Y. Chang&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Yanchunas&quot;},{&quot;first_name&quot;:&quot;Deepa&quot;,&quot;last_name&quot;:&quot;Calambur&quot;},{&quot;first_name&quot;:&quot;Mian&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Shuster&quot;},{&quot;first_name&quot;:&quot;Vojkan&quot;,&quot;last_name&quot;:&quot;Susulic&quot;},{&quot;first_name&quot;:&quot;Jenny&quot;,&quot;last_name&quot;:&quot;H. Xie&quot;},{&quot;first_name&quot;:&quot;Victor&quot;,&quot;last_name&quot;:&quot;R. Guarino&quot;},{&quot;first_name&quot;:&quot;Dauh-Rurng&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Kurt&quot;,&quot;last_name&quot;:&quot;R. Gregor&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;B. Goldstine&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Hynes&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;E. Macor&quot;},{&quot;first_name&quot;:&quot;Luisa&quot;,&quot;last_name&quot;:&quot;Salter-Cid&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;R. Burke&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;J. Shaw&quot;},{&quot;first_name&quot;:&quot;T.&quot;,&quot;last_name&quot;:&quot;G. Murali Dhar&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;15050-15071&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01732&quot;},&quot;abstract&quot;:&quot;Scaffold hopping and structure-based drug design were employed to identify substituted 4-aminoquinolines and 4-aminonaphthyridines as potent, small molecule inhibitors of tumor necrosis factor alpha (TNFα). Structure–activity relationships in both the quinoline and naphthyridine series leading to the identification of compound 42 with excellent potency and pharmacokinetic profile are discussed. X-ray co-crystal structure analysis and ultracentrifugation experiments clearly demonstrate that these inhibitors distort the TNFα trimer upon binding, leading to aberrant signaling when the trimer binds to TNF receptor 1 (TNFR1). Pharmacokinetic–pharmacodynamic activity of compound 42 in a TNF-induced IL-6 mouse model and in vivo activity in a collagen antibody-induced arthritis model, where it showed biologic-like in vivo efficacy, will be discussed.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01732&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01732" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01732&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01732" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01732&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01732" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01732&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01732&amp;href=/doi/10.1021/acs.jmedchem.0c01732" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01732" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01732" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01732%26sid%3Dliteratum%253Aachs%26pmid%3D33261314%26genre%3Darticle%26aulast%3DXiao%26date%3D2020%26atitle%3DBiologic-like%2BIn%2BVivo%2BEfficacy%2Bwith%2BSmall%2BMolecule%2BInhibitors%2Bof%2BTNF%25CE%25B1%2BIdentified%2BUsing%2BScaffold%2BHopping%2Band%2BStructure-Based%2BDrug%2BDesign%2BApproaches%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D23%26spage%3D15050%26epage%3D15071%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=290795" title="Quinolines">Quinolines</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/jmcmar.2020.63.issue-23/20201210/jmcmar.2020.63.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Scaffold hopping and structure-based drug design were employed to identify substituted 4-aminoquinolines and 4-aminonaphthyridines as potent, small molecule inhibitors of tumor necrosis factor alpha (TNFα). Structure–activity relationships in both the quinoline and naphthyridine series leading to the identification of compound <b>42</b> with excellent potency and pharmacokinetic profile are discussed. X-ray co-crystal structure analysis and ultracentrifugation experiments clearly demonstrate that these inhibitors distort the TNFα trimer upon binding, leading to aberrant signaling when the trimer binds to TNF receptor 1 (TNFR1). Pharmacokinetic–pharmacodynamic activity of compound <b>42</b> in a TNF-induced IL-6 mouse model and in vivo activity in a collagen antibody-induced arthritis model, where it showed biologic-like in vivo efficacy, will be discussed.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08382" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08382" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">TNFα is a multifunctional cytokine produced by monocytes and macrophages as part of the inflammatory process and can lead to a diverse range of cellular responses including differentiation, proliferation, inflammation, and cell death.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> TNFα is the archetypal member of the TNF superfamily (TNFSF), a diverse family of ligands involved in the orchestration of immune and inflammatory processes.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Similar to other TNFSF members, TNFα is a type II transmembrane protein that can be cleaved and secreted as a soluble form.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Both the transmembrane and soluble forms of TNFα exist predominantly as biologically active trimeric complexes that signal through TNF receptors 1 and 2.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Based on the proinflammatory role of TNFα, a number of biologics that act to inhibit TNF binding to TNF receptors have been tested clinically. These agents include antibodies specific to TNFα that interfere with binding to TNFRs (adalimumab, golimumab, certolizumab, and infliximab) and a dimeric soluble form of TNFR2 (etanercept). These agents have proven to be clinically effective in a number of autoimmune and autoinflammatory diseases, including rheumatoid arthritis (RA), psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, psoriasis, juvenile idiopathic arthritis, ulcerative colitis, hidradenitis suppurativa, and certain types of uveitis.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Owing to the success of biologics targeting TNFα or its receptor, significant efforts have been made to identify small molecule inhibitors that disrupt the TNFα/TNFR interaction.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Small molecule approaches have significant advantages over biologics, in terms of oral delivery, being nonimmunogenic, and cost-effective, particularly for chronic indications. Therefore, small molecules with drug-like properties that deliver equivalent activity to anti-TNF biologics are highly desirable. Although significant work has been done in this area, a majority of these efforts have led to compounds that are micromolar inhibitors of this interaction at best, thus hindering their progressability. More recently, seminal work conducted by scientists at UCB Pharma has led to the identification of potent small molecule inhibitors of TNFα.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> These compounds were identified using fragment-based approaches and were shown to bind to an allosteric site within TNFα and stabilize the trimeric unit in a nonsymmetrical conformation that allows the TNFα trimer to recruit only two out of the three copies of TNFR1, leading to an incompetent TNF-TNFR1 signaling complex.</div><div class="NLM_p">Inspired by this discovery, we adopted a scaffold hopping approach starting from the reported benzimidazole-based scaffold (<b>1</b>)<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> to identify novel inhibitors of TNFα, generically represented by <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Scaffold hopping approach to novel inhibitors of TNFα.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">For the purposes of progressing compounds we mostly relied on a high-throughput human cell-based reporter gene assay measuring the response of secreted alkaline phosphatase (SEAP)-linked NF-κB, to TNF stimulation, in the HEK 293 cell-line (HEK-Blue). An analogous assay employing the CD40 ligand (CD40L) as the stimulant was used as an initial selectivity measure of the compounds within the TNFSF. Because the human assays were run in 10% fetal bovine serum (FBS), it gave us a preliminary indication of the extent of protein binding of the compounds and allowed us to optimize for cellular potency. In addition, we employed a homogeneous time resolved fluorescence (HTRF) assay to determine the binding of compounds to TNFα.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08830" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08830" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For initial proof of concept studies, we used commercially available 6-bromo-4-chloroquinoline (<b>3</b>) and 6-bromo-3,4-dichloroquinoline (<b>4</b>) as starting materials because these substrates would allow us to explore key structure–activity relationships (SAR) at the 3- and 4-positions of the quinoline scaffold. In addition, for the initial set of compounds (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), we decided to keep the 2,5-dimethylaniline substituent at the C-4 position and the 2-(pyrimidin-2-yl)propan-2-ol and picolinonitrile substituents for R<sup>3</sup> constant because these were among the moieties that were explored for the benzimidazoles (<b>1</b>). A general protocol for the synthesis of these compounds is outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 4-Amino-6-substituted Quinolines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) camphor-10-sulfonic acid, 150 °C; (b) R<sup>3</sup>B(OR)<sub>2</sub> (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> for R<sub>3</sub>), K<sub>2</sub>CO<sub>3</sub>, dioxane, PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct, 100 °C (22–81% over two steps).</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR at 2-, 3-, and 6-Positions of the Quinoline Core<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0011.gif" alt="" id="GRAPHIC-d7e487-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center">TNFα HTRF IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">HEK-Blue IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">LM, % remaining (h, m)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">rCYP IC<sub>50</sub> (μM) 2C9, 2C19</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">202 ± 53<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">428</td><td class="colsep0 rowsep0" align="left">>25,000</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">840 ± 257</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">73 ± 31</td><td class="colsep0 rowsep0" align="left">33, 30</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">105 ± 19</td><td class="colsep0 rowsep0" align="left">35, 24</td><td class="colsep0 rowsep0" align="left">0.6, 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">107 ± 19</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">51 ± 13</td><td class="colsep0 rowsep0" align="left">196 ± 63</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">2.8, 2.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Standard deviation (SD) is provided for means of three or more experiments. Where SD is not provided, values are means of two or more experiments. See <a class="ref internalNav" href="#sec6" aria-label="Experimental Section">Experimental Section</a> for assay protocols.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Metabolic stability in human (h) and mouse (m) liver microsomes; values are percentage of parent remaining after 10 min of incubation.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">See ref <a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a>.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">See <a class="ref internalNav" href="#sec6" aria-label="Experimental Section">Experimental Section</a> for the synthetic protocol.</p></div></div></div><div class="NLM_p">The SAR for the initial set of compounds is outlined in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_p">As the data from <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> indicates, the parent quinoline compound (<b>5</b>) was inactive in the HEK-Blue assay. Although this result was disappointing, we were delighted to see that the 3-chloroquinoline analogue (<b>7</b>) exhibited very good potency in the same assay. The fact that a single atom change, H to Cl, led to this remarkable result is intriguing and this SAR trend was observed with other analogues in this series (vide infra). It is also interesting to note that the bromo analogue (<b>6</b>), which was an intermediate in the synthetic sequence, also showed sub-micromolar activity in the HEK-Blue assay, clearly suggesting a key role for the chloro or methyl substituent (<b>9</b>) in potentially stabilizing the TNFα trimer (vide infra) and interfering with TNFα signaling.</div><div class="NLM_p">Although compounds shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> were moderately potent in the HEK-Blue assay, we were unable to drive down the potency and/or address the metabolic stability issues seen with these and related analogues in this series. In addition, we noted potent CYP2C9 and 2C19 inhibition with compounds unsubstituted at the C-2 position of the quinoline ring. However, we were able to right shift the potency in the CYP assays without significantly compromising potency in the cellular assay, by introducing a methyl substituent at the C-2 position (compare <b>8</b> and <b>10</b>). To address the potency and metabolic stability issues, we decided to explore the <i>N</i>-benzyl analogues of 4-aminiquinoline, and these results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of 4-Benzylamino Quinoline Analogues<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0012.gif" alt="" id="GRAPHIC-d7e694-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center">TNFα HTRF IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">HEK-Blue IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">LM % remaining (h, m)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">82 ± 41</td><td class="colsep0 rowsep0" align="left">>25,000</td><td class="colsep0 rowsep0" align="left">57, 61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">496</td><td class="colsep0 rowsep0" align="left">45, 50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">943</td><td class="colsep0 rowsep0" align="left">>25,000</td><td class="colsep0 rowsep0" align="left">32, 26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">>10,000</td><td class="colsep0 rowsep0" align="left">>25,000</td><td class="colsep0 rowsep0" align="left">76, 47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">190</td><td class="colsep0 rowsep0" align="left">51, 34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">17 ± 8</td><td class="colsep0 rowsep0" align="left">110 ± 26</td><td class="colsep0 rowsep0" align="left">59, 54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">1037</td><td class="colsep0 rowsep0" align="left">47, 32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">840</td><td class="colsep0 rowsep0" align="left">42, 38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">368 ± 184</td><td class="colsep0 rowsep0" align="left">57, 38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left">826 ± 459</td><td class="colsep0 rowsep0" align="left">69, 13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="left">407</td><td class="colsep0 rowsep0" align="left">81, 49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">264</td><td class="colsep0 rowsep0" align="left">>25,000</td><td class="colsep0 rowsep0" align="left">50, 21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">49</td><td class="colsep0 rowsep0" align="left">79, 23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">37</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">70, 45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">15,125</td><td class="colsep0 rowsep0" align="left">>25,000</td><td class="colsep0 rowsep0" align="left">46, 51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">94</td><td class="colsep0 rowsep0" align="left">331</td><td class="colsep0 rowsep0" align="left">30, 18</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Standard deviation (SD) is provided for means of three or more experiments. Where SD is not provided, values are means of two or more experiments.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Metabolic stability in human (h) and mouse (m) liver microsomes; values are percentage of parent remaining after 10 min of incubation.</p></div></div></div><div class="NLM_p">We were pleased to note that the parent benzyl compound <b>11</b> showed reasonable binding in the HTRF assay, although it was inactive in the cellular assay. Our first breakthrough in the benzyl series came with the (<i>R</i>)-methylbenzyl analogue (<b>12</b>), which showed excellent binding in the HTRF assay and moderate potency in the HEK-Blue assay. The (<i>S</i>)-methyl analogue (<b>13</b>) showed significantly reduced binding in the HTRF assay and was inactive in the cellular assay. In order to improve the potency, we explored substitutions on the phenyl ring of the benzylamine moiety. As is evident from <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, the (<i>R</i>)-1-(2-fluorophenyl)ethan-1-amine analogue (<b>16</b>) showed a 4–5 fold improvement in cellular potency versus the des-fluoro analogue (<b>12</b>). It is interesting to note that although the meta-fluoro and para-fluoro analogues (<b>17</b> and <b>18</b>, respectively) retained potency in the HTRF assay, they were significantly less potent in the HEK-Blue assay.</div><div class="NLM_p">In order to understand the binding mode of these compounds and the potential mechanism of action, we obtained an X-ray co-crystal structure of <b>16</b> with TNFα (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray co-crystal structure of compound <b>16</b> with TNFα. Chain A is colored orange, chain B is blue, and chain C is purple. Compound <b>16</b> is shown in yellow. Waters are rendered as red spheres. Hydrogen bonds between compound <b>16</b> and TNF are shown as yellow dashed lines. Omit <i>F</i><sub>o</sub>–<i>F</i><sub>c</sub> electron density was contoured at 3.0 rmsd (gray) (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7JRA">7JRA</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Examination of the X-ray co-crystal structure<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> revealed that the quinoline nitrogen engages in a critical H-bond with Tyr227<sup>C</sup> and the quinoline ring is engaged in a face to face π–π interaction with Tyr135<sup>C</sup>. The fluorophenyl moiety is engaged in an edge to face π–π interaction with Tyr135<sup>A</sup> and the quinoline −NH is engaged in an H-bonding interaction with Tyr195<sup>B</sup>. The proximal section of the C-6 pyrimidine substituent is located in a hydrophobic pocket formed by Leu233<sup>A</sup>, Leu133<sup>B</sup>, and Leu133<sup>C</sup> with a hydrogen bond with the hydroxyl group and carboxy terminus of Leu233<sup>A</sup>. Beyond this pocket, a number of water molecules are localized and the distal portion of the pyrimidine moiety appears to be exposed to the solvent. The chloro substituent is located in a small hydrophobic pocket formed by the side chains of Tyr195<sup>B</sup> and Tyr195<sup>C</sup> and the main chains of Leu196<sup>C</sup> and Gly197<sup>C</sup>. As discussed earlier and as will be apparent later, engagement of these residues appears to be critical in imparting functional activity for this series of TNFα inhibitors. In addition, it is possible that the chloro (and methyl) substituent can orient the <i>N</i>-benzyl moiety in the bioactive conformation required for functional activity. The improvement in cellular potency seen with the ortho-fluoro substituent could potentially be because of the increased H-bonding donor capability of the quinoline −NH with Tyr195<sup>B</sup> (due to the negative inductive effect of fluorine) leading to the stabilization of the trimer. This is consistent with the decreased cellular potency observed for the unsubstituted benzyl compound (<b>12</b>) and the meta and para-fluoro analogues (<b>17</b> and <b>18</b>, respectively).</div><div class="NLM_p">Other observations from the X-ray co-crystal structure are as follows: (a) the inhibitor binding site is a cavity within TNFα trimer created via movement of monomer A, (b) the inhibitor stabilizes the trimer in an inactive conformation by forming key π–π and hydrogen bonding interactions, (c) inhibitor <b>16</b> binds to TNFα trimer leading to major disruption of one TNFR binding site and minor disruption of a second site, while the third site remains unchanged, and (d) the inhibitor modulates TNFR activity through an allosteric mechanism rather than direct competition with TNFR. Based on these observations, it is reasonable to assume that binding of the inhibitor to the symmetric TNFα trimer leads to the formation of an asymmetric trimer which prevents the recruitment of three TNF receptor molecules that are necessary for signaling.</div><div class="NLM_p">In addition to the SAR for the α-methylbenzyl moiety described above, other key takeaways from <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> are as follows—the methyl group on the benzylic carbon appears to be optimal because increasing the size to ethyl (<b>19</b>) or isopropyl (<b>20</b>) leads to a drop in functional potency. Similarly, replacing the ortho-fluoro substituent with a more electron-withdrawing but bulkier CF<sub>3</sub> group (<b>21</b>) leads to a ∼2-fold decrease in binding and functional potency compared to <b>15</b>. The 2-pyridyl analogue (<b>22</b>) is significantly less potent in the HTRF assay and inactive in the HEK-Blue assay. A similar trend was observed for the 3- and 4-pyridyl analogues (data not shown). In order to improve the potency of the series, we examined the aforementioned X-ray co-crystal structure of <b>16</b> with TNFα and noticed a structural water that forms hydrogen bonds to the Tyr195<sup>A</sup> side chain and Gly197<sup>B</sup> and is in the vicinity of the C-5 position of the fluorophenyl ring. We reasoned that we could engage the structural water with an H-bonding donor substituent projecting off the C-5 position of the phenyl ring or displace it using a nitrile moiety. We also noted that the Tyr195<sup>A</sup> side chain was flexible, suggesting the tolerance for bulkier substituents in this region of the protein. To test this hypothesis, we synthesized the nitrile (<b>23</b>) and the aniline analogues (<b>24</b>)—both compounds were approximately 2-fold more potent than the parent fluorophenyl analogue <b>16</b> in the cellular assay. Bulky substituents at the C-5 position are tolerated as exemplified by the pyrrolidine analogue <b>26</b>; however, it is approximately 3-fold less potent than <b>16</b>. Consistent with the earlier observation of the importance of the chlorine atom on the quinoline ring for binding and cellular potency, analogue <b>25</b> is significantly less potent/inactive in the HTRF and HEK-Blue assays versus the chloro analogue <b>26</b>. Of the different analogues shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, the nitrile analogue <b>23</b> appeared particularly appealing for further testing and progression. Unfortunately, the in vitro metabolic stability of the compound in the mouse liver microsomal assay was less than desirable for advancement into an in vivo pharmacodynamic (PD) model. All of the compounds shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> (and in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>–<named-content content-type="anchor" rid="tbl4" type="simple"></named-content><a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> below) are very selective against CD40L (IC<sub>50</sub> > 10 μM, data not shown).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR at Position 6 of the Quinoline Core<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0013.gif" alt="" id="GRAPHIC-d7e1133-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center">TNFα HTRF IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">HEK-Blue IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">LM % remaining (h, m)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">47 ± 32</td><td class="colsep0 rowsep0" align="left">65</td><td class="colsep0 rowsep0" align="left">73, 24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">15 ± 3</td><td class="colsep0 rowsep0" align="left">587 ± 196</td><td class="colsep0 rowsep0" align="left">32, 28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">115 ± 17</td><td class="colsep0 rowsep0" align="left">86, 57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">15 ± 3</td><td class="colsep0 rowsep0" align="left">909 ± 273</td><td class="colsep0 rowsep0" align="left">33, 31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">25 ± 8</td><td class="colsep0 rowsep0" align="left">152 ± 59</td><td class="colsep0 rowsep0" align="left">57, 34</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Standard deviation (SD) is provided for means of three or more experiments. Where SD is not provided, values are means of two or more experiments.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Metabolic stability in human (h) and mouse (m) liver microsomes; values are percentage of parent remaining after 10 min of incubation.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR at Positions 5, 7, and 8 Employing Halogens<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0014.gif" alt="" id="GRAPHIC-d7e1240-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center">R═</th><th class="colsep0 rowsep0" align="center">TNFα HTRF IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">HEK-Blue IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">LM remaining (h, m)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">5-Cl</td><td class="colsep0 rowsep0" align="left">116 ± 5</td><td class="colsep0 rowsep0" align="left">365 ± 84</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">7-Cl</td><td class="colsep0 rowsep0" align="left">54 ± 6</td><td class="colsep0 rowsep0" align="left">178 ± 56</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">8-Cl</td><td class="colsep0 rowsep0" align="left">106</td><td class="colsep0 rowsep0" align="left">>25,000</td><td class="colsep0 rowsep0" align="left">40, 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">7-F</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">70, 28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">8-F</td><td class="colsep0 rowsep0" align="left">46 ± 38</td><td class="colsep0 rowsep0" align="left">224 ± 33</td><td class="colsep0 rowsep0" align="left">67, 25</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Standard deviation (SD) is provided for means of three or more experiments. Where SD is not provided, values are means of two or more experiments.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Metabolic stability in human (h) and mouse (m) liver microsomes; values are percentage of parent remaining after 10 min of incubation.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Naphthyridine SAR<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0015.gif" alt="" id="GRAPHIC-d7e1359-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center">TNFα HTRF IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">HEK-Blue IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">LM % remaining (h, m)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">rCYP IC<sub>50</sub> (μM) 2C9, 2C19</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">24 ± 15</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">753</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">473</td><td class="colsep0 rowsep0" align="left">84, 41</td><td class="colsep0 rowsep0" align="left">ND, 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">400</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">207 ± 22</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Standard deviation (SD) is provided for means of three or more experiments. Where SD is not provided, values are means of two or more experiments.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Metabolic stability in human (h) and mouse (m) liver microsomes; values are percentage of parent remaining after 10 min of incubation.</p></div></div></div><div class="NLM_p">Having identified the key SAR drivers at the 4-position, we turned our attention to explore the SAR at the 6-position of the aminoquinoline moiety. A number of compounds were synthesized to explore the SAR in this region of the molecule—a representative set is shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. Consistent with the X-ray co-crystal structure, a variety of substituents are tolerated at this position because this region of the ligand, particularly substituents coming off at the 2-position of the pyrimidine ring, is open to the solvent. However, as is apparent from <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, the cellular potencies of the compounds varied significantly although the binding potencies were within a few fold of each other. We decided to keep the pyrimidine moiety constant for subsequent SAR studies because it gave us an ideal combination of potency, hydrophilicity, and the ability to be used as a prodrug, in case of potential PK issues with tool compounds during the optimization process. In addition, we were able to synthesize a fluorescein probe for use in our HTRF assay (See <a class="ref internalNav" href="#sec6" aria-label="Experimental Sectio">Experimental Sectio</a>n for details) because the X-ray co-crystal structure of <b>16</b> suggested that the 2-position of the pyrimidine ring was open to the solvent.</div><div class="NLM_p">Next, we briefly examined SAR at positions 5, 7, and 8 of the quinoline scaffold, and this data are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>.</div><div class="NLM_p">As the table clearly suggests, chloro and fluoro substitutions at 5-, 7-, and 8-positions are tolerated from a binding perspective. However, the best functional potency, within this data set, is seen with the 7-fluoro analogue (<b>35</b>). The C-5 chloro analogue (<b>32</b>) is approximately 2–3 fold less potent in the binding and functional assays, compared to the corresponding des-chloro analogue <b>16</b>. On the other hand, although the C-8 chloro analogue (<b>34</b>) is moderately potent in the binding assay, it is inactive in the HEK-Blue cellular assay. Consistent with this observation, the smaller C-8 fluorine analog (<b>36</b>) is active both in the binding and functional assays. As is clear from the table, the binding potency for the C-5 and C-8 chloro analogues (<b>32</b> and <b>34</b>) are similar; however, <b>32</b> is moderately potent in the functional assay, whereas the C-8 analogue <b>34</b> is completely inactive. One potential explanation for the binding and functional assay disconnect seen here, and with other analogues, could be that in the HTRF binding assay we are looking purely at the displacement of the probe molecule by the ligand. In this situation, some movement of residues within the TNFα binding pocket may accommodate the ligand (potentially the case for the C-8 chloro analogue) or the neighboring moieties in the ligand itself move slightly (potentially in the case of the C-5 chloro analogue, resulting in a slightly different orientation of the pyrimidine moiety at C-6). However, in the cellular assay, the ligand-bound TNFα trimer engages TNFR1, and the inhibition of the signaling process may also depend on the relative strength of the interaction between the binding partners (ligand-bound TNFα trimer and TNFR1).</div><div class="NLM_p">As a final exercise, we briefly examined naphthyridines as alternatives to the quinoline core and this SAR is summarized in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>.</div><div class="NLM_p">Of the three naphthyridines tested, the 1,5-naphthyridines (<b>37–39</b>) were the most potent in the HTRF assay. The improved potency seen with 1,5 naphthyridine analogue versus the 1,7- and 1,8-analogues (<b>40</b> and <b>41</b> respectively) may be due to better π-stacking capability of this ring system with Tyr135<sup>C</sup> (vide supra). This was supported by the Jaguar calculated interaction energies (H-bond and π–π stacking) for these compounds, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In addition, in the case of 1,7- and 1,8-napthyridines, the additional nitrogen atom is placed in a hydrophobic environment leading to a significant desolvation penalty, thereby lowering the potency in the binding assay.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Jaguar Calculated Interaction Energies (H-Bond and π–π Stacking) for Quinoline, 1,5-Naphthyridine, 1,7-Naphthyridine, and 1,8-Naphthyridine</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0016.gif" alt="" id="GRAPHIC-d7e1555-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">H-bond</th><th class="colsep0 rowsep0" align="center" char=".">π–π stack</th><th class="colsep0 rowsep0" align="center" char=".">total</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">quinoline</td><td class="colsep0 rowsep0" align="char" char=".">–9.73</td><td class="colsep0 rowsep0" align="char" char=".">–5.12</td><td class="colsep0 rowsep0" align="char" char=".">–14.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1,5-naphthyridine</td><td class="colsep0 rowsep0" align="char" char=".">–9.35</td><td class="colsep0 rowsep0" align="char" char=".">–5.66</td><td class="colsep0 rowsep0" align="char" char=".">–15.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1,7-naphthyridine</td><td class="colsep0 rowsep0" align="char" char=".">–8.64</td><td class="colsep0 rowsep0" align="char" char=".">–4.48</td><td class="colsep0 rowsep0" align="char" char=".">–13.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1,8-naphthyridine</td><td class="colsep0 rowsep0" align="char" char=".">–8.90</td><td class="colsep0 rowsep0" align="char" char=".">–4.90</td><td class="colsep0 rowsep0" align="char" char=".">–13.8</td></tr></tbody></table></div></div><div class="NLM_p">Although the cellular potency of the 1,5-naphthyridine analogue <b>39</b> was approximately 2.5-fold lower than the corresponding quinoline analogue (<b>16</b>), the metabolic stability of the compound in the in vitro human or mice microsomal assay appeared promising (compare <b>39</b> versus <b>16</b> for human and <b>39</b> versus <b>23</b> and <b>35</b> for mouse). Therefore, our SAR efforts were focused on further improving potency, metabolic stability, and the CYP inhibition profile of this compound by incorporating key learnings from the aforementioned SAR studies, as represented in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Optimization of <b>39</b><sup>a</sup>. <sup>a</sup>Standard deviation (SD) is provided for means of three or more experiments. Where SD is not provided, values are means of two or more experiments. <sup>b</sup>Metabolic stability in human and mouse liver microsome; values are the percentage of parent remaining after 10 min of incubation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As outlined in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, we were very pleased to note that the proposed SAR changes to the 1,5-naphthyridine core were additive, leading to compound <b>42</b> with excellent cellular potency and metabolic stability in the mouse and human liver microsomal assays along with a significantly improved CYP inhibition profile. In addition, the compound was selective for TNFα compared to other TNFSF ligands such as CD40L, FasL, and LT beta (IC<sub>50</sub>, > 10 μM, data not shown). The compound was also tested against a panel of >150 kinases and was found to be inactive at the highest concentration tested.</div><div class="NLM_p">Before venturing into profiling and PK studies with <b>42</b>, we decided to investigate the effects of binding of the asymmetrical TNFα trimer with TNFR1 using ultracentrifugation experiments. In addition, we also wanted to show in a confirmatory secondary assay that the interaction of <b>42</b> bound TNFα occurs via TNFR1.</div><div class="NLM_p">To understand the mechanism of action of compound <b>42</b>, we studied its effect on the TNF receptor/TNFα trimer interaction. In order to clarify the stoichiometry of receptor binding under conditions where interactant concentrations could be carefully controlled, we undertook sedimentation velocity AUC studies. <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> summarizes the effect of compound <b>42</b> on the sedimentation of each of the individual proteins and the TNFα/TNFR1 complex, and results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Sedimentation velocity results of TNF (10 μM) and TNFR1 (15 μM) alone and in combination with or without compound <b>42</b> (25 μM). Molecular size, in terms of the sedimentation coefficient, is plotted as a function of relative concentration, in absorbance units, per <i>S</i> value, at the wavelength used for the detection of 280 nm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Results from Sedimentation Velocity Studies of <b>42</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center"><i>S</i> value observed</th><th class="rowsep1 colsep0" colspan="3" align="center">apparent MW<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> (kDa)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">sample</th><th class="colsep0 rowsep0" align="center">TNFR1 peak</th><th class="colsep0 rowsep0" align="center" char=".">TNF peak</th><th class="colsep0 rowsep0" align="center">interaction peak</th><th class="colsep0 rowsep0" align="center">TNFR1 peak</th><th class="colsep0 rowsep0" align="center" char=".">TNF peak</th><th class="colsep0 rowsep0" align="center">interaction peak</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TNF</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">59</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TNFR1</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cmpd <b>42</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TNF + cmpd <b>42</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">61</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TNFR1 + cmpd <b>42</b></td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TNF + TNFR1</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="left">6.7</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="left">149</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TNF + TNFR1 + cmpd <b>42</b></td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="left">5.8</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="left">118</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Apparent MW determined using the assumptions outlined in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01732/suppl_file/jm0c01732_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></div></div><div class="NLM_p">Compound <b>42</b> by itself gave no significant signal in the range of the observed <i>S</i>-values for the various proteins and combinations, though a small amount of the compound signal can be seen sedimenting at <0.5 <i>S</i>. The presence of compound <b>42</b> had little or no effect on the sedimentation of the TNFR1, which is consistent with lack of direct receptor binding. The addition of the compound led to a slight effect on the sedimentation rate of TNFα, which is consistent with the binding of the inhibitor to the TNFα trimer, with a slight shift to a higher <i>S</i> value in the presence of the compound. The largest effect of compound <b>42</b> was on the formation of the TNFR1/TNFα complex. In the absence of the inhibitor, the apparent MW of the complex was 149 kDa, consistent with a 3:3 TNFR1/TNFα complex (the 3:3 complex MW based on MW observed for the individual proteins = [3 × 27 kDa] + 59 kDa = 140 kDa). In the presence of the inhibitor, the apparent MW of the TNFR1/TNFα complex was 118 kDa, consistent with a 2:3 complex (expected MW of the 2:3 TNFR1/TNFα complex = [2 × 27 kDa] + 61 kDa = 115 kDa). In other words, the observed difference in apparent MW in the presence of inhibitor was 31 kDa, the MW of approximately one TNFR1. Pre-incubation of the inhibitor with TNFα clearly led to a decrease in the size of the TNFR1/TNFα complex, consistent with the disruption of one of the TNFR binding sites on the TNF trimer by compound <b>42</b>. This result is in alignment with the X-ray co-crystallography results (vide supra) showing skewing of the relative positions of the TNFα monomers when inhibitors are bound, leading to significant alternation of one of the receptor binding sites compared to TNF in the apo form.</div><div class="NLM_p last">For secondary confirmation in a cellular setting that the interaction of <b>42</b> bound TNFα occurs via TNFR1, we determined the impact of <b>42</b> on E-selectin upregulation on human umbilical vein endothelial cells (HUVEC) induced by soluble TNF. In endothelial cells, TNFα interaction with a TNFα receptor (TNFR1) leads to the activation of both JNK/p38 kinases and NF-κB signal transduction pathways.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> HUVECs, which do not express E-selectin under basal conditions, upregulate E-selectin after TNFα stimulation, with a maximal surface expression after 3–6 h and a return to basal levels within 24 h. Prior to the stimulation of HUVECs, <b>42</b> was pre-incubated with soluble TNFα (0.625 ng/mL) for 30 min. After stimulation, culture medium was removed, and cells were washed, detached, and stained with a CD62E-PE. E-selectin expression was augmented 100-fold as compared to the vehicle dimethyl sulfoxide (DMSO) control, which was potently inhibited by <b>42</b> with an average IC<sub>50</sub> of 30 nM (<i>Y</i><sub>max</sub> >95%), which is comparable to the potency observed in the HEK-Blue assay (IC<sub>50</sub> = 27 nM).</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Profiling PK–PD and Efficacy Studies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57172" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57172" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>42</b> provided us an opportunity to validate in vivo proof-of-concept for this mechanism, with a small molecule TNFα inhibitor. Before doing such studies, we tested the compound in key in vitro liability and profiling assays, and the results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Key Profiling Data for Compound <b>42</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">result</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">met. stab. <i>t</i><sub>1/2</sub> (h, r, m; min)</td><td class="colsep0 rowsep0" align="left">>120, 69, 78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 (AB/BA; nm/s)</td><td class="colsep0 rowsep0" align="left">200/80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG patch clamp IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rCYP IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A2</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2C8</td><td class="colsep0 rowsep0" align="left">>6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2C9</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2C19</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2D6</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3A4 (BFC substrate)</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protein binding (h/r/m; % free)</td><td class="colsep0 rowsep0" align="left">0.35/0.4/0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility (μg/mL)</td><td class="colsep0 rowsep0" align="left">1</td></tr></tbody></table></div></div><div class="NLM_p">As is evident from the table, the compound has good metabolic stability based on its half-life in the human, rat, and mouse liver microsomal assays. In addition, the compound has excellent permeability characteristics based on the data in the Caco-2 assay, despite its poor solubility (BCS category, Class II). Based on its good overall in vitro profile, compound <b>42</b> was subjected to mouse PK studies, and the data are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Pharmacokinetic Profile of <b>42</b> in Mouse<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>tot</sub> (μM h)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IV</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PO</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.47</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">58</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">PK parameters are mean values.</p></div><div class="footnote" id="t9fn2"><sup><sup>b</sup></sup><p class="last">PK parameters are based on whole blood exposures. Vehicle information: PO, 5/5/90 EtOH/TPGS/PEG400 at 5 mL/kg; IV, 50/50 PEG400/water at 3 mL/kg by IV bolus.</p></div></div></div><div class="NLM_p">Consistent with its good in vitro metabolic stability profile, <b>42</b> showed excellent PK properties in terms of low Cl, long <i>t</i><sub>1/2</sub>, and good oral bioavailability in mice. This data set the stage for testing the compound in mouse pharmacokinetic–PD (PK–PD) and efficacy studies.</div><div class="NLM_p">We used the mouse TNFα-induced serum IL-6 model for PK–PD studies. As mentioned earlier, TNF is a proinflammatory cytokine that induces the production of a number of downstream cytokines. In order to identify a robust PD endpoint downstream of TNF signaling, mice were injected with TNF and serum cytokines were measured at the 3 h time point. IL-6 was chosen as one of the cytokines because TNF signaling leads to the induction of serum IL-6, which can be blocked with biologics such as etanercept (Enbrel). In the event, compound <b>42</b> was dosed to female C57Bl/6 mice at 5 and 25 mg/kg PO, 1 h prior to TNF stimulation. Two hours after TNF injection, the blood was collected for serum separation and used for mouse IL-6 analysis by ELISA (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c01732/suppl_file/jm0c01732_si_001.pdf" class="ext-link">Supporting Information</a> for study protocol).</div><div class="NLM_p">As is evident from <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, compound <b>42</b> inhibited IL-6 moderately at 5 mg/kg while the inhibition at 25 mg/kg was similar to mouse Enbrel, which served as the positive control in the study. Average exposures (3 h) at 5 and 25 mg/kg were 470 and 1860 nM, respectively. Taking into consideration the protein binding adjusted HEK-Blue IC<sub>50</sub> of 256 nM [HEK-Blue IC<sub>50</sub> = 27 nM, mouse protein binding = 0.6% free], the exposures in the PD study correspond to covering approximately 2-fold the HEK-Blue IC<sub>50</sub> at 5 mg/kg and approximately 7-fold HEK-Blue IC<sub>50</sub> at 25 mg/kg.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mouse TNFα-induced PK–PD model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based on these PK–PD data, two doses (2 and 10 mg/kg, BID) were selected for use in a collagen antibody-induced arthritis (CAIA) model, a preclinical mouse model for RA that is partially dependent on TNF signaling. The 2 and 10 mg/kg doses were expected to provide approximately 1- and 4-fold HEK-Blue IC<sub>50</sub> coverage, respectively.</div><div class="NLM_p">In this arthritis model, a cocktail mixture of 4 monoclonal anti-mouse type II collagen antibodies (1 mg of each) was administered intraperitoneally (IP) to female BALB/c mice. Three days later, the mice were injected IP with 10 μg of lipopolysaccharide. Compound <b>42</b> was administered (PO, BID at 2, 10, mg/kg daily), 6 h after the LPS challenge. The placebo group received the same dosing regimen with a blank formulation vehicle (90:5:5 PEG 400: TPGS/ethanol). The positive control, mouse Enbrel, was administered subcutaneously (SC) at 10 mg/kg twice a week, initiated 6 h after the LPS challenge. Mice were monitored daily, starting on day 4, for development and severity of paw inflammation. Paws were evaluated visually and scored based on the severity of inflammation/swelling of the digits and paws until day 12 (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c01732/suppl_file/jm0c01732_si_001.pdf" class="ext-link">Supporting Information</a> for study protocol).</div><div class="NLM_p">It is clear from <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, compound <b>42</b> dose dependently reduced both the clinical score as well as the levels of inflammatory cytokines and leukocyte cell surface receptors (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>), similar to mouse Enbrel, at the 10 mg/kg dose. Terminal exposures at this dose were ∼1130 nM. Taking into consideration the protein binding adjusted HEK-Blue IC<sub>50</sub> of 256 nM, the exposures at the 10 mg/kg dose correspond to covering approximately 4.4-fold HEK-Blue IC<sub>50</sub>. The fact that only moderate efficacy was seen at the 2 mg/kg dose (terminal exposures, ∼340 nM, which corresponds to the coverage of approximately 1-fold HEK Blue IC<sub>50</sub>) suggests multiples of IC<sub>50</sub> coverage are required to see biologic-like efficacy in this preclinical model of RA, for this mechanism, using small molecule inhibitors.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Efficacy of <b>42</b> in a Mouse CAIA model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Percent Reduction in the Levels of Inflammatory Cytokines and Leukocyte Cell Surface Receptors (Paw RT-PCR)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">IL-1β</th><th class="colsep0 rowsep0" align="center">IL-6</th><th class="colsep0 rowsep0" align="center">TNFα</th><th class="colsep0 rowsep0" align="center">MCP-1</th><th class="colsep0 rowsep0" align="center">CXCL12</th><th class="colsep0 rowsep0" align="center">CXCL10</th><th class="colsep0 rowsep0" align="center">IL-17a</th><th class="colsep0 rowsep0" align="center">B-220</th><th class="colsep0 rowsep0" align="center">CD3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b><a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">*97%</td><td class="colsep0 rowsep0" align="left">89%</td><td class="colsep0 rowsep0" align="left">*69%</td><td class="colsep0 rowsep0" align="left">*82%</td><td class="colsep0 rowsep0" align="left">*92%</td><td class="colsep0 rowsep0" align="left">*89%</td><td class="colsep0 rowsep0" align="left">*77%</td><td class="colsep0 rowsep0" align="left">*63%</td><td class="colsep0 rowsep0" align="left">*61%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mEnbrel</td><td class="colsep0 rowsep0" align="left">*96%</td><td class="colsep0 rowsep0" align="left">96%</td><td class="colsep0 rowsep0" align="left">*63%</td><td class="colsep0 rowsep0" align="left">*66%</td><td class="colsep0 rowsep0" align="left">*91%</td><td class="colsep0 rowsep0" align="left">*86%</td><td class="colsep0 rowsep0" align="left">*64%</td><td class="colsep0 rowsep0" align="left">56%</td><td class="colsep0 rowsep0" align="left">44%</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup><sup>a</sup></sup><p class="last">At 10 mg/kg. *<i>p</i> < 0.05 vs vehicle control (Anova, Dunnett’s).</p></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43820" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43820" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a class="ref internalNav" href="#sch2" aria-label="Schemes 2">Schemes 2</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a> outline the synthesis of key compounds <b>16</b> and <b>42</b> described in the manuscript. Detailed synthetic protocols for other analogues shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> are described in the experimental and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01732/suppl_file/jm0c01732_si_001.pdf" class="ext-link">Supporting Information</a> sections.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the 4-Amino-quinoline Analogue <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>43</b>, B<sub>2</sub>pin<sub>2</sub>, PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct, KOAc, dioxane, 80 °C, then <b>4</b>, K<sub>2</sub>CO<sub>3</sub>, 100 °C, 76%; (b) <b>45</b>, camphor-10-sulfonic acid, DMA, 140 °C, 90%; and (c) ChiralPak AS-H (3 × 25 cm, 5 μm), 40% desired enantiomer <b>16</b>.</p></p></figure><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 1,5-Naphthyridine Analogue <b>42</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) AcOH and toluene, reflux, 42%; (b) Ph<sub>2</sub>O, 250 °C, 78%; (c) NCS and AcOH, 65 °C, 72%; (d) POCl<sub>3</sub>, 105 °C, 68%; (e) <b>43</b>, B<sub>2</sub>pin<sub>2</sub>, PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct, KOAc, and dioxane, 80 °C, then <b>50</b>, K<sub>2</sub>CO<sub>3</sub>, 100 °C, 44%; (f) <b>52</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, and toluene, 100 °C, 84%.</p></p></figure><div class="NLM_p">Commercially available 6-bromo-3,4-dichloroquinoline (<b>4</b>) was subjected to Suzuki coupling with the boronic ester derived from 2-(5-bromopyrimidin-2-yl)propan-2-ol (<b>43</b>) to provide <b>44</b>, which was heated with (±)-1-(2-fluorophenyl)ethan-1-amine (<b>45</b>) in the presence of a catalytic amount of camphor-10-sulfonic acid to yield racemic <b>16</b>. Chiral HPLC separation using a ChiralPak AS-H column yielded homochiral <b>16</b>, the absolute configuration of which was established from its X-ray co-crystal structure with TNFα (vide supra).</div><div class="NLM_p last">Condensation of commercially available aminopyridine <b>46</b> with ethyl 3-oxobutanoate (<b>47</b>) gave the aminoacrylate <b>48</b> in 42% yield. Intramolecular acylation of the pyridine ring at 250 °C yielded the hydoxynaphthyridine <b>49</b> in 78% yield, which was transformed into bromodichloronaphthyridine <b>50</b> by chlorination at the C3 position with NCS, followed by treatment with POCl<sub>3</sub>. Suzuki coupling of the bromodichloronaphthyridine <b>50</b> with a boronic ester generated in situ from 2-(5-bromopyrimidin-2-yl)propan-2-ol (<b>43</b>) afforded dichloronaphthyridine <b>51</b> in 44% yield which was subjected to Buchwald–Hartwig amination with (<i>R</i>)-3-(1-aminoethyl)-4-fluorobenzonitrile (<b>52</b>) to yield <b>42</b> in 84% yield.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37834" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37834" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, scaffold hopping and structure-based drug design (SBDD) approaches have led to the identification of a novel series of quinolines and 1,5-naphthyridines as potent inhibitors of the TNFα/TNFR interaction. To the best of our knowledge, this may be one of the very few reports describing low nanomolar small molecule inhibitors of TNFα, in a cellular setting. From a SAR perspective, a single atom/group change (H to Cl or Me) acting like an “on/off” switch for cellular activity is worth noting. In terms of the mechanism of action, X-ray co-crystallography and ultracentrifugation experiments provided insights on how the ligand induces structural changes to the TNF trimer, interfering with contact points and engagement with the receptor to modulate the TNF/TNFR signaling cascade. Finally, compound <b>42</b> was tested in a CAIA efficacy model, a preclinical model of rheumatoid arthritis, where it showed biologic-like efficacy, providing in vivo proof-of-principle for this mechanism from a small molecule perspective.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83326" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83326" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Biology</h3><div class="NLM_p last">All the experiments involving animals have been performed in accordance with institutional guidelines as defined by the Institutional Animal Care and Use Committee for U. S. Institutions.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> HTRF Assay Protocol</h3><div class="NLM_p">Compounds were received in DMSO at a top concentration of 10 mM (50 μM final concentration in the assay). Serial dilutions of 1:3 were prepared for 11 total concentrations per compound. The compounds were dispensed into the assay plate using a LabCyte ECHO, adding 100 nL to each assay plate (Corning 3573, black nontreated plates). Columns 1 and 2 of the Corning plate contained DMSO to provide the background and total values.</div><div class="NLM_p">Assay buffer was prepared containing 20 mM Hepes pH 7.5 (Gibco), 10 mM MgCl<sub>2</sub> (Sigma), 0.015% Brij-35 (Sigma), 4 mM dithiothreitol (Sigma), and 0.05 mg/mL bovine serum albumin (Sigma). A 2× concentration of anti-his antibody Tb-labeled (Cis Bio) was prepared in assay buffer. The 2× antibody stock (1 mL) was removed and added to column 1 of the Corning plate for a final assay concentration of 0.2 nM (stock concentration was 4034 nM). This was to be used as the assay background. To the remaining 2× antibody stock, a 2× His TNF concentration was added (in-house sources) for a final concentration of 1 nM.</div><div class="NLM_p">Antibody/antibody-enzyme (10 μL) was added to each assay plate by a Multidrop Combi (Thermo),covered to protect from light, and preincubated with the compound for 1 h at room temperature. Plates were moved by a Thermo robotic arm to the carousel for incubation. After the 1 h preincubation, the Thermo robotic arm transferred plates back to the Multidrop Combi. A 10 μL of an in-house fluorescent probe (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c01732/suppl_file/jm0c01732_si_001.pdf" class="ext-link">Supporting Information</a> for structure) was added to all wells. The probe was added at the <i>K</i><sub>d</sub> level of a final concentration of 89 nM. Assay plates were covered again and incubated for 3 h at room temperature.</div><div class="NLM_p">After the final incubation, plates were uncovered and moved by the robotic arm to the PerkinElmer Envision plate reader. Plates were read at an excitation of 340 nm and a dual emission of 490 and 520 nm.</div><div class="NLM_p last">Data obtained were used to plot dose response curves using proprietary BMS data analysis software processing tools.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> HEK-Blue Assay Protocol</h3><div class="NLM_p">HEK-Blue CD40L cells were grown in cell medium containing Dulbecco’s modified Eagle’s medium, 4.5 g/L of glucose (Life Technologies, Cat. 21063-029), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Life Technologies, Cat. 25030-081), 10% (v/v) heat-inactivated FBS (Sigma, F4135), 100 U/mL of penicillin (Life Technologies, Cat. 15140-122), 100 μg/mL of streptomycin, and 100 μg/mL of Normocin (Life Technologies, Cat. 15240-112). Cells were incubated at 37 °C with 5% CO<sub>2</sub>.</div><div id="sec6_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> For the HEK-Blue TNFα SEAP Reporter Assays</h4><div class="NLM_p last">Various concentrations (100 nL) of test compounds are added to 384-well polypropylene cell culture plates (BD Falcon plate, Cat. 353962). Assay buffer (30 μL) containing a 0.5 ng/mL final concentration of TNFα is then added into each well, followed by 10 μL of assay buffer containing 20K HEK-Blue CD40L cells. Assay buffer is the same as cell medium. The plates are then incubated for 18 h at 37 °C with 5% CO<sub>2</sub>.</div></div><div id="sec6_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> For the HEK-Blue CD40L SEAP Reporter Assays</h4><div class="NLM_p">Various concentrations (100 nL) of test compounds are added to 384-well polypropylene cell culture plates. Assay buffer (30 μL) containing 30 ng/mL final concentration of hCD40L (non-isoleucine zipper) is then added into each well, followed by 10 μL of assay buffer containing 20 K HEK-Blue CD40L cells. Assay buffer is the same as cell medium. The plates are then incubated for 18 h at 37 °C with 5% CO<sub>2</sub>.</div><div class="NLM_p last">SEAP activities mediated via TNFα or CD40L are assessed separately using the QUANTI-Blue reagent (InvivoGen, Cat. rep-qb1) with optical absorbance readouts at 620 nm according to the manufacturer’s instructions. Percent inhibition is calculated based on the average signals of the stimulated and unstimulated controls. Results are plotted to generate dose response curves. The IC<sub>50</sub> is defined as the concentration of the test compound corresponding to 50% inhibition derived from the 11-point fitted curve and the IC<sub>50</sub> values are determined using a four-parameter logistic regression model.</div></div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Chemistry</h3><div class="NLM_p">All commercially available chemicals and solvents were used without further purification. Reactions were performed under an atmosphere of nitrogen. All new compounds gave satisfactory <sup>1</sup>H NMR and/or LC/MS results. <sup>1</sup>H NMR spectra were obtained on a Bruker 400 MHz or a JEOL 500 MHz NMR spectrometer using the solvent as the internal reference. Electrospray ionization (ESI) mass spectra were obtained on a Waters ZQ single quadrupole mass spectrometer. We do not believe that this series of compounds has PAINS liabilities. As mentioned in the <a class="ref internalNav" href="#sec2" aria-label="Results and Discussion">Results and Discussion</a> section, the compounds show specific activity against TNFα and are selective over other TNFα family members and kinases. Additionally, in vivo PK–PD and efficacy studies have confirmed activity for compound <b>42</b>. The purity of the tested compounds determined by analytical HPLC was >95%. HPLC methods are listed below:</div><div id="sec6_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Method A</h4><div class="NLM_p last">Column: Waters Acquity UPLC BEH C<sub>18</sub>, 2.1 × 50 mm, 1.7 μm particles; mobile phase A: 5:95 acetonitrile/water with 10 mM ammonium acetate; mobile phase B: 95:5 acetonitrile/water with 10 mM ammonium acetate; temperature: 50 °C; gradient: 0–100% B over 3 min, then a 0.75 min hold at 100% B; flow rate: 1.0 mL/min.</div></div><div id="sec6_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Method B</h4><div class="NLM_p last">Column: BEH C<sub>18</sub>, 2.1 × 50 mm, 1.7 μm particles; mobile phase A: 5:95 acetonitrile/water with 10 mM ammonium acetate; mobile phase B: 95:5 acetonitrile/water with 10 mM ammonium acetate; temperature: 50 °C; gradient: 0–100% B over 1 min, then a 0.50 min hold at 100% B; flow: 0.8 mL/min.</div></div><div id="sec6_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Method C</h4><div class="NLM_p last">Column: Waters Acquity UPLC BEH C<sub>l8</sub>, 2.1 × 50 mm, 1.7 μm particles; mobile phase A: 5:95 acetonitrile/water with 0.1% TFA; mobile phase B: 95:5 acetonitrile/water with 0.1% TFA; temperature: 50 °C; gradient: 2–98% B over 1 min, then a 0.5 min hold at 98% B; flow rate: 0.8 mL/min.</div></div><div id="sec6_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Method D</h4><div class="NLM_p last">Column: Waters XBridge C<sub>18</sub>, 2.1 mm × 50 mm, 1.7 μm particles; mobile phase A: 5:95 acetonitrile/water with 10 mM ammonium acetate; mobile phase B: 95:5 acetonitrile/water with 10 mM ammonium acetate; temperature: 50 °C; gradient: 0–100% B over 3 min, then a 0.75 min hold at 100% B; flow: 1 mL/min.</div></div><div id="sec6_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Prep-HPLC Method E</h4><div class="NLM_p last">Column: XBridge C<sub>18</sub> 19 × 200 mm, 5 μm particles; mobile phase A: 5:95 acetonitrile/water with 0.1% trifluoroacetic acid; mobile phase B: 95:5 acetonitrile/water with 0.1% trifluoroacetic acid; gradient: depending on compound; flow rate 20 mL/min; detection: MS and UV (220 nm). Fractions containing the desired product were combined and dried via centrifugal evaporation.</div></div><div id="sec6_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Prep-HPLC Method F</h4><div class="NLM_p last">Column: XBridge C<sub>18</sub> 19 × 200 mm, 5 μm particles; mobile phase A: 5:95 acetonitrile/water with 10 mM ammonium acetate; mobile phase B: 95:5 acetonitrile/water with 10 mM ammonium acetate; gradient: depending on compound; flow rate 20 mL/min; detection: MS and UV (220 nm). Fractions containing the desired product were combined and dried via centrifugal evaporation.</div></div><div id="sec6_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 5-(4-((2,5-Dimethylphenyl)amino)quinolin-6-yl)picolinonitrile (<b>5</b>)</h4><div class="NLM_p last">A mixture of 2,5-dimethylaniline (0.618 mL, 4.95 mmol), 6-bromo-4-chloroquinoline (0.4 g, 1.649 mmol), (1<i>R</i>)-(−)-camphor-10-sulfonic acid (0.192 g, 0.825 mmol), and anhydrous dimethylacetamide (DMA) (0.5 mL) was stirred at 140 °C for 2 h. 2-Cyanopyridine-5-boronic acid pinacol ester (0.455 g, 1.979 mmol), 2 M aqueous K<sub>2</sub>CO<sub>3</sub> solution (4.12 mL, 8.25 mmol), and dioxane (5.50 mL) were added at RT. The mixture was purged with nitrogen before a PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct (0.202 g, 0.247 mmol) was added. The mixture was purged again with nitrogen and then vigorously stirred at 100 °C for 3 h. The reaction mixture was cooled to RT and extracted with EtOAc (3 × 5 mL). The combined organic solutions were dried over anhydrous sodium sulfate and concentrated. Flash chromatography purification (silica gel column, gradient elution from 15 to 100% of ethyl acetate in hexanes) and trituration with MeOH/EtOH afforded 5-(4-((2,5-dimethylphenyl)amino)quinolin-6-yl)picolinonitrile (<b>5</b>) (0.47 g, 1.341 mmol, 81% yield). HPLC <i>t</i><sub>R</sub> 1.79 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>19</sub>N<sub>4</sub> [M + H]<sup>+</sup>, 351.2; found, 351.2. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 9.23 (d, <i>J</i> = 1.1 Hz, 1H), 8.78 (d, <i>J</i> = 1.7 Hz, 1H), 8.45 (d, <i>J</i> = 8.3 Hz, 1H), 8.33 (d, <i>J</i> = 5.5 Hz, 1H), 8.10 (dt, <i>J</i> = 8.7, 1.5 Hz, 1H), 8.02 (d, <i>J</i> = 7.8 Hz, 1H), 7.99 (s, 1H), 7.27 (d, <i>J</i> = 7.6 Hz, 1H), 7.13 (s, 1H), 7.12 (d, <i>J</i> = 7.3 Hz, 1H), 6.22 (d, <i>J</i> = 5.6 Hz, 1H), 2.35 (s, 3H), 2.20 (s, 3H).</div></div><div id="sec6_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 6-Bromo-3-chloro-<i>N</i>-(2,5-dimethylphenyl)quinolin-4-amine (<b>6</b>)</h4><div class="NLM_p last">A mixture of 6-bromo-3,4-dichloroquinoline (0.36 g, 1.300 mmol), (1<i>R</i>)-(−)-camphor-10-sulfonic acid (0.015 g, 0.065 mmol), and 2,5-dimethylaniline (0.65 mL, 5.20 mmol) was heated at 150 °C under a nitrogen atmosphere in a microwave reactor for 30 min. The mixture was cooled and partitioned between saturated aqueous sodium bicarbonate solution (3 mL) and EtOAc (3 mL). The aqueous layer was separated and extracted with ethyl acetate (2 × 2 mL). The combined organic solutions were dried over sodium sulfate, filtered, and concentrated under reduced pressure. Flash chromatography purification (silica gel column, gradient elution from 5 to 100% of ethyl acetate in hexanes) afforded the desired product (0.92 g), which was contaminated with traces of 2,5-dimethylaniline. Further purification using Prep-HPLC (Method F) afforded <b>6</b>. HPLC <i>t</i><sub>R</sub> 2.37 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>15</sub>BrClN<sub>2</sub> [M + H]<sup>+</sup>, 363.0; found, 363.0. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.63 (s, 1H), 8.37 (d, <i>J</i> = 2.0 Hz, 1H), 8.30 (s, 1H), 7.88 (d, <i>J</i> = 8.8 Hz, 1H), 7.84 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 7.13 (d, <i>J</i> = 7.6 Hz, 1H), 6.86 (d, <i>J</i> = 7.8 Hz, 1H), 6.58 (s, 1H), 2.19 (s, 3H), 2.16 (s, 3H).</div></div><div id="sec6_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 5-(3-Chloro-4-((2,5-dimethylphenyl)amino)quinolin-6-yl)picolinonitrile (<b>7</b>)</h4><div class="NLM_p last">A mixture of 2-cyanopyridine-5-boronic acid pinacol ester (13 mg, 0.088 mmol), 6-bromo-3-chloro-<i>N</i>-(2,5-dimethylphenyl)quinolin-4-amine (<b>6</b>, 28 mg, 0.077 mmol), PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct (9.48 mg, 0.012 mmol), dioxane (0.25 mL), and 2 M aqueous solution of potassium carbonate (0.135 mL, 0.27 mmol) was purged with nitrogen and then heated at 110 °C for 75 min. Purification using Prep-HPLC (Method F) gave 5-(3-chloro-4-((2,5-dimethylphenyl)amino)quinolin-6-yl)picolinonitrile (<b>7</b>) (8.8 mg, 0.023 mmol, 30% yield). HPLC <i>t</i><sub>R</sub> 2.18 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>18</sub>ClN<sub>4</sub> [M + H]<sup>+</sup>, 385.1; found, 385.2. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.09 (s, 1H), 8.62 (s, 1H), 8.56 (s, 1H), 8.53 (br s, 1H), 8.38 (dd, <i>J</i> = 8.1, 1.9 Hz, 1H), 8.18 (t, <i>J</i> = 6.9 Hz, 2H), 8.06 (d, <i>J</i> = 8.8 Hz, 1H), 7.17 (d, <i>J</i> = 7.7 Hz, 1H), 6.94 (br d, <i>J</i> = 7.6 Hz, 1H), 6.74 (s, 1H), 2.19 (s, 6H).</div></div><div id="sec6_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-(5-(3-Chloro-4-((2,5-dimethylphenyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>8</b>)</h4><div class="NLM_p last">This compound was synthesized according to the procedure outlined for the synthesis of <b>7.</b> HPLC <i>t</i><sub>R</sub> = 2.06 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>24</sub>ClN<sub>4</sub>O [M + H]<sup>+</sup>, 419.2; found, 419.3. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.07 (s, 2H), 8.61 (s, 1H), 8.46 (d, <i>J</i> = 1.6 Hz, 1H), 8.40 (s, 1H), 8.15 (dd, <i>J</i> = 8.7, 1.7 Hz, 1H), 8.07 (d, <i>J</i> = 8.8 Hz, 1H), 7.17 (d, <i>J</i> = 7.7 Hz, 1H), 6.92 (d, <i>J</i> = 7.3 Hz, 1H), 6.68 (s, 1H), 5.20 (s, 1H), 2.20 (s, 3H), 2.17 (s, 3H), 1.52 (s, 6H).</div></div><div id="sec6_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-(5-(4-((2,5-Dimethylphenyl)amino)-3-methylquinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>9</b>)</h4><div class="NLM_p last">To a mixture of 2-(5-(3-chloro-4-((2,5-dimethylphenyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>8</b>) (45 mg, 0.107 mmol) in toluene (2 mL) and water (0.1 mL) were added methylboronic acid (16.08 mg, 0.269 mmol), tricyclohexylphosphine (60.2 mg, 0.043 mmol), phosphoric acid, potassium salt (68.4 mg, 0.322 mmol), and palladium(II) acetate (4.82 mg, 0.021 mmol) under a nitrogen atmosphere. The reaction mixture was heated at 100 °C for 16 h. After cooling to RT, the reaction mixture was diluted with EtOAc (10 mL) and water (10 mL). The organic layer was separated, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The residue was washed with EtOAc to give 2-(5-(4-((2,5-dimethylphenyl)amino)-3-methylquinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>9</b>) (10 mg, 0.024 mmol, 22% yield) as white solids. HPLC <i>t</i><sub>R</sub> = 0.72 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>27</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 399.2; found, 399.3. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.15 (s, 2H), 8.60 (s, 1H), 8.51 (d, <i>J</i> = 1.5 Hz, 1H), 8.11–8.03 (m, 2H), 7.79 (s, 1H), 7.13 (d, <i>J</i> = 7.6 Hz, 1H), 6.77 (d, <i>J</i> = 7.6 Hz, 1H), 6.39 (s, 1H), 5.11 (s, 1H), 2.29 (s, 3H), 2.12 (s, 3H), 1.99 (s, 3H), 1.53 (s, 6H).</div></div><div id="sec6_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-(5-(3-Chloro-4-((2,5-dimethylphenyl)amino)-2-methylquinolin-6-yl)pyrimidin-2-yl)propan-2-ol, TFA (<b>10</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0017.gif" alt="" id="dgr1" /></img>Step a: A mixture of 6-bromo-4-chloro-2-methylquinoline (0.1 g, 0.390 mmol), (1<i>R</i>)-(−)-camphor-10-sulfonic acid (0.045 g, 0.195 mmol), and 2,5-dimethylaniline (0.2 mL, 1.601 mmol) was stirred at 140 °C under a nitrogen atmosphere for 2 h. The mixture was partitioned between EtOAc (3 mL) and saturated aqueous sodium bicarbonate solution (3 mL). The aqueous layer was separated and extracted with ethyl acetate (3 × 1 mL). The combined organic solutions were dried over sodium sulfate and concentrated under reduced pressure. Flash chromatography purification (12 g silica gel column, gradient elution from 15 to 100% of ethyl acetate in hexanes) afforded 6-bromo-<i>N</i>-(2,5-dimethylphenyl)-2-methylquinolin-4-amine (0.13 g, 0.381 mmol, 98% yield). HPLC <i>t</i><sub>R</sub> = 0.79 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>18</sub>H<sub>18</sub>BrN<sub>2</sub> [M + H]<sup>+</sup>, 341.1; found, 341.1. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.50 (d, <i>J</i> = 2.0 Hz, 1H), 7.75 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H), 7.71 (d, <i>J</i> = 8.9 Hz, 1H), 7.25 (d, <i>J</i> = 7.7 Hz, 1H), 7.10 (d, <i>J</i> = 7.7 Hz, 1H), 7.07 (s, 1H), 6.04 (s, 1H), 2.40 (s, 3H), 2.35 (s, 3H), 2.16 (s, 3H).</div><div class="NLM_p">Step b. A solution of 6-bromo-<i>N</i>-(2,5-dimethylphenyl)-2-methylquinolin-4-amine (106 mg, 0.311 mmol) and <i>N</i>-chlorosuccinimide (41.5 mg, 0.311 mmol) in anhydrous dimethylformamide (DMF) (1 mL) was stirred at RT for 1.5 days. The mixture was concentrated. Flash chromatography gave impure 6-bromo-3-chloro-<i>N</i>-(2,5-dimethylphenyl)-2-methylquinolin-4-amine (20 mg, 0.053 mmol, 17% yield) as a solid. The compound was used in the next step without further purification.</div><div class="NLM_p last">Step c. To 2-(1-hydroxy-1-methylethyl)pyrimidine-5-boronic acid pinacol ester (16.87 mg, 0.064 mmol) was added 6-bromo-3-chloro-<i>N</i>-(2,5-dimethylphenyl)-2-methylquinolin-4-amine (20 mg) and 2 M aqueous K<sub>2</sub>CO<sub>3</sub> solution (66.5 μL, 0.133 mmol) followed by dioxane (177 μL). The mixture was purged with nitrogen before a PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct (6.52 mg, 7.99 μmol) was added. The mixture was purged with nitrogen again, the vial was sealed and stirred at 100 °C under a nitrogen atmosphere for 3 h. Prep-HPLC purification (Method E) gave 2-(5-(3-chloro-4-((2,5-dimethylphenyl)amino)-2-methylquinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>10</b>) as the TFA salt (8.6 mg, 0.015 mmol, 29% yield). HPLC <i>t</i><sub>R</sub> = 2.13 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>26</sub>ClN<sub>4</sub>O [M + H]<sup>+</sup>, 433.2; found, 433.0. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.96 (br s, 1H), 8.91 (s, 2H), 8.33 (d, <i>J</i> = 7.5 Hz, 1H), 8.26 (s, 1H), 8.05 (d, <i>J</i> = 8.8 Hz, 1H), 7.32–7.26 (m, 1H), 7.19–7.15 (m, 1H), 7.03 (s, 1H), 2.76 (s, 3H), 2.25 (s, 3H), 2.18 (s, 3H), 1.51 (s, 6H).</div></div><div id="sec6_4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-(5-(4-(Benzylamino)-3-chloroquinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>11</b>)</h4><div class="NLM_p last">This compound was synthesized according to the procedure outlined for the synthesis of <b>15</b>. HPLC <i>t</i><sub>R</sub> = 1.85 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>22</sub>ClN<sub>4</sub>O [M + H]<sup>+</sup>, 405.2; found, 405.2. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.20 (s, 2H), 8.72 (s, 1H), 8.41 (s, 1H), 8.11 (br d, <i>J</i> = 8.7 Hz, 1H), 7.96 (d, <i>J</i> = 8.7 Hz, 1H), 7.59 (br t, <i>J</i> = 6.4 Hz, 1H), 7.35 (d, <i>J</i> = 7.1 Hz, 2H), 7.29 (br t, <i>J</i> = 7.5 Hz, 2H), 7.22–7.18 (m, 1H), 5.00 (br d, <i>J</i> = 6.8 Hz, 2H), 1.55 (s, 6H).</div></div><div id="sec6_4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>R</i>)-2-(5-(3-Chloro-4-((1-phenylethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>12</b>)</h4><div class="NLM_p last">This compound was synthesized according to the procedure outlined for the synthesis of <b>15</b>. HPLC <i>t</i><sub>R</sub> = 2.00 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>24</sub>ClN<sub>4</sub>O [M + H]<sup>+</sup>, 419.2; found, 418.9. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.21 (s, 2H), 8.69 (s, 1H), 8.45 (s, 1H), 8.09 (br d, <i>J</i> = 8.6 Hz, 1H), 7.96 (d, <i>J</i> = 8.7 Hz, 1H), 7.40 (br d, <i>J</i> = 7.5 Hz, 2H), 7.25 (t, <i>J</i> = 7.5 Hz, 2H), 7.16 (t, <i>J</i> = 7.4 Hz, 1H), 6.71 (br d, <i>J</i> = 8.9 Hz, 1H), 5.63–5.51 (m, 1H), 3.56–3.52 (m, 1H), 1.65 (br d, <i>J</i> = 6.6 Hz, 3H), 1.56 (s, 6H).</div></div><div id="sec6_4_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>S</i>)-2-(5-(3-Chloro-4-((1-phenylethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>13</b>)</h4><div class="NLM_p last">This compound was synthesized according to the procedure outlined for the synthesis of <b>15</b>. HPLC <i>t</i><sub>R</sub> = 2.00 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>24</sub>ClN<sub>4</sub>O [M + H]<sup>+</sup>, 419.2; found, 418.9. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.20 (s, 2H), 8.69 (s, 1H), 8.45 (s, 1H), 8.09 (br d, <i>J</i> = 8.6 Hz, 1H), 7.96 (d, <i>J</i> = 8.7 Hz, 1H), 7.40 (br d, <i>J</i> = 7.6 Hz, 2H), 7.25 (br t, <i>J</i> = 7.5 Hz, 2H), 7.16 (t, <i>J</i> = 7.4 Hz, 1H), 6.73 (br d, <i>J</i> = 8.8 Hz, 1H), 5.60–5.51 (m, 1H), 1.65 (br d, <i>J</i> = 6.7 Hz, 3H), 1.55 (s, 6H).</div></div><div id="sec6_4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-(5-(3-Chloro-4-((2-phenylpropan-2-yl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>14</b>)</h4><div class="NLM_p last">A mixture of 2-phenylpropan-2-amine (22.25 mg, 0.165 mmol), 2-(5-(3,4-dichloroquinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>44</b>) (50 mg, 0.150 mmol), sodium <i>tert</i>-butoxide (35.9 mg, 0.374 mmol), and anhydrous dioxane (0.5 mL) was purged with nitrogen before bis(tri-<i>tert</i>-butylphosphine)palladium(0) (7.65 mg, 0.015 mmol) was added. The reaction mixture was purged with nitrogen again and stirred at 130 °C under a nitrogen atmosphere for 20 h. Prep-HPLC purification (Method F) gave 2-(5-(3-chloro-4-((2-phenylpropan-2-yl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>14</b>) (8 mg, 0.018 mmol, 12% yield). HPLC <i>t</i><sub>R</sub> = 2.17 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>26</sub>ClN<sub>4</sub>O [M + H]<sup>+</sup>, 433.2; found, 433.3. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.67 (s, 1H), 8.55 (s, 2H), 8.03–7.96 (m, 2H), 7.81 (s, 1H), 7.67 (br d, <i>J</i> = 7.6 Hz, 2H), 7.34 (t, <i>J</i> = 7.1 Hz, 2H), 7.26 (t, <i>J</i> = 7.1 Hz, 1H), 6.02 (s, 1H), 1.63 (s, 6H), 1.52 (s, 6H).</div></div><div id="sec6_4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-(5-(3-Chloro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>15</b>)</h4><div class="NLM_p">A mixture of 2-(5-bromopyrimidin-2-yl)propan-2-ol (<b>43</b>) (470 mg, 2.165 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (660 mg, 2.60 mmol), potassium acetate (319 mg, 3.25 mmol), and 1,4-dioxane (10 mL) was purged with nitrogen before a PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct (111 mg, 0.217 mmol) was added. The mixture was purged with nitrogen again and heated at 80 °C under a nitrogen atmosphere for 2 h. After cooling to RT, 6-bromo-3,4-dichloroquinoline (540 mg, 1.949 mmol) and potassium carbonate (2 M aqueous solution) (2.71 mL, 5.41 mmol) were added to the reaction. The reaction mixture was purged with nitrogen and heated at 100 °C for 3 h. After cooling to RT, the reaction mixture was diluted with EtOAc (20 mL) and water (20 mL). The organic layer was separated, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by flash chromatography (silica gel column, gradient from 0 to 100% of EtOAc in hexanes) to afford 2-(5-(3,4-dichloroquinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>44</b>) (550 mg, 1.646 mmol, 76% yield) as a tan solid. HPLC <i>t</i><sub>R</sub> 0.94 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>14</sub>Cl<sub>2</sub>N<sub>3</sub>O [M + H]<sup>+</sup>, 334.1; found, 334.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.09 (s, 2H), 8.92 (s, 1H), 8.43 (d, <i>J</i> = 1.7 Hz, 1H), 8.29 (d, <i>J</i> = 8.8 Hz, 1H), 7.99 (dd, <i>J</i> = 8.7, 2.0 Hz, 1H), 4.64 (s, 1H), 1.69 (s, 6H).</div><div class="NLM_p last">A mixture of 1-(2-fluorophenyl)ethanamine (<b>45</b>) (31.2 mg, 0.224 mmol), 2-(5-(3,4-dichloroquinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>44</b>) (25 mg, 0.075 mmol), (1<i>R</i>)-(−)-camphor-10-sulfonic acid (8.69 mg, 0.037 mmol), and anhydrous DMA (0.05 mL) was stirred at 140 °C under a nitrogen atmosphere for 5 h. After cooling to RT, the reaction was diluted with dichloromethane (DCM) (5 mL) and water (5 mL). The organic layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by flash chromatography (silica gel column, gradient from 0 to 100% of EtOAc in hexanes) to give 2-(5-(3-chloro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>15</b>) (30 mg, 0.068 mmol, 90% yield). HPLC <i>t</i><sub>R</sub> = 0.73 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>23</sub>ClFN<sub>4</sub>O [M + H]<sup>+</sup>, 437.2; found, 437.2. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.22 (s, 2H), 8.68 (s, 1H), 8.44 (s, 1H), 8.10 (br d, <i>J</i> = 8.6 Hz, 1H), 7.97 (d, <i>J</i> = 8.7 Hz, 1H), 7.52 (br t, <i>J</i> = 7.5 Hz, 1H), 7.25–7.20 (m, 1H), 7.13–7.05 (m, 2H), 6.77 (br d, <i>J</i> = 8.8 Hz, 1H), 5.83–5.77 (m, 1H), 1.66 (br d, <i>J</i> = 6.6 Hz, 3H), 1.56 (s, 6H).</div></div><div id="sec6_4_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>R</i>)-2-(5-(3-Chloro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>16</b>)</h4><div class="NLM_p last">Compound <b>15</b> (30 mg) was separated using chiral SFC [Column: ChiralPak AS-H (3 × 25 cm, 5 μm); mobile phase: CO<sub>2</sub>/MeOH (80/20) with 0.1% NH<sub>4</sub>OH; column temp.: 45 °C; flow rate: 180/min; detector wavelength: 266 nm] to give (<i>R</i>)-2-(5-(3-chloro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>16</b>) (peak 2; 12 mg; 40% yield). HPLC <i>t</i><sub>R</sub> = 0.73 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>23</sub>ClFN<sub>4</sub>O [M + H]<sup>+</sup>, 437.2; found, 437.1. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.81 (s, 2H), 8.68 (s, 1H), 8.12 (d, <i>J</i> = 8.7 Hz, 1H), 8.09 (d, <i>J</i> = 1.8 Hz, 1H), 7.83 (d, <i>J</i> = 8.4 Hz, 1H), 7.48 (td, <i>J</i> = 7.6, 1.7 Hz, 1H), 7.34–7.28 (m, 1H), 7.17 (td, <i>J</i> = 7.5, 1.1 Hz, 1H), 7.09 (ddd, <i>J</i> = 10.7, 8.3, 1.0 Hz, 1H), 5.45–5.36 (m, 1H), 5.18 (br d, <i>J</i> = 8.6 Hz, 1H), 3.50 (s, 1H), 1.72 (d, <i>J</i> = 6.6 Hz, 3H), 1.68 (s, 6H).</div></div><div id="sec6_4_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-(5-(3-Chloro-4-((1-(3-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>17</b>)</h4><div class="NLM_p last">This compound was synthesized according to the procedure outlined for the synthesis of <b>15</b>. HPLC <i>t</i><sub>R</sub> = 2.01 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>23</sub>ClFN<sub>4</sub>O [M + H]<sup>+</sup>, 437.2; found, 437.3. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.20 (s, 2H), 8.66 (s, 1H), 8.47 (s, 1H), 8.10 (d, <i>J</i> = 8.7 Hz, 1H), 7.98 (d, <i>J</i> = 8.7 Hz, 1H), 7.34–7.25 (m, 2H), 7.22 (d, <i>J</i> = 7.6 Hz, 1H), 7.03–6.95 (m, 1H), 6.73 (br d, <i>J</i> = 8.9 Hz, 1H), 5.58–5.50 (m, 1H), 1.64 (d, <i>J</i> = 6.6 Hz, 3H), 1.55 (s, 6H).</div></div><div id="sec6_4_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-(5-(3-Chloro-4-((1-(4-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>18</b>)</h4><div class="NLM_p last">This compound was synthesized according to the procedure outlined for the synthesis of <b>15</b>. HPLC <i>t</i><sub>R</sub> = 2.01 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>23</sub>ClFN<sub>4</sub>O [M + H]<sup>+</sup>, 437.2; found, 437.2. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.18 (s, 2H), 8.60 (s, 1H), 8.43 (s, 1H), 8.07 (br d, <i>J</i> = 8.9 Hz, 1H), 7.96 (d, <i>J</i> = 8.8 Hz, 1H), 7.42 (br dd, <i>J</i> = 8.2, 5.5 Hz, 2H), 7.05 (br t, <i>J</i> = 8.8 Hz, 2H), 6.68 (br d, <i>J</i> = 8.5 Hz, 1H), 5.55–5.48 (m, 1H), 5.36 (s, 1H), 1.61 (br d, <i>J</i> = 6.6 Hz, 3H), 1.54 (s, 6H).</div></div><div id="sec6_4_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-(5-(3-Chloro-4-((1-(2-fluorophenyl)propyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>19</b>)</h4><div class="NLM_p last">A mixture of 1-(2-fluorophenyl)propan-1-amine (10.08 mg, 0.066 mmol), 2-(5-(3,4-dichloroquinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>44</b>) (20 mg, 0.060 mmol), sodium <i>tert</i>-butoxide (14.38 mg, 0.150 mmol), and anhydrous dioxane (0.2 mL) was purged with nitrogen before bis(tri-<i>tert</i>-butylphosphine)palladium(0) (3.06 mg, 5.98 μmol) was added. The reaction mixture was purged with nitrogen and stirred at 100 °C under a nitrogen atmosphere for 3 h. Prep-HPLC purification (Method F) gave 2-(5-(3-chloro-4-((1-(2-fluorophenyl)propyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>19</b>) (4.7 mg, 10.11 μmol, 17% yield). HPLC <i>t</i><sub>R</sub> = 2.12 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>25</sub>ClFN<sub>4</sub>O [M + H]<sup>+</sup>, 451.2; found, 450.9. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.21 (s, 2H), 8.68 (s, 1H), 8.47 (s, 1H), 8.11 (br d, <i>J</i> = 8.8 Hz, 1H), 7.98 (d, <i>J</i> = 8.8 Hz, 1H), 7.59 (br t, <i>J</i> = 7.3 Hz, 1H), 7.27–7.20 (m, 1H), 7.14 (t, <i>J</i> = 7.4 Hz, 1H), 7.09 (t, <i>J</i> = 9.5 Hz, 1H), 6.71 (br d, <i>J</i> = 9.2 Hz, 1H), 5.59–5.46 (m, 1H), 5.23 (d, <i>J</i> = 1.9 Hz, 1H), 2.22–2.07 (m, 1H), 1.99–1.83 (m, 1H), 1.57 (s, 6H), 0.98 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec6_4_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-(5-(3-Chloro-4-((1-(2-fluorophenyl)-2-methylpropyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>20</b>)</h4><div class="NLM_p last">This compound was synthesized according to the procedure outlined for the synthesis of <b>19</b>. HPLC <i>t</i><sub>R</sub> = 2.29 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>27</sub>ClFN<sub>4</sub>O [M + H]<sup>+</sup>, 465.2; found, 465.3. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.17 (s, 2H), 8.60 (s, 1H), 8.49 (s, 1H), 8.08 (br d, <i>J</i> = 9.8 Hz, 1H), 7.96 (d, <i>J</i> = 8.5 Hz, 1H), 7.64 (t, <i>J</i> = 6.8 Hz, 1H), 7.26–7.17 (m, 1H), 7.13 (t, <i>J</i> = 7.1 Hz, 1H), 7.04 (t, <i>J</i> = 9.6 Hz, 1H), 6.62 (br d, <i>J</i> = 10.0 Hz, 1H), 5.32–5.20 (m, 2H), 2.42–2.27 (m, 1H), 1.56 (s, 6H), 1.18 (br d, <i>J</i> = 6.3 Hz, 3H), 0.76 (br d, <i>J</i> = 6.9 Hz, 3H).</div></div><div id="sec6_4_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-(5-(3-Chloro-4-((1-(2-(trifluoromethyl)phenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>21</b>)</h4><div class="NLM_p last">This compound was synthesized according to the procedure outlined for the synthesis of <b>15</b>. HPLC <i>t</i><sub>R</sub> = 2.16 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>23</sub>ClF<sub>3</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 487.2; found, 487.2. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.16 (s, 2H), 8.56–8.53 (m, 2H), 8.17 (br d, <i>J</i> = 7.9 Hz, 1H), 8.09 (d, <i>J</i> = 8.5 Hz, 1H), 7.98 (d, <i>J</i> = 8.8 Hz, 1H), 7.68 (t, <i>J</i> = 7.6 Hz, 1H), 7.57 (br d, <i>J</i> = 7.7 Hz, 1H), 7.40 (t, <i>J</i> = 7.6 Hz, 1H), 6.77 (br d, <i>J</i> = 9.3 Hz, 1H), 5.70–5.61 (m, 1H), 1.68 (br d, <i>J</i> = 6.6 Hz, 3H), 1.56 (s, 6H).</div></div><div id="sec6_4_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-(5-(3-Chloro-4-((1-(pyridin-2-yl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>22</b>)</h4><div class="NLM_p last">This compound was synthesized according to the procedure outlined for the synthesis of <b>15</b>. HPLC <i>t</i><sub>R</sub> = 1.77 min (Method D). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>23</sub>ClN<sub>5</sub>O [M + H]<sup>+</sup>, 420.2; found, 420.2. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.26 (s, 2H), 8.70 (s, 1H), 8.53 (s, 1H), 8.51 (br d, <i>J</i> = 4.4 Hz, 1H), 8.13 (dd, <i>J</i> = 8.5, 1.4 Hz, 1H), 7.99 (d, <i>J</i> = 8.5 Hz, 1H), 7.80–7.72 (m, 1H), 7.52 (d, <i>J</i> = 8.0 Hz, 1H), 7.25 (dd, <i>J</i> = 6.7, 5.1 Hz, 1H), 7.00 (br d, <i>J</i> = 7.4 Hz, 1H), 5.68–5.58 (m, 1H), 1.65 (d, <i>J</i> = 6.6 Hz, 3H), 1.57 (s, 6H).</div></div><div id="sec6_4_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>R</i>)-3-(1-((3-Chloro-6-(2-(2-hydroxypropan-2-yl)pyrimidin-5-yl)quinolin-4-yl)amino)ethyl)-4-fluorobenzonitrile (<b>23</b>)</h4><div class="NLM_p">Step a: (<i>R</i>)-2-(5-(4-((1-(5-Bromo-2-fluorophenyl)ethyl)amino)-3-chloroquinolin-6-yl)pyrimidin-2-yl)propan-2-ol was synthesized according to the procedure outlined for the synthesis of <b>15</b>. HPLC <i>t</i><sub>R</sub> = 0.79 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>22</sub>BrClFN<sub>4</sub>O [M + H]<sup>+</sup>, 515.1; found, 515.1.</div><div class="NLM_p last">Step b: A stirred DMF (1 mL) solution of (<i>R</i>)-2-(5-(4-((1-(5-bromo-2-fluorophenyl)ethyl)amino)-3-chloroquinolin-6-yl)pyrimidin-2-yl)propan-2-ol (20 mg, 0.039 mmol), dicyanozinc (9.11 mg, 0.078 mmol), di-<i>tert</i>-butyl(2′,4′,6′-triisopropyl-[1,1′-biphenyl]-2-yl)phosphine (3.29 mg, 7.75 μmol), Pd<sub>2</sub>(dba)<sub>3</sub> (3.55 mg, 3.88 μmol), and zinc (5.07 mg, 0.078 mmol) was degassed and refilled with nitrogen. The reaction vessel was sealed and heated at 95 °C for 2 h. The solvent was evaporated and the residue triturated with 10% aqueous LiCl solution (2 mL) and filtered. The solid was washed with water (2 mL) and dried in vacuo. Prep-HPLC purification (Method F) gave (<i>R</i>)-3-(1-((3-chloro-6-(2-(2-hydroxypropan-2-yl)pyrimidin-5-yl)quinolin-4-yl)amino)ethyl)-4-fluorobenzonitrile (<b>23</b>) (9.1 mg, 0.02 mmol, 50% yield). HPLC <i>t</i><sub>R</sub> = 1.94 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>22</sub>ClFN<sub>5</sub>O [M + H]<sup>+</sup>, 462.2; found, 462.0. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.26 (s, 2H), 8.66 (s, 1H), 8.50 (s, 1H), 8.17–8.10 (m, 2H), 8.01 (d, <i>J</i> = 8.5 Hz, 1H), 7.81 (br s, 1H), 7.43–7.34 (m, 1H), 6.79 (d, <i>J</i> = 8.9 Hz, 1H), 5.79–5.70 (m, 1H), 1.67 (d, <i>J</i> = 6.7 Hz, 3H), 1.57 (s, 6H).</div></div><div id="sec6_4_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>R</i>)-2-(5-(4-((1-(5-Amino-2-fluorophenyl)ethyl)amino)-3-chloroquinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>24</b>)</h4><div class="NLM_p last">A stirred dioxane (0.5 mL) solution of (<i>R</i>)-2-(5-(4-((1-(5-bromo-2-fluorophenyl)ethyl)amino)-3-chloroquinolin-6-yl)pyrimidin-2-yl)propan-2-ol (compound <b>23</b>, step a) (57 mg, 0.036 mmol), <i>tert</i>-butyl carbamate (42.7 mg, 0.365 mmol), <i>N</i><sub>1</sub>,<i>N</i><sub>2</sub>-dimethylethane-1,2-diamine (0.020 mL, 0.182 mmol), copper(I) iodide (1.389 mg, 0.0073 mmol), and potassium carbonate (25.2 mg, 0.182 mmol) was degassed using vacuum and refilled with nitrogen. The reaction vessel was sealed and heated at 110 °C for 20 h. Prep-HPLC purification (Method F) gave (<i>R</i>)-2-(5-(4-((1-(5-amino-2-fluorophenyl)ethyl)amino)-3-chloroquinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>24</b>) (1.8 mg, 0.004 mmol, 11% yield). HPLC <i>t</i><sub>R</sub> = 1.77 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>24</sub>ClFN<sub>5</sub>O [M + H]<sup>+</sup>, 452.2; found, 452.3. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.24 (s, 2H), 8.71 (s, 1H), 8.51 (s, 1H), 8.15 (br d, <i>J</i> = 8.5 Hz, 1H), 7.99 (d, <i>J</i> = 8.9 Hz, 1H), 7.94 (s, 1H), 6.89 (br d, <i>J</i> = 7.9 Hz, 1H), 6.85–6.76 (m, 1H), 6.72 (dd, <i>J</i> = 6.1, 2.4 Hz, 1H), 6.48–6.42 (m, 1H), 5.73 (quin, <i>J</i> = 6.9 Hz, 1H), 1.64 (d, <i>J</i> = 6.4 Hz, 3H), 1.57 (s, 6H).</div></div><div id="sec6_4_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>R</i>)-2-(5-(4-((1-(2-Fluoro-5-(pyrrolidin-1-yl)phenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>25</b>)</h4><div class="NLM_p last">A DMF (0.5 mL) solution of (<i>R</i>)-2-(5-(4-((1-(4-bromo-2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (prepared analogous to compound <b>15</b> starting from, 6-bromo-4-chloroquinoline and (<i>R</i>)-1-(4-bromo-2-fluorophenyl)ethan-1-amine) (10 mg, 0.019 mmol), pyrrolidine (13.79 mg, 0.194 mmol), palladium acetate (0.261 mg, 0.0012 mmol), dicyclohexyl-(2′,4′,6′-triisopropyl-biphenyl-3-yl)-phosphane (XPhos) (0.924 mg, 0.0019 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (15.79 mg, 0.048 mmol) was degassed using vacuum and refilled with nitrogen. The reaction vessel was sealed and heated at 100 °C for 20 h. Flash chromatography (silica gel column, 0–100% EtOAc in hexanes, then 0–10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) followed by Prep-HPLC purification (Method F) gave (<i>R</i>)-2-(5-(4-((1-(2-fluoro-5-(pyrrolidin-1-yl)phenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>25</b>) (2.1 mg, 0.0042 mmol, 22% yield). HPLC <i>t</i><sub>R</sub> = 2.07 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>31</sub>FN<sub>5</sub>O [M + H]<sup>+</sup>, 472.3; found, 472.0. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.32 (s, 2H), 8.91 (s, 1H), 8.36 (d, <i>J</i> = 5.6 Hz, 1H), 8.12 (d, <i>J</i> = 8.6 Hz, 1H), 7.92 (d, <i>J</i> = 8.7 Hz, 1H), 7.81 (br s, 1H), 7.01 (t, <i>J</i> = 9.4 Hz, 1H), 6.58 (br s, 1H), 6.41–6.31 (m, 2H), 5.02 (t, <i>J</i> = 6.7 Hz, 1H), 3.10 (d, <i>J</i> = 6.9 Hz, 2H), 3.03 (d, <i>J</i> = 6.8 Hz, 2H), 1.84 (br s, 4H), 1.68 (d, <i>J</i> = 6.6 Hz, 3H), 1.57 (s, 6H).</div></div><div id="sec6_4_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>R</i>)-2-(5-(3-Chloro-4-((1-(2-fluoro-5-(pyrrolidin-1-yl)phenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>26</b>)</h4><div class="NLM_p last">This compound was synthesized according to the procedure outlined for the synthesis of <b>25</b> starting from (<i>R</i>)-2-(5-(4-((1-(5-bromo-2-fluorophenyl)ethyl)amino)-3-chloroquinolin-6-yl)pyrimidin-2-yl)propan-2-ol (compound <b>23</b>, step a). However, the reaction was heated only for 1 h. HPLC <i>t</i><sub>R</sub> = 2.50 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>30</sub>ClFN<sub>5</sub>O [M + H]<sup>+</sup>, 506.2; found, 505.9. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.25 (s, 2H), 8.76 (s, 1H), 8.52 (s, 1H), 8.11 (d, <i>J</i> = 8.8 Hz, 1H), 7.98 (d, <i>J</i> = 8.5 Hz, 1H), 6.82 (t, <i>J</i> = 9.6 Hz, 1H), 6.74–6.65 (m, 2H), 6.28–6.20 (m, 1H), 5.80–5.69 (m, 1H), 3.02 (d, <i>J</i> = 5.8 Hz, 2H), 2.93–2.88 (m, 2H), 1.76 (br s, 4H), 1.67 (d, <i>J</i> = 6.7 Hz, 3H), 1.57 (s, 6H).</div></div><div id="sec6_4_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (<i>R</i>)-2-(4-(3-Chloro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)phenyl)propan-2-ol (<b>27</b>)</h4><div class="NLM_p">A mixture of 1-(2-fluorophenyl)ethanamine (633 mg, 4.55 mmol), 6-bromo-3,4-dichloroquinoline (<b>4</b>) (420 mg, 1.517 mmol), (1<i>R</i>)-(−)-camphor-10-sulfonic acid (176 mg, 0.758 mmol), and anhydrous DMA (1.5 mL) was stirred at 140 °C under a nitrogen atmosphere for 5 h. After cooling to RT, the reaction was diluted with DCM (10 mL) and water (10 mL). The organic layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by flash chromatography (silica gel column, 0–50% EtOAc in hexanes) to give 6-bromo-3-chloro-<i>N</i>-(1-(2-fluorophenyl)ethyl)quinolin-4-amine (400 mg, 1.054 mmol, 70% yield). The racemic mixture was separated using chiral SFC [Column: ChiralPak AD-H (5 × 25 cm, 5 mm); mobile phase: CO<sub>2</sub>/isopropanol (78/22) with 0.1% NH<sub>4</sub>OH; column temp.: 40 °C; flow rate: 280/min; detector wavelength: 220 nm] to give 170 mg of peak 1. HPLC <i>t</i><sub>R</sub> = 0.81 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>14</sub>BrClFN<sub>2</sub> [M + H]<sup>+</sup>, 379.0; found, 379.1. A portion of peak 1 was converted to <b>16</b> and the retention times were compared to make certain that the compounds obtained using the method outlined above and from <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> were identical.</div><div class="NLM_p last">(<i>R</i>)-2-(4-(3-Chloro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)phenyl)propan-2-ol (<b>27</b>) was synthesized according to the procedure outlined for the synthesis of <b>7</b>, using the above chiral intermediate and (4-(2-hydroxypropan-2-yl)phenyl)boronic acid. HPLC <i>t</i><sub>R</sub> = 2.28 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>25</sub>ClFN<sub>2</sub>O [M + H]<sup>+</sup>, 435.2; found, 435.2. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.46–8.40 (m, 2H), 7.98 (d, <i>J</i> = 8.2 Hz, 1H), 7.91 (d, <i>J</i> = 8.5 Hz, 1H), 7.65 (d, <i>J</i> = 8.4 Hz, 2H), 7.61 (br t, <i>J</i> = 7.9 Hz, 1H), 7.57 (br d, <i>J</i> = 8.3 Hz, 2H), 7.28–7.23 (m, 1H), 7.17–7.09 (m, 2H), 6.65 (br d, <i>J</i> = 8.6 Hz, 1H), 5.69–5.62 (m, 1H), 5.22 (br s, 1H), 1.65 (d, <i>J</i> = 6.7 Hz, 3H), 1.46 (s, 6H).</div></div><div id="sec6_4_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (<i>R</i>)-3-Chloro-6-(2-ethoxypyrimidin-5-yl)-<i>N</i>-(1-(2-fluorophenyl)ethyl)quinolin-4-amine (<b>28</b>)</h4><div class="NLM_p last">This compound was synthesized according to the procedure outlined for the synthesis of <b>27</b>. HPLC <i>t</i><sub>R</sub> = 2.20 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>21</sub>ClFN<sub>4</sub>O [M + H]<sup>+</sup>, 423.1; found, 423.3. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.04 (s, 2H), 8.58 (s, 1H), 8.43 (s, 1H), 8.04 (d, <i>J</i> = 8.7 Hz, 1H), 7.94 (d, <i>J</i> = 8.7 Hz, 1H), 7.54 (br t, <i>J</i> = 7.4 Hz, 1H), 7.23 (br d, <i>J</i> = 6.1 Hz, 1H), 7.14–7.06 (m, 2H), 6.71 (br d, <i>J</i> = 8.6 Hz, 1H), 5.82–5.73 (m, 1H), 4.43 (q, <i>J</i> = 7.0 Hz, 2H), 1.66 (d, <i>J</i> = 6.7 Hz, 3H), 1.38 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec6_4_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (<i>R</i>)-2-(4-(5-(3-Chloro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)piperazin-1-yl)acetic Acid (<b>29</b>)</h4><div class="NLM_p">Ethyl (<i>R</i>)-2-(4-(5-(3-chloro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)piperazin-1-yl)acetate was synthesized according to the procedure outlined for the synthesis of <b>27</b>. HPLC <i>t</i><sub>R</sub> = 0.71 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>31</sub>ClFN<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 549.2; found, 549.3.</div><div class="NLM_p last">To a stirred solution of ethyl (<i>R</i>)-2-(4-(5-(3-chloro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)piperazin-1-yl)acetate (5 mg, 9.11 μmol) in MeOH (0.05 mL) and tetrahydrofuran (THF) (0.1 mL) was added 1 M aqueous solution of NaOH (0.018 mL, 0.018 mmol). The reaction was allowed to stir at room temperature for 16 h. Prep-HPLC purification (Method F) gave 2-(4-(5-(3-chloro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)piperazin-1-yl)acetic acid (<b>29</b>) (2.9 mg, 5.46 μmol, 60% yield). HPLC <i>t</i><sub>R</sub> = 1.56 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>27</sub>ClFN<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 521.2; found, 521.3. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.85 (s, 2H), 8.48 (s, 1H), 8.40 (s, 1H), 7.98 (br d, <i>J</i> = 8.8 Hz, 1H), 7.89 (d, <i>J</i> = 8.9 Hz, 1H), 7.53 (br t, <i>J</i> = 7.3 Hz, 1H), 7.27–7.18 (m, 1H), 7.14–7.04 (m, 2H), 6.65 (br d, <i>J</i> = 8.2 Hz, 1H), 5.80–5.70 (m, 1H), 3.89 (br s, 4H), 3.26 (br s, 2H), 2.89–2.68 (m, 4H), 1.65 (br d, <i>J</i> = 6.6 Hz, 3H).</div></div><div id="sec6_4_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (<i>R</i>)-3-Chloro-<i>N</i>-(1-(2-fluorophenyl)ethyl)-6-(6-(methylsulfonyl)pyridin-3-yl)quinolin-4-amine (<b>30</b>)</h4><div class="NLM_p last">This compound was synthesized according to the procedure outlined for the synthesis of <b>27</b>. HPLC <i>t</i><sub>R</sub> = 1.92 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>20</sub>ClFN<sub>3</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, 456.1; found, 455.8. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.20 (s, 1H), 8.68 (s, 1H), 8.51–8.47 (m, 1H), 8.47 (s, 1H), 8.17 (d, <i>J</i> = 8.1 Hz, 1H), 8.11 (br d, <i>J</i> = 8.7 Hz, 1H), 7.99 (d, <i>J</i> = 8.8 Hz, 1H), 7.53 (br t, <i>J</i> = 7.6 Hz, 1H), 7.23 (q, <i>J</i> = 6.5 Hz, 1H), 7.14–7.05 (m, 2H), 6.80 (br d, <i>J</i> = 8.9 Hz, 1H), 5.80–5.73 (m, 1H), 3.33 (s, 3H), 1.66 (d, <i>J</i> = 6.7 Hz, 3H).</div></div><div id="sec6_4_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>R</i>)-4-(5-(3-Chloro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)thiomorpholine-1,1-dioxide (<b>31</b>)</h4><div class="NLM_p last">This compound was synthesized according to the procedure outlined for the synthesis of <b>27</b>. HPLC <i>t</i><sub>R</sub> = 2.00 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>24</sub>ClFN<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, 512.1; found, 511.8. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.94 (s, 2H), 8.54 (s, 1H), 8.41 (s, 1H), 8.02 (br d, <i>J</i> = 8.7 Hz, 1H), 7.92 (d, <i>J</i> = 8.8 Hz, 1H), 7.54 (br t, <i>J</i> = 7.5 Hz, 1H), 7.26–7.21 (m, 1H), 7.14–7.06 (m, 2H), 6.66 (br d, <i>J</i> = 8.8 Hz, 1H), 5.79–5.73 (m, 1H), 4.30 (br s, 4H), 3.21 (br s, 4H), 1.66 (br d, <i>J</i> = 6.7 Hz, 3H).</div></div><div id="sec6_4_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2-(5-(3,5-Dichloro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>32</b>) and 2-(5-(3,7-Dichloro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>33</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0018.gif" alt="" id="dgr2" /></img>Step a. A mixture of 2,2-dimethyl-1,3-dioxane-4,6-dione (4.19 g, 29.1 mmol) and trimethyl orthoformate (13.38 mL, 121 mmol) was stirred at 100 °C for 90 min. The mixture was cooled to 80 °C. 4-Bromo-3-chloroaniline (5.0 g, 24.22 mmol) and acetonitrile (60 mL) were added to the mixture and the reaction was stirred at 100 °C for 3.5 h. The mixture was poured into diethyl ether (300 mL). The solid was collected by filtration and dried under high vacuum to afford 5-(((4-bromo-3-chlorophenyl)amino) methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione (6.01 g, 15.83 mmol, 65% yield) as an off-white solid. HPLC <i>t</i><sub>R</sub> = 1.00 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>12</sub>BrClNO<sub>4</sub> [M + H]<sup>+</sup>, 360.0; found, 360. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.22 (br s, 1H), 8.58 (s, 1H), 7.99 (d, <i>J</i> = 2.6 Hz, 1H), 7.80 (d, <i>J</i> = 8.8 Hz, 1H), 7.53 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 1.68 (s, 6H).</div><div class="NLM_p">Step b. A mixture of 5-(((4-bromo-3-chlorophenyl)amino)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione (6.0 g, 16.64 mmol) and Dowtherm A (50 mL) was stirred at 245 °C for 20 min. The mixture was cooled to room temperature. Hexane (35 mL) was added and the solid was collected by filtration. The brown solid was a mixture of 6-bromo-5-chloroquinolin-4-ol compound and 6-bromo-7-chloroquinolin-4-ol (3.10 g, 5.70 mmol, 34% yield). HPLC <i>t</i><sub>R</sub> = 0.67 and 0.71 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>9</sub>H<sub>6</sub>BrClNO [M + H]<sup>+</sup>, 259.9; found, 260.</div><div class="NLM_p">Step c. A mixture of 6-bromo-5-chloroquinolin-4-ol compound and 6-bromo-7-chloroquinolin-4-ol (1:1) (200 mg, 0.387 mmol) and NCS (62.0 mg, 0.464 mmol) in acetonitrile (10 mL) and acetic acid (2 mL) was stirred at 90 °C for 18 h. The solid was collected by filtration, washed with acetonitrile, and dried under high vacuum to give a mixture of 6-bromo-3,5-dichloroquinolin-4-ol compound and 6-bromo-3,7-dichloroquinolin-4-ol (1:1) as a light brown solid. HPLC <i>t</i><sub>R</sub> = 0.76 and 0.79 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>9</sub>H<sub>5</sub>BrCl<sub>2</sub>NO [M + H]<sup>+</sup>, 291.9; found, 292.</div><div class="NLM_p">Step d. A mixture of 6-bromo-3,5-dichloroquinolin-4-ol and 6-bromo-3,7-dichloroquinolin-4-ol (1:1) and POCl<sub>3</sub> (0.721 mL, 7.74 mmol) was stirred at 90 °C for 60 min. The mixture was cooled to room temperature, concentrated, diluted with DCM (15 mL), and washed with a solution of saturated aqueous sodium bicarbonate (15 mL). The DCM layer was dried over sodium sulfate and concentrated. The crude product was subjected to flash chromatography (silica gel column, gradient elution from 0 to 100% of ethyl acetate in hexanes). The white solid was a 1:1 mixture of 6-bromo-3,4,5-trichloroquinoline compound and 6-bromo-3,4,7-trichloroquinoline (146 mg, 0.211 mmol, 55% yield). HPLC <i>t</i><sub>R</sub> = 1.13 and 1.27 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>9</sub>H<sub>4</sub>BrCl<sub>3</sub>N [M + H]<sup>+</sup>, 309.9; found, 310.</div><div class="NLM_p">Step e. To 6-bromo-3,4,5-trichloroquinoline and 6-bromo-3,4,7-trichloroquinoline (1:1) (70 mg, 0.112 mmol) was added 1-(2-fluorophenyl)ethanamine (46.9 mg, 0.337 mmol), (1<i>R</i>)-(−)-camphor-10-sulfonic acid (13.05 mg, 0.056 mmol), and anhydrous DMA (0.100 mL). The reaction mixture was stirred at 130 °C for 2.5 h and at 140 °C for 2 h. Another portion of 1-(2-fluorophenyl)ethanamine (46.9 mg, 0.337 mmol) and (1<i>R</i>)-(−)-camphor-10-sulfonic acid (13.05 mg, 0.056 mmol) was added, and the contents were stirred at 140 °C for 2 h. The reaction mixture was cooled to room temperature, and the crude product was purified by Prep-HPLC (column: Phenomenex, Luna 5 μm 30 × 250 mm; mobile phase A: 10:90 acetonitrile/water with 0.1% TFA; mobile phase B: 90:10 acetonitrile/water with 0.1% TFA; gradient: 20–100% B over 30 min; flow rate = 30 mL/min). Two peaks were isolated. <sup>1</sup>HNMR indicated the first eluted peak to be 6-bromo-3,7-dichloro-<i>N</i>-(1-(2-fluorophenyl)ethyl)quinolin-4-amine (12 mg, 0.028 mmol, 24.5% yield). HPLC <i>t</i><sub>R</sub> = 0.97 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>13</sub>BrCl<sub>2</sub>FN<sub>2</sub> [M + H]<sup>+</sup>, 413.0; found, 413. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.80 (s, 1H), 8.40 (s, 1H), 8.30 (s, 1H), 7.43–7.32 (m, 2H), 7.25–7.14 (m, 2H), 5.72 (q, <i>J</i> = 6.6 Hz, 1H), 1.87 (d, <i>J</i> = 6.6 Hz, 3H). The second eluted peak was 6-bromo-3,5-dichloro-<i>N</i>-(1-(2-fluorophenyl)ethyl)quinolin-4-amine (29 mg, 0.067 mmol, 59% yield). HPLC <i>t</i><sub>R</sub> = 1.03 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>13</sub>BrCl<sub>2</sub>FN<sub>2</sub> [M + H]<sup>+</sup>, 413.0; found, 413. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.64 (s, 1H), 8.04–7.99 (m, 1H), 7.98–7.91 (m, 1H), 7.33–7.21 (m, 2H), 7.16–7.00 (m, 2H), 5.83 (q, <i>J</i> = 6.6 Hz, 1H), 1.76 (d, <i>J</i> = 6.8 Hz, 3H).</div><div class="NLM_p">Step f (<b>32</b>). A mixture of 6-bromo-3,5-dichloro-<i>N</i>-(1-(2-fluorophenyl)ethyl)quinolin-4-amine (second eluted isomer; 9.0 mg, 0.022 mmol), 2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)propan-2-ol (5.74 mg, 0.022 mmol), 2 M aqueous solution of potassium phosphate tribasic (0.033 mL, 0.065 mmol), 1,1′-bis(di-<i>tert</i>-butylphosphino)ferrocene palladium dichloride (0.708 mg, 1.087 μmol), and dioxane (1.0 mL) was stirred at 60 °C in a sealed vial under a nitrogen atmosphere for 2 h. The reaction mixture was diluted with EtOAc (2 mL) and washed with a solution of saturated aqueous sodium bicarbonate (2 mL). The ethyl acetate layer was dried over sodium sulfate and concentrated. Prep-HPLC purification (Method F) gave 2-(5-(3,5-dichloro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>32</b>) (4.50 mg, 9.07 μmol, 42% yield). HPLC <i>t</i><sub>R</sub> 2.21 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>22</sub>Cl<sub>2</sub>FN<sub>4</sub>O [M + H]<sup>+</sup>, 471.1; found, 471.2. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.99 (s, 2H), 8.58 (s, 1H), 7.95 (d, <i>J</i> = 8.6 Hz, 1H), 7.79 (d, <i>J</i> = 8.6 Hz, 1H), 7.48 (t, <i>J</i> = 7.4 Hz, 1H), 7.27–7.16 (m, 1H), 7.15–6.97 (m, 2H), 6.55 (d, <i>J</i> = 9.8 Hz, 1H), 5.38 (dd, <i>J</i> = 9.5, 6.9 Hz, 1H), 5.27 (s, 1H), 1.66–1.52 (m, 9H).</div><div class="NLM_p last">Step g (<b>33</b>). This compound was synthesized according to the procedure outlined for step f for the synthesis of <b>32</b>, using the first eluted isomer from step e as the starting material. HPLC <i>t</i><sub>R</sub> 2.26 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>22</sub>Cl<sub>2</sub>FN<sub>4</sub>O [M + H]<sup>+</sup>, 471.1; found, 471.1. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.01 (s, 2H), 8.58 (s, 1H), 8.48 (s, 1H), 8.08 (s, 1H), 7.47 (t, <i>J</i> = 7.4 Hz, 1H), 7.29–7.19 (m, 1H), 7.17–7.04 (m, 2H), 6.88 (d, <i>J</i> = 8.4 Hz, 1H), 5.83 (t, <i>J</i> = 7.3 Hz, 1H), 5.28 (s, 1H), 1.66–1.51 (m, 9H).</div></div><div id="sec6_4_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 2-(5-(3,8-Dichloro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol, 2 TFA (<b>34</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0019.gif" alt="" id="dgr3" /></img>Step a. A mixture of 1-(2-fluorophenyl)ethylamine (3.79 g, 27.2 mmol), 6-bromo-4-chloroquinoline (2.2 g, 9.07 mmol), anhydrous DMA (2 mL), and (1<i>R</i>)-(−)-camphor-10-sulfonic acid (1.054 g, 4.54 mmol) was stirred at 140 °C under a nitrogen atmosphere for 3 h. The mixture was cooled, mixed with DCM, MeOH, and DBU (2.051 mL, 13.61 mmol). Flash chromatography purification (silica gel column, gradient elution from 0 to 100% of ethyl acetate in hexanes) afforded 6-bromo-<i>N</i>-(1-(2-fluorophenyl)ethyl)quinolin-4-amine (3.0 g, 8.69 mmol, 96% yield). HPLC <i>t</i><sub>R</sub> 0.76 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>15</sub>BrFN<sub>2</sub> [M + H]<sup>+</sup>, 345.0; found, 345.0.</div><div class="NLM_p">Step b. To a stirred solution of 6-bromo-<i>N</i>-(1-(2-fluorophenyl)ethyl)quinolin-4-amine (3 g, 8.69 mmol) in anhydrous DMF (10 mL) was added <i>N</i>-chlorosuccinimide (2.32 g, 17.38 mmol) portionwise at 0 °C. The mixture was stirred at RT overnight. More <i>N</i>-chlorosuccinimide (1.160 g, 8.69 mmol) was added and the mixture was stirred at RT for 1 day. The reaction mixture was concentrated to remove DMF, made basic using 1 M aqueous NaOH solution, and extracted with diethyl ether. The combined ether extracts were dried over anhydrous sodium sulfate and concentrated. Flash chromatography purification and trituration with Et<sub>2</sub>O gave 6-bromo-3,8-dichloro-<i>N</i>-(1-(2-fluorophenyl)ethyl)quinolin-4-amine (0.8 g, 1.546 mmol, 18% yield). The compound was used as such for the next step without further purification. HPLC <i>t</i><sub>R</sub> 1.05 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>13</sub>BrCl<sub>2</sub>FN<sub>2</sub> [M + H]<sup>+</sup>, 413.0; found, 412.9.</div><div class="NLM_p last">Step c. A mixture of 2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)propan-2-ol (11.48 mg, 0.043 mmol), 6-bromo-3,8-dichloro-<i>N</i>-(1-(2-fluorophenyl)ethyl)quinolin-4-amine (15 mg, 0.029 mmol), 2 M aqueous solution of K<sub>2</sub>CO<sub>3</sub> (43.5 μL, 0.087 mmol), dioxane (97 μL), and PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct (4.73 mg, 5.80 μmol) was purged with nitrogen. The vessel was sealed and stirred vigorously at 100 °C for 3 h. Prep-HPLC purification (Method E) gave 2-(5-(3,8-dichloro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>34</b>) as the bis TFA salt (6.0 mg, 8.58 μmol, 30% yield). HPLC <i>t</i><sub>R</sub> 2.20 min (Method D). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>22</sub>Cl<sub>2</sub>FN4O [M + H]<sup>+</sup>, 471.1; found, 471.2. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.27 (s, 2H), 8.69 (s, 1H), 8.55 (s, 1H), 8.38 (s, 1H), 7.53 (br t, <i>J</i> = 7.6 Hz, 1H), 7.30–7.05 (m, 6H), 6.94 (br d, <i>J</i> = 8.9 Hz, 1H), 5.83 (quin, <i>J</i> = 7.2 Hz, 1H), 1.67 (d, <i>J</i> = 6.6 Hz, 3H), 1.56 (s, 6H).</div></div><div id="sec6_4_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2-(5-(3-Chloro-7-fluoro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>35</b>)</h4><div class="NLM_p last">This compound was synthesized according to the procedure outlined for the synthesis of <b>33</b> using 4-bromo-3-fluoroaniline as the starting material. HPLC <i>t</i><sub>R</sub> = 2.14 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>22</sub>ClF<sub>2</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 455.2; found, 455.3. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.10 (s, 2H), 8.67 (d, <i>J</i> = 7.8 Hz, 1H), 8.47 (s, 1H), 7.77 (d, <i>J</i> = 11.5 Hz, 1H), 7.49 (t, <i>J</i> = 7.5 Hz, 1H), 7.30–7.20 (m, 1H), 7.17–7.05 (m, 2H), 6.87 (d, <i>J</i> = 8.6 Hz, 1H), 5.91–5.74 (m, 1H), 1.64 (d, <i>J</i> = 6.6 Hz, 3H), 1.57 (s, 6H).</div></div><div id="sec6_4_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 2-(5-(3-Chloro-8-fluoro-4-((1-(2-fluorophenyl)ethyl)amino)quinolin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>36</b>)</h4><div class="NLM_p last">This compound was synthesized according to the procedure outlined for the synthesis of <b>32</b> using 4-bromo-2-fluoroaniline as the starting material. HPLC <i>t</i><sub>R</sub> = 2.05 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>22</sub>ClF<sub>2</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 455.2; found, 454.8. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.25 (s, 2H), 8.60–8.43 (m, 2H), 8.07 (d, <i>J</i> = 11.4 Hz, 1H), 7.52 (t, <i>J</i> = 7.4 Hz, 1H), 7.29–7.20 (m, 1H), 7.18–7.05 (m, 2H), 6.90 (d, <i>J</i> = 8.6 Hz, 1H), 5.89–5.78 (m, 1H), 1.67 (d, <i>J</i> = 6.7 Hz, 3H), 1.56 (s, 6H).</div></div><div id="sec6_4_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 2-(5-(7-Chloro-8-((1-(2-fluorophenyl)ethyl)amino)-1,5-naphthyridin-2-yl)pyrimidin-2-yl)propan-2-ol, 2 TFA (<b>37</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0020.gif" alt="" id="dgr4" /></img>Step a. To a solution of 6-methoxypyridin-3-amine (11.7 g, 94 mmol) in ethanol (150 mL) were added 2,2-dimethyl-1,3-dioxane-4,6-dione (16.98 g, 118 mmol) and trimethyl orthoformate (15.83 mL, 95 mmol). The reaction mixture was refluxed for 2 h. After cooling to RT, the solids were filtered, washed with ethanol, and dried to give 5-(((6-methoxypyridin-3-yl)amino)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione (26.2 g, 94 mmol, 100% yield). HPLC <i>t</i><sub>R</sub> = 0.72 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>15</sub>N<sub>2</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 279.1; found, 279.1. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 11.19 (br d, <i>J</i> = 13.6 Hz, 1H), 8.50 (d, <i>J</i> = 14.2 Hz, 1H), 8.13 (d, <i>J</i> = 2.9 Hz, 1H), 7.52 (dd, <i>J</i> = 8.9, 2.9 Hz, 1H), 6.83 (d, <i>J</i> = 8.9 Hz, 1H), 3.97 (s, 3H), 1.77 (s, 6H).</div><div class="NLM_p">Step b. 5-(((6-Methoxypyridin-3-yl)amino)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione (23 g, 83 mmol) was added portionwise to refluxing diphenyl ether (230 mL) over 2 h. The reaction mixture was stirred for 30 min at the same temperature, cooled to RT, and ether (100 mL) was added. The solids were filtered, suspended in ether, and filtered to yield 6-methoxy-1,5-naphthyridin-4-ol (10.6 g, 60.2 mmol, 73% yield). HPLC <i>t</i><sub>R</sub> = 0.45 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>9</sub>H<sub>9</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 177.1; found, 177.0.</div><div class="NLM_p">Step c. To a mixture of 6-methoxy-1,5-naphthyridin-4-ol (10.6 g, 60.2 mmol) and NCS (8.7 g, 65.2 mmol) was added acetic acid (120 mL). The reaction mixture was stirred at 65 °C for 2 h and then cooled to RT. The solids were filtered, washed with water, and dried to give 3-chloro-6-methoxy-1,5-naphthyridin-4-ol (9 g, 42.7 mmol, 71% yield). HPLC <i>t</i><sub>R</sub> = 0.47 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>9</sub>H<sub>8</sub>ClN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 211.0; found, 211.0. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.34 (br s, 1H), 8.40 (br s, 1H), 7.99 (d, <i>J</i> = 8.7 Hz, 1H), 7.21 (d, <i>J</i> = 8.9 Hz, 1H), 3.96 (s, 3H).</div><div class="NLM_p">Step d. 3-Chloro-6-methoxy-1,5-naphthyridin-4-ol (1 g, 4.75 mmol) was added to a 100 mL flask, followed by POCl<sub>3</sub> (20 mL). The reaction mixture was stirred at 105 °C for 2 h. After cooling to 0 °C, water (20 mL) was added dropwise. The reaction mixture was heated at 105 °C for 30 min, cooled to 0 °C, and 30% aqueous NaOH solution was added slowly to adjust the pH to 7. The solids were collected by filtration, washed with water, and dried under vacuum to give 7,8-dichloro-1,5-naphthyridin-2-ol (1.9 g, 8.84 mmol, 93% yield). HPLC <i>t</i><sub>R</sub> = 0.64 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>8</sub>H<sub>5</sub>Cl<sub>2</sub>N<sub>2</sub>O [M + H]<sup>+</sup>, 215.0; found, 214.9. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.68 (br s, 1H), 8.63 (s, 1H), 7.99 (d, <i>J</i> = 9.2 Hz, 1H), 6.87 (d, <i>J</i> = 9.3 Hz, 1H).</div><div class="NLM_p">Step e. To a stirred solution of 7,8-dichloro-1,5-naphthyridin-2-ol (1 g, 4.65 mmol), 2,6-lutidine (0.9 mL, 7.77 mmol), and <i>N</i>,<i>N</i>-dimethylpyridin-4-amine (0.1 g, 0.819 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (10 mL) at 0 °C was added trifluoromethanesulfonic anhydride (1 mL, 5.94 mmol) dropwise. The reaction mixture was stirred at RT for 4 h and then poured into saturated aqueous NH<sub>4</sub>Cl solution (10 mL). The organic layer was separated, washed with water (10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash chromatography (silica gel column, gradient elution from 0 to 5% of MeOH in DCM) to give 7,8-dichloro-1,5-naphthyridin-2-yl trifluoromethanesulfonate (1.5 g, 4.32 mmol, 93% yield) as a white solid. HPLC <i>t</i><sub>R</sub> = 1.07 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>9</sub>H<sub>4</sub>Cl<sub>2</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 346.9; found, 346.9. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.01 (s, 1H), 8.63 (d, <i>J</i> = 8.9 Hz, 1H), 7.55 (d, <i>J</i> = 8.9 Hz, 1H).</div><div class="NLM_p">Step f. A mixture of 2-(5-bromopyrimidin-2-yl)propan-2-ol (0.275 g, 1.268 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (0.322 g, 1.268 mmol), potassium acetate (0.170 g, 1.729 mmol), 1,4-dioxane (10 mL), and [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) (0.084 g, 0.115 mmol) was purged with nitrogen and then stirred at 80 °C for 2 h. After cooling to RT, 7,8-dichloro-1,5-naphthyridin-2-yl trifluoromethanesulfonate (0.4 g, 1.152 mmol), potassium carbonate (0.398 g, 2.88 mmol), and water (0.5 mL, 27.8 mmol) were added. The reaction mixture was purged with nitrogen and then stirred at 100 °C for 2 h. After cooling to RT, the reaction mixture was diluted water (5 mL) and extracted with ethyl acetate (10 mL, 3 × 4 mL). The combined organic solutions were dried over sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by flash chromatography. The product obtained was crystalized using EtOAc/hexanes to give 2-(5-(7,8-dichloro-1,5-naphthyridin-2-yl)pyrimidin-2-yl)propan-2-ol (0.26 g, 0.776 mmol, 67% yield) as a solid. HPLC <i>t</i><sub>R</sub> = 0.92 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>15</sub>H<sub>13</sub>Cl<sub>2</sub>N<sub>4</sub>O [M + H]<sup>+</sup>, 335.1; found, 335.1.</div><div class="NLM_p last">Step g. A mixture of 1-(2-fluorophenyl)ethylamine (17.44 mg, 0.125 mmol), 2-(5-(7,8-dichloro-1,5-naphthyridin-2-yl)pyrimidin-2-yl)propan-2-ol (14 mg, 0.042 mmol), anhydrous DMA (0.05 mL), and (1<i>R</i>)-(−)-camphor-10-sulfonic acid (4.85 mg, 0.021 mmol) was stirred at 140 °C under a nitrogen atmosphere for 1.5 h. Prep-HPLC purification (Method E) gave 2-(5-(7-chloro-8-((1-(2-fluorophenyl)ethyl)amino)-1,5-naphthyridin-2-yl)pyrimidin-2-yl)propan-2-ol (<b>37</b>), as the bis TFA salt (6.1 mg, 0.00861 mmol, 21% yield). HPLC <i>t</i><sub>R</sub> = 2.11 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>22</sub>ClFN<sub>5</sub>O [M + H]<sup>+</sup>, 438.2; found, 437.8. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.56 (s, 2H), 8.60 (s, 1H), 8.47 (d, <i>J</i> = 8.9 Hz, 1H), 8.38 (d, <i>J</i> = 8.8 Hz, 1H), 7.72 (br d, <i>J</i> = 8.0 Hz, 1H), 7.45 (t, <i>J</i> = 7.3 Hz, 1H), 7.31–7.20 (m, 2H), 7.20–7.03 (m, 3H), 6.45–6.32 (m, 1H), 1.72 (d, <i>J</i> = 6.7 Hz, 3H), 1.56 (s, 6H).</div></div><div id="sec6_4_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 2-(5-(7-Chloro-8-((1-(2-fluorophenyl)ethyl)amino)-1,5-naphthyridin-2-yl)pyrimidin-2-yl)propan-2-ol (<b>38</b>) and (<b>39</b>)</h4><div class="NLM_p last">Free base <b>37</b> (20 mg) was subjected to chiral SFC separation [column: OJ-H (3 × 25 cm, 5 μm); mobile phase: CO<sub>2</sub>/MeOH (75/25) with 0.1% NH<sub>4</sub>OH; column temp.: 35 °C; flow rate: 180 mL/min; detector wavelength: 220 nm] to yield enantiomer 1 (<b>38</b>) (first eluted isomer; 7 mg) and enantiomer 2 (<b>39</b>) (second eluted isomer; 8 mg).</div></div><div id="sec6_4_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 2-(5-(3-Chloro-4-((1-(2-fluorophenyl)ethyl)amino)-1,7-naphthyridin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>40</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0021.gif" alt="" id="dgr5" /></img>Step a. Hexanes solution (2.5 M) of <i>n</i>-BuLi (38.5 mL, 96 mmol) was added to a stirred solution of TMEDA (15.02 mL, 100 mmol) and <i>tert</i>-butyl (6-methoxypyridin-3-yl)carbamate (7.2 g, 32.1 mmol) in anhydrous ether (170 mL) at −78 °C over 30 min. The reaction mixture was allowed to warm up to −10 °C and kept at −10 °C for 2 h, before being cooled back to −78 °C. <i>N</i>-Methoxy-<i>N</i>-methylacetamide (7.51 mL, 70.6 mmol) was added over 30 min at −78 °C. The reaction mixture was allowed to warm to 10 °C. Aqueous NH<sub>4</sub>Cl solution (200 mL) was added and the contents stirred at RT overnight. The reaction mixture was extracted with EtOAc (2 × 200 mL) and combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash chromatography (silica gel column, gradient from 0 to 20% of EtOAc in hexanes) to afford <i>tert</i>-butyl(4-acetyl-6-methoxypyridin-3-yl)carbamate (2.1 g, 7.89 mmol, 25% yield) as white solids. HPLC <i>t</i><sub>R</sub> 0.95 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>19</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 267.1; found, 267.1. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.59 (br s, 1H), 9.19 (s, 1H), 7.09 (s, 1H), 3.96 (s, 3H), 2.63 (s, 3H), 1.53 (s, 9H).</div><div class="NLM_p">Step b. DMF–DMA (1.282 mL, 9.58 mmol) was added to a solution of <i>tert</i>-butyl (4-acetyl-6-methoxypyridin-3-yl)carbamate (1.5 g, 5.63 mmol) in toluene (15 mL). The mixture was heated at 80 °C for 3 h, cooled to RT, and concentrated. Flash chromatography (silica gel column, gradient from 0 to 8% of MeOH in DCM) gave <i>tert</i>-butyl(4-(3-(dimethylamino)acryloyl)-6-methoxypyridin-3-yl)carbamate (1.4 g, 4.36 mmol, 77% yield) as a yellow solid. HPLC <i>t</i><sub>R</sub> 0.84 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 322.2; found, 322.3. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.49 (br s, 1H), 9.01 (s, 1H), 7.78 (br d, <i>J</i> = 12.2 Hz, 1H), 6.93 (s, 1H), 5.56 (d, <i>J</i> = 12.2 Hz, 1H), 3.94 (s, 3H), 3.20 (s, 3H), 2.94 (s, 3H), 1.50 (s, 9H).</div><div class="NLM_p">Step c. Methanol solution (0.5 M) of sodium methoxide (3.73 mL, 1.867 mmol) was added to a solution of <i>tert</i>-butyl (4-(3-(dimethylamino)acryloyl)-6-methoxypyridin-3-yl)carbamate (600 mg, 1.867 mmol) in methanol (10 mL) at RT. The reaction mixture was stirred at RT for 16 h. HCl solution (1 M, 1.867 mL, 1.867 mmol) was added, and the yellow solid that separated out was filtered and used as such for the subsequent step without further purification. HPLC <i>t</i><sub>R</sub> 0.46 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>9</sub>H<sub>9</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 177.1; found, 177.0. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.83 (br s, 1H), 8.75 (s, 1H), 7.97 (d, <i>J</i> = 7.3 Hz, 1H), 7.23 (d, <i>J</i> = 0.6 Hz, 1H), 6.03 (br d, <i>J</i> = 7.3 Hz, 1H), 3.91 (s, 3H).</div><div class="NLM_p">Step d. To a mixture of 6-methoxy-1,7-naphthyridin-4-ol (360 mg, 2.043 mmol) and NCS (297 mg, 2.227 mmol) was added acetic acid (5 mL). The reaction mixture was stirred at 65 °C for 2 h, cooled to RT, filtered, and the solid was washed with water and dried (350 mg, 1.662 mmol, 81% yield). HPLC <i>t</i><sub>R</sub> 0.52 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>9</sub>H<sub>8</sub>ClN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 211.0; found, 211.0. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.60 (br s, 1H), 8.78 (s, 1H), 8.48 (s, 1H), 7.28 (s, 1H), 3.93 (s, 3H).</div><div class="NLM_p">Step e. 3-Chloro-6-methoxy-1,7-naphthyridin-4-ol (650 mg, 3.09 mmol) was added to a 100 mL flask, followed by POCl<sub>3</sub> (3 mL). The reaction mixture was stirred at 105 °C for 2 h. POCl<sub>3</sub> was removed under reduced pressure and the residue was diluted with DCM (10 mL) and saturated aqueous NaHCO<sub>3</sub> (10 mL). The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by flash chromatography (silica gel column, gradient from 0 to 20% of EtOAc in hexanes) to give 3,4-dichloro-6-methoxy-1,7-naphthyridine (600 mg, 2.62 mmol, 85% yield) as a white solid. HPLC <i>t</i><sub>R</sub> 0.97 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>9</sub>H<sub>7</sub>Cl<sub>2</sub>N<sub>2</sub>O [M + H]<sup>+</sup>, 229.0; found, 228.9. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.26 (s, 1H), 8.75 (s, 1H), 7.33 (d, <i>J</i> = 0.7 Hz, 1H), 4.12 (s, 3H).</div><div class="NLM_p">Step f. A mixture of 1-(2-fluorophenyl)ethanamine (365 mg, 2.62 mmol), 3,4-dichloro-6-methoxy-1,7-naphthyridine (200 mg, 0.873 mmol), (1<i>R</i>)-(−)-camphor-10-sulfonic acid (101 mg, 0.437 mmol), and anhydrous DMA (0.3 mL) was stirred at 140 °C under a nitrogen atmosphere for 3 h. After cooling to RT, the reaction was diluted with DCM (5 mL) and water (5 mL). The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by flash chromatography (silica gel column, gradient from 0 to 20% of EtOAc in hexanes) to give 3-chloro-<i>N</i>-(1-(2-fluorophenyl)ethyl)-6-methoxy-1,7-naphthyridin-4-amine (180 mg, 0.543 mmol, 62% yield). HPLC <i>t</i><sub>R</sub> 0.83 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>16</sub>ClFN<sub>3</sub>O [M + H]<sup>+</sup>, 332.1; found, 332.1.</div><div class="NLM_p">Step g. 3-Chloro-<i>N</i>-(1-(2-fluorophenyl)ethyl)-6-methoxy-1,7-naphthyridin-4-amine (30 mg, 0.090 mmol) was dissolved in DMF (1 mL). PBr<sub>3</sub> (0.05 mL) was added at RT. The mixture was stirred at 60 °C for 1 h and at 80 °C for 2 h. After cooling to 0 °C, water (2 mL) was added to quench the reaction, and the residue was extracted with DCM (3 × 10 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and purified by flash chromatography (silica gel column, gradient from 0 to 100% of EtOAc in hexanes) to give 3-chloro-4-((1-(2-fluorophenyl)ethyl)amino)-1,7-s, 52% yield) as a yellow solid. HPLC <i>t</i><sub>R</sub> 0.73 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>14</sub>ClFN<sub>3</sub>O [M + H]<sup>+</sup>, 318.1; found, 318.1. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.84 (s, 1H), 8.42 (s, 1H), 7.36–7.20 (m, 2H), 7.13–7.03 (m, 3H), 5.46 (dq, <i>J</i> = 9.5, 6.7 Hz, 1H), 5.04 (br d, <i>J</i> = 9.5 Hz, 1H), 1.71 (d, <i>J</i> = 6.7 Hz, 3H).</div><div class="NLM_p">Step h. To a stirred solution of 3-chloro-4-((1-(2-fluorophenyl)ethyl)amino)-1,7-naphthyridin-6-ol (90 mg, 0.283 mmol) in anhydrous DCM (5 mL) at 0 °C was added triethylamine (0.205 mL, 1.416 mmol), followed by trifluoromethanesulfonic anhydride (0.048 mL, 0.283 mmol). The reaction mixture was stirred for 0.5 h and then quenched with aqueous NH<sub>4</sub>Cl solution (2 mL). The organic layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated. The residue was purified by flash chromatography (silica gel column, gradient from 0 to 20% of EtOAc in hexanes) to give 3-chloro-4-((1-(2-fluorophenyl)ethyl)amino)-1,7-naphthyridin-6-yl trifluoromethanesulfonate (110 mg, 0.245 mmol, 86% yield) as colorless oil. HPLC <i>t</i><sub>R</sub> 1.11 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>13</sub>ClF<sub>4</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 450.0; found, 450.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.14 (s, 1H), 8.73 (s, 1H), 7.62 (s, 1H), 7.37–7.28 (m, 2H), 7.17–7.08 (m, 2H), 5.42–5.30 (m, 2H), 1.75 (d, <i>J</i> = 6.1 Hz, 3H).</div><div class="NLM_p last">Step i. 3-Chloro-4-((1-(2-fluorophenyl)ethyl)amino)-1,7-naphthyridin-6-yl trifluoromethanesulfonate (22 mg, 0.049 mmol) and 2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)propan-2-ol (14.21 mg, 0.054 mmol) were dissolved in DMF (0.5 mL). The PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct (2.396 mg, 2.93 μmol) and 2 M aqueous solution of Na<sub>2</sub>CO<sub>3</sub> (0.024 mL, 0.049 mmol) were added, and the reaction mixture was purged with argon. The contents were sealed in a pressure vial and stirred at 90 °C for 30 min. After cooling to RT, the reaction was diluted with MeOH (1.5 mL). Prep-HPLC purification (Method F) gave 2-(5-(3-chloro-4-((1-(2-fluorophenyl)ethyl)amino)-1,7-naphthyridin-6-yl)pyrimidin-2-yl)propan-2-ol (<b>40</b>) (9.2 mg, 0.021 mmol, 43% yield). HPLC <i>t</i><sub>R</sub> = 1.98 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>22</sub>ClFN<sub>5</sub>O [M + H]<sup>+</sup>, 438.2; found, 438.2. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.51 (s, 2H), 9.30 (s, 1H), 8.90 (s, 1H), 8.54 (s, 1H), 7.48 (t, <i>J</i> = 7.8 Hz, 1H), 7.25 (q, <i>J</i> = 6.3 Hz, 1H), 7.14–7.10 (m, 2H), 7.01 (br d, <i>J</i> = 8.4 Hz, 1H), 5.92 (quin, <i>J</i> = 7.0 Hz, 1H), 5.24 (s, 1H), 1.69 (br d, <i>J</i> = 6.6 Hz, 3H), 1.56 (s, 6H).</div></div><div id="sec6_4_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 2-(5-(6-Chloro-5-((1-(2-fluorophenyl)ethyl)amino)-1,8-naphthyridin-3-yl)pyrimidin-2-yl)propan-2-ol (<b>41</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0022.gif" alt="" id="dgr6" /></img>Step a. To a mixture of 6-bromo-1,8-naphthyridin-4-ol (110 mg, 0.489 mmol) (<i>ACS Med. Chem. Lett.</i><b>2015,</b><i>6,</i> 434–438) and NCS (71.1 mg, 0.533 mmol) was added acetic acid (3 mL). The reaction mixture was stirred at 65 °C for 2 h. The contents were cooled to RT and filtered. The solids were washed with water and dried to give 6-bromo-3-chloro-1,8-naphthyridin-4-ol (80 mg, 0.308 mmol, 63% yield). HPLC <i>t</i><sub>R</sub> 0.61 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>8</sub>H<sub>5</sub>BrClN<sub>2</sub>O [M + H]<sup>+</sup>, 260.9; found, 260.9. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.94 (br s, 1H), 8.91 (d, <i>J</i> = 2.6 Hz, 1H), 8.62 (d, <i>J</i> = 2.4 Hz, 1H), 8.47 (s, 1H).</div><div class="NLM_p">Step b. A mixture of 6-bromo-3-chloro-1,8-naphthyridin-4-ol (80 mg, 0.308 mmol) and POCl<sub>3</sub> (0.5 mL) was stirred at 105 °C under a nitrogen atmosphere for 1.5 h. The mixture was concentrated at reduced pressure. The residue was mixed with ice and then made basic with concentrated ammonium hydroxide. The mixture was stirred at 0 °C for 30 min. The solid was filtered and washed with water to give 6-bromo-3,4-dichloro-1,8-naphthyridine (60 mg, 0.216 mmol, 70% yield) as a solid. HPLC <i>t</i><sub>R</sub> 0.88 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>8</sub>H<sub>4</sub>BrCl<sub>2</sub>N<sub>2</sub> [M + H]<sup>+</sup>, 278.9; found, 278.9. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.17 (d, <i>J</i> = 2.3 Hz, 1H), 9.11 (s, 1H), 8.77 (d, <i>J</i> = 2.4 Hz, 1H).</div><div class="NLM_p">Step c. A mixture of 1-(2-fluorophenyl)ethanamine (75 mg, 0.540 mmol), 6-bromo-3,4-dichloro-1,8-naphthyridine (50 mg, 0.180 mmol), (1<i>R</i>)-(−)-camphor-10-sulfonic acid (20.90 mg, 0.090 mmol), and anhydrous DMA (0.2 mL) was stirred at 140 °C under a nitrogen atmosphere for 3 h. After cooling to RT, the reaction was diluted with DCM (5 mL) and water (5 mL). The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by flash chromatography (silica gel column, gradient elution from 0 to 50% of ethyl acetate in hexanes) to give 6-bromo-3-chloro-<i>N</i>-(1-(2-fluorophenyl)ethyl)-1,8-naphthyridin-4-amine (60 mg, 0.158 mmol, 88% yield). HPLC <i>t</i><sub>R</sub> 0.74 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>13</sub>BrClFN<sub>3</sub> [M + H]<sup>+</sup>, 382.0; found, 381.9. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.97 (d, <i>J</i> = 2.3 Hz, 1H), 8.80 (s, 1H), 8.47 (d, <i>J</i> = 2.3 Hz, 1H), 7.41–7.25 (m, 2H), 7.18–7.04 (m, 2H), 5.38–5.20 (m, 2H), 1.74 (d, <i>J</i> = 6.4 Hz, 3H).</div><div class="NLM_p last">Step d. A mixture of 2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)propan-2-ol (20.61 mg, 0.078 mmol), 6-bromo-3-chloro-<i>N</i>-(1-(2-fluorophenyl)ethyl)-1,8-naphthyridin-4-amine (27 mg, 0.071 mmol), 2 M aqueous solution of K<sub>2</sub>CO<sub>3</sub> (0.089 mL, 0.177 mmol), and dioxane (0.3 mL) was purged with nitrogen before PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct (8.69 mg, 10.64 μmol) was added. The contents were purged with nitrogen again. The reaction vessel was sealed, and the mixture was vigorously stirred at 100 °C for 3 h. After cooling to RT, the reaction mixture was diluted with MeOH (1.5 mL). Prep-HPLC purification (Method F) gave 2-(5-(6-chloro-5-((1-(2-fluorophenyl)ethyl)amino)-1,8-naphthyridin-3-yl)pyrimidin-2-yl)propan-2-ol (<b>41</b>) (16.4 mg, 0.037 mmol, 52% yield). HPLC <i>t</i><sub>R</sub> 1.77 min (Method A). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>22</sub>ClFN<sub>5</sub>O [M + H]<sup>+</sup>, 438.2; found, 438.2. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.40 (d, <i>J</i> = 1.8 Hz, 1H), 9.33 (s, 2H), 9.21 (d, <i>J</i> = 2.1 Hz, 1H), 8.61 (s, 1H), 7.51 (t, <i>J</i> = 7.2 Hz, 1H), 7.32–7.21 (m, 1H), 7.18–7.08 (m, 2H), 7.02 (d, <i>J</i> = 8.5 Hz, 1H), 5.98–5.85 (m, 1H), 5.21 (s, 1H), 1.69 (d, <i>J</i> = 6.7 Hz, 3H), 1.58 (s, 6H).</div></div><div id="sec6_4_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (<i>R</i>)-3-(1-((3-Chloro-7-fluoro-6-(2-(2-hydroxypropan-2-yl)pyrimidin-5-yl)-2-methyl-1,5-naphthyridin-4-yl)amino)ethyl)-4-fluorobenzonitrile (<b>42</b>)</h4><div class="NLM_p">A toluene (80 mL) suspension of 6-bromo-5-fluoropyridin-3-amine (<b>46</b>) (12 g, 62.8 mmol), ethyl 3-oxobutanoate (<b>47</b>) (8.02 mL, 62.8 mmol), and acetic acid (0.279 g, 4.65 mmol) was heated to reflux for 4 h using a Dean–Stark trap. After cooling to RT, the reaction mixture was filtered through a short bed of celite. The bed was washed with EtOAc (200 mL). The filtrate was concentrated, and the residue purified by flash chromatography (silica gel column, gradient from 0 to 20% of EtOAc in hexanes) to give ethyl 3-((6-bromo-5-fluoropyridin-3-yl)amino)but-2-enoate (<b>48</b>) (8 g, 26.4 mmol, 42% yield) as a white solid. HPLC <i>t</i><sub>R</sub> 1.03 min (Method B). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>11</sub>H<sub>13</sub>BrFN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 305.0; found, 305.1. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.58 (br s, 1H), 8.04 (d, <i>J</i> = 2.4 Hz, 1H), 7.18 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), 4.87 (d, <i>J</i> = 0.6 Hz, 1H), 4.17 (q, <i>J</i> = 7.2 Hz, 2H), 2.09 (s, 3H), 1.30 (t, <i>J</i> = 7.1 Hz, 3H).</div><div class="NLM_p">Ethyl 3-((6-bromo-5-fluoropyridin-3-yl)amino)but-2-enoate (<b>48</b>) (8 g, 26.4 mmol) was dissolved in diphenyl ether (80 mL) at RT and heated to 250 °C for 0.5 h until a thick suspension was formed. After cooling to RT, the suspension was filtered. The solid was washed with ether (2 × 10 mL) and then dried in vacuo to obtain 6-bromo-7-fluoro-2-methyl-1,5-naphthyridin-4-ol (<b>49</b>) (5.3 g, 20.62 mmol, 78% yield). HPLC <i>t</i><sub>R</sub> 1.10 min (Method B) LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>9</sub>H<sub>7</sub>BrFN<sub>2</sub>O [M + H]<sup>+</sup>, 259.0; found, 259.0. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.91 (br s, 1H), 7.81 (d, <i>J</i> = 8.4 Hz, 1H), 6.13 (s, 1H), 2.35 (s, 3H).</div><div class="NLM_p">To a mixture of 6-bromo-7-fluoro-2-methyl-1,5-naphthyridin-4-ol (<b>49</b>) (5.3 g, 20.62 mmol) and NCS (3.03 g, 22.68 mmol) was added acetic acid (100 mL). The reaction mixture was stirred at 65 °C for 2 h, cooled to RT, and filtered. The solid was washed with water and dried to yield 6-bromo-3-chloro-7-fluoro-2-methyl-1,5-naphthyridin-4-ol (4.3 g, 14.75 mmol, 72% yield). HPLC <i>t</i><sub>R</sub> 0.56 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>9</sub>H<sub>6</sub>BrClFN<sub>2</sub>O [M + H]<sup>+</sup>, 290.9; found, 290.9. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.49 (br s, 1H), 7.88 (d, <i>J</i> = 8.2 Hz, 1H), 2.53 (s, 3H).</div><div class="NLM_p">6-Bromo-3-chloro-7-fluoro-2-methyl-1,5-naphthyridin-4-ol (4.3 g, 14.75 mmol) was added to a 250 mL flask, followed by POCl<sub>3</sub> (40 mL). The reaction mixture was stirred at 105 °C for 2 h and then cooled to RT. POCl<sub>3</sub> was removed under reduced pressure. The residue was diluted with water (20 mL). Aqueous NaOH solution (1 N) was added to adjust the pH to 6. The slurry was stirred at RT for 1 h and filtered. Flash chromatography (silica gel column, gradient from 0 to 20% of EtOAc in hexanes) gave 6-bromo-3,4-dichloro-7-fluoro-2-methyl-1,5-naphthyridine (<b>50</b>) (3.1 g, 10.00 mmol, 68% yield) as a grey solid. HPLC <i>t</i><sub>R</sub> 1.05 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>9</sub>H<sub>5</sub>BrCl<sub>2</sub>FN<sub>2</sub> [M + H]<sup>+</sup>, 310.9; found, 310.6. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.03 (d, <i>J</i> = 7.8 Hz, 1H), 2.87 (s, 3H).</div><div class="NLM_p">A mixture of 2-(5-bromopyrimidin-2-yl)propan-2-ol (<b>43</b>) (2.7 g, 12.44 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (3.79 g, 14.93 mmol), potassium acetate (1.831 g, 18.66 mmol), and 1,4-dioxane (80 mL) was purged with nitrogen before a PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct (0.636 g, 1.244 mmol) was added. The mixture was purged with nitrogen again and then heated at 80 °C for 3 h. After cooling to RT, 6-bromo-3,4-dichloro-7-fluoro-2-methyl-1,5-naphthyridine (<b>50</b>) (3.08 g, 9.95 mmol), and potassium carbonate (2 M aqueous solution) (12.44 mL, 24.88 mmol) were added to the reaction. The reaction mixture was purged with nitrogen and then heated at 100 °C for 3 h. After cooling to RT, the reaction mixture was diluted with EtOAc (100 mL) and water (60 mL). The organic layer was separated, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by flash chromatography (silica gel column, gradient from 0 to 50% of EtOAc in hexanes) to give a brown solid. The crude product was triturated with MeOH (20 mL) to afford 2-(5-(7,8-dichloro-3-fluoro-6-methyl-1,5-naphthyridin-2-yl)pyrimidin-2-yl)propan-2-ol (<b>51</b>) (2.0 g, 5.45 mmol, 44% yield) as a pink solid. HPLC <i>t</i><sub>R</sub> = 1.01 min (Method C). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>14</sub>Cl<sub>2</sub>FN<sub>4</sub>O [M + H]<sup>+</sup>, 367.1; found, 367.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.55 (d, <i>J</i> = 1.3 Hz, 2H), 8.14 (d, <i>J</i> = 11.0 Hz, 1H), 4.69 (s, 1H), 2.91 (s, 3H), 1.69 (s, 6H).</div><div class="NLM_p last">A mixture of (<i>R</i>)-3-(1-aminoethyl)-4-fluorobenzonitrile (<b>52</b>) (0.676 g, 4.12 mmol), 2-(5-(7,8-dichloro-3-fluoro-6-methyl-1,5-naphthyridin-2-yl)pyrimidin-2-yl)propan-2-ol (<b>51</b>) (1.26 g, 3.43 mmol), cesium carbonate (1.677 g, 5.15 mmol), tris(dibenzylideneacetone)dipalladium(0) (0.314 g, 0.343 mmol), 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (0.427 g, 0.686 mmol), and anhydrous toluene (49.0 mL) was purged with nitrogen. The reaction mixture was stirred at 100 °C under a nitrogen atmosphere for 4 h. After cooling to RT, the solids were filtered off. The filtrate was concentrated and the residue was purified by flash chromatography (silica gel column, gradient from 0 to 50% of EtOAc in hexanes) to give (<i>R</i>)-3-(1-((3-chloro-7-fluoro-6-(2-(2-hydroxypropan-2-yl)pyrimidin-5-yl)-2-methyl-1,5-naphthyridin-4-yl)amino)ethyl)-4-fluorobenzonitrile (<b>42</b>) (1.45 g, 2.87 mmol, 84% yield) as a yellow solid. HPLC <i>t</i><sub>R</sub> = 2.14 min (Method D). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>22</sub>ClF<sub>2</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, 495.2; found, 495.3. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>22</sub>ClF<sub>2</sub>N<sub>6</sub>O [M + H]<sup>+</sup>, 495.1506; found, 495.1507. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.21 (s, 2H), 8.20 (d, <i>J</i> = 11.6 Hz, 1H), 8.02 (dd, <i>J</i> = 7.0, 2.0 Hz, 1H), 7.78 (ddd, <i>J</i> = 8.5, 4.8, 2.1 Hz, 1H), 7.26 (dd, <i>J</i> = 10.1, 8.7 Hz, 1H), 7.02 (br d, <i>J</i> = 8.6 Hz, 1H), 6.31 (quin, <i>J</i> = 7.1 Hz, 1H), 5.20 (s, 1H), 2.64 (s, 3H), 1.65 (d, <i>J</i> = 6.8 Hz, 3H), 1.58 (s, 6H).</div></div><div id="sec6_4_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Synthesis of Probe Compound for the HTRF Assay—5-(3-Chloro-4-((2,5-dimethylphenyl)amino)-2-methylquinolin-6-yl)-<i>N</i>-(4-(3′,6′-dihydroxy-3-oxo-3<i>H</i>-spiro[isobenzofuran-1,9′-xanthene]-5-carboxamido)butyl)picolinamide (<b>53</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0023.gif" alt="" id="dgr7" /></img>Step a. <i>N</i>-Chlorosuccinimide (1.7 g, 12.9 mmol) was added to an acetonitrile (120 mL)/acetic acid (6.00 mL) suspension of 6-bromo-2-methylquinolin-4-ol (3 g, 12.6 mmol) at 80 °C in small portions, under a nitrogen atmosphere, over 1 h. The resulting mixture was heated at 80 °C for an additional 3 h. After cooling to room temperature, the suspension was filtered. The solids were washed with acetonitrile (2 × 50 mL) and dried under vacuum to give 6-bromo-3-chloro-2-methylquinolin-4-ol (3.13 g, 11.48 mmol, 91% yield) as a white solid. HPLC <i>t</i><sub>R</sub> = 0.67 min (Method C, see <a class="ref internalNav" href="#sec6" aria-label="Experimental Section">Experimental Section</a>). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>10</sub>H<sub>8</sub>BrClNO [M + H]<sup>+</sup>, 274.0; found, 274.0. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.29 (br s, 1H), 8.18 (d, <i>J</i> = 2.3 Hz, 1H), 7.82 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 7.53 (d, <i>J</i> = 8.8 Hz, 1H), 2.52 (s, 3H).</div><div class="NLM_p">Step b. A stirred POCl<sub>3</sub> (10.7 mL, 115 mmol) suspension of 6-bromo-3-chloro-2-methylquinolin-4-ol (3.13 g, 11.5 mmol) was heated to 100 °C for 3 h. After cooling to room temperature, the resulting suspension was added dropwise to ice-cold water (200 mL). Additional ice was added to the aqueous suspension to prevent overheating. Solid K<sub>2</sub>CO<sub>3</sub> (20 g, 145 mmol) was added in small portions. The resulting suspension was filtered. The solids were washed with water (20 mL) and then dried under vacuum to give 6-bromo-3,4-dichloro-2-methylquinoline (3.04 g, 10.45 mmol, 91% yield) as a white solid. HPLC <i>t</i><sub>R</sub> = 1.18 min (Method C, see <a class="ref internalNav" href="#sec6" aria-label="Experimental Section">Experimental Section</a>). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>10</sub>H<sub>7</sub>BrCl<sub>2</sub>N [M + H]<sup>+</sup>, 291.9; found, 292.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.32 (d, <i>J</i> = 2.1 Hz, 1H), 7.93–7.87 (m, 1H), 7.83–7.77 (m, 1H), 2.84 (s, 3H).</div><div class="NLM_p">Step c. A mixture of 6-bromo-3,4-dichloro-2-methylquinoline (0.51 g, 1.753 mmol), (1<i>R</i>)-(−)-camphor-10-sulfonic acid (0.204 g, 0.876 mmol), and 2,5-dimethylaniline (0.657 mL, 5.26 mmol) was stirred at 140 °C under a nitrogen atmosphere for 3 h and cooled. DCM and DBU (0.396 mL, 2.63 mmol) were added. Flash chromatography purification (silica gel column, gradient elution from 10 to 40% of ethyl acetate in hexanes) afforded a solid. The solid was triturated with a mixture of EtOAc and hexanes to give 6-bromo-3-chloro-<i>N</i>-(2,5-dimethylphenyl)-2-methylquinolin-4-amine (0.50 g, 1.32 mmol, 75% yield). HPLC <i>t</i><sub>R</sub> = 0.84 min (Method C, see <a class="ref internalNav" href="#sec6" aria-label="Experimental Section">Experimental Section</a>). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>18</sub>H<sub>17</sub>BrClN<sub>2</sub> [M + H]<sup>+</sup>, 375.0; found, 375.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>): δ 7.81 (d, <i>J</i> = 8.9 Hz, 1H), 7.66–7.60 (m, 1H), 7.58 (d, <i>J</i> = 2.0 Hz, 1H), 7.16 (d, <i>J</i> = 7.7 Hz, 1H), 6.88 (d, <i>J</i> = 7.8 Hz, 1H), 6.44 (s, 1H), 6.22 (s, 1H), 2.79 (s, 3H), 2.35 (s, 3H), 2.15 (s, 3H).</div><div class="NLM_p">Step d. 6-Bromo-3-chloro-<i>N</i>-(2,5-dimethylphenyl)-2-methylquinolin-4-amine (100 mg, 0.266 mmol), 6-(methoxycarbonyl)pyridine-3-boronic acid pinacol ester (84 mg, 0.319 mmol), and 2 M aqueous K<sub>2</sub>CO<sub>3</sub> (333 μL, 0.665 mmol) were mixed with dioxane (887 μL). The mixture was purged with nitrogen before the PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct (32.6 mg, 0.040 mmol) was added. The mixture was purged with nitrogen again and the vessel was sealed. The contents were vigorously stirred at 100 °C for 3 h. Aqueous NaOH solution (30%, 400 mg, 3.00 mmol) was added, and the mixture was stirred at 40 °C for 1 h. Water (3 mL) was added followed by AcOH at RT to neutralize the reaction mixture. The solid was filtered and washed with water and then EtOAc to give 5-(3-chloro-4-((2,5-dimethylphenyl)amino)-2-methylquinolin-6-yl)picolinic acid (126 mg, 0.302 mmol) as a greenish yellow solid. HPLC <i>t</i><sub>R</sub> = 0.68 min (Method C, see <a class="ref internalNav" href="#sec6" aria-label="Experimental Section">Experimental Section</a>). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>21</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 418.1; found, 418.1. The compound was used as such for the subsequent step without further purification.</div><div class="NLM_p">Step e. To a stirred solution of 5-(3-chloro-4-((2,5-dimethylphenyl)amino)-2-methylquinolin-6-yl)picolinic acid (70 mg, 0.168 mmol), <i>tert</i>-butyl <i>N</i>-(4-aminobutyl)carbamate (0.064 mL, 0.335 mmol), and DIEA (0.117 mL, 0.670 mmol) in anhydrous DCM (2 mL) was added BOP (148 mg, 0.335 mmol) at RT. The mixture was stirred at RT for 3 h. Saturated aqueous sodium bicarbonate solution (2 mL) was added to quench the reaction. The aqueous layer was separated and extracted with ethyl acetate (3 × 1 mL). The combined organic solutions were dried over sodium sulfate, filtered, and concentrated under reduced pressure. Flash chromatography (silica gel column, gradient elution from 20 to 100% of ethyl acetate in hexanes) gave <i>tert</i>-butyl (4-(5-(3-chloro-4-((2,5-dimethylphenyl)amino)-2-methylquinolin-6-yl)picolinamido)butyl)carbamate (75 mg, 0.128 mmol, 76% yield) as a solid. HPLC <i>t</i><sub>R</sub> = 0.85 min (Method C, see <a class="ref internalNav" href="#sec6" aria-label="Experimental Section">Experimental Section</a>). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>33</sub>H<sub>39</sub>ClN<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 588.3; found, 588.3.</div><div class="NLM_p">Step f. A mixture of <i>tert</i>-butyl(4-(5-(3-chloro-4-((2,5-dimethylphenyl)amino)-2-methylquinolin-6-yl)picolinamido)butyl)carbamate (72 mg, 0.122 mmol) and TFA (1 mL) was stirred at RT for 1 h. Dichloroethane (1 mL) was added and the solvents were removed in vacuo. The residue was dissolved in MeOH. 1 N aqueous solution of HCl (0.245 mL, 0.245 mmol) was added. Lyophilization gave <i>N</i>-(4-aminobutyl)-5-(3-chloro-4-((2,5-dimethylphenyl)amino)-2-methylquinolin-6-yl)picolinamide (88 mg, 0.124 mmol, TFA/HCl salt) as a solid. HPLC <i>t</i><sub>R</sub> = 0.63 min (Method C, see <a class="ref internalNav" href="#sec6" aria-label="Experimental Section">Experimental Section</a>). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>31</sub>ClN<sub>5</sub>O [M + H]<sup>+</sup>, 488.2; found, 488.2. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.48 (d, <i>J</i> = 2.2 Hz, 1H), 8.26 (dd, <i>J</i> = 8.9, 1.8 Hz, 1H), 8.09 (d, <i>J</i> = 7.9 Hz, 1H), 8.01 (d, <i>J</i> = 8.8 Hz, 1H), 7.82–7.77 (m, 2H), 7.41–7.38 (m, 1H), 7.36–7.33 (m, 1H), 7.24 (s, 1H), 3.53–3.47 (m, 2H), 3.05–2.96 (m, 2H), 2.91 (s, 3H), 2.36 (s, 3H), 2.23 (s, 3H), 1.79–1.70 (m, 4H).</div><div class="NLM_p last">Step g. To a stirred solution <i>N</i>-(4-aminobutyl)-5-(3-chloro-4-((2,5-dimethylphenyl)amino)-2-methylquinolin-6-yl)picolinamide (45 mg, 0.067 mmol, HCl/TFA salt) and DIEA (0.047 mL, 0.267 mmol) in anhydrous THF (5 mL) were added 5-carboxyfluorescein <i>N</i>-succinimidyl ester (31.6 mg, 0.067 mmol) at RT, followed by anhydrous DMF (2 mL). The suspension was stirred at RT for 3 h. The clear solution obtained was concentrated to remove THF. The residue was dissolved in MeOH and purified using Prep-HPLC [column: Phen Luna S5 ODS C<sub>18</sub> 21.2 × 100 mm; mobile phase A: 5:95 acetonitrile/water with 10 mM ammonium acetate; mobile phase B: 95:5 acetonitrile/water with 10 mM ammonium acetate; gradient flow rate 20 mL/min; detection: UV (220 nm)]. Fractions containing the desired product were combined and concentrated. Lyophilization gave 5-(3-chloro-4-((2,5-dimethylphenyl)amino)-2-methylquinolin-6-yl)-<i>N</i>-(4-(3′,6′-dihydroxy-3-oxo-3<i>H</i>-spiro[isobenzofuran-1,9′-xanthen]-5-ylcarboxamido)butyl)picolinamide (<b>53</b>) (27 mg, 0.031 mmol, 46% yield) as a yellow solid. HPLC <i>t</i><sub>R</sub> = 1.01 min (Method B). LCMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>49</sub>H<sub>41</sub>ClN<sub>5</sub>O<sub>7</sub> [M + H]<sup>+</sup>, 846.3; found, 846.5. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.49 (d, <i>J</i> = 1.6 Hz, 1H), 8.45 (d, <i>J</i> = 1.1 Hz, 1H), 8.12 (d, <i>J</i> = 7.5 Hz, 1H), 8.06 (d, <i>J</i> = 7.7 Hz, 1H), 7.99–7.92 (m, 2H), 7.82 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 7.78 (s, 1H), 7.29 (d, <i>J</i> = 7.6 Hz, 1H), 7.22 (d, <i>J</i> = 8.0 Hz, 1H), 7.04 (d, <i>J</i> = 8.4 Hz, 1H), 6.81–6.73 (m, 3H), 6.68 (d, <i>J</i> = 2.3 Hz, 2H), 6.56 (dd, <i>J</i> = 8.9, 2.3 Hz, 2H), 3.51 (br d, <i>J</i> = 3.2 Hz, 4H), 2.78 (s, 3H), 2.23 (s, 3H), 2.20 (s, 3H), 1.77 (br s, 4H).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01732" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21527" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21527" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01732?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01732</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Description of mouse TNFα induced PK–PD model, CAIA model, protein expression, purification and crystallization, X-ray crystal structure data collection and structure refinement and analytical data for representative compounds, and SMILES representation of compounds with key data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01732/suppl_file/jm0c01732_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01732/suppl_file/jm0c01732_si_002.xlsx" class="ext-link">XLSX</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01732/suppl_file/jm0c01732_si_001.pdf">jm0c01732_si_001.pdf (742.63 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01732/suppl_file/jm0c01732_si_002.xlsx">jm0c01732_si_002.xlsx (51.1 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01732" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86246" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86246" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hai-Yun Xiao</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1f777e76666a713167767e705f7d726c317c7072"><span class="__cf_email__" data-cfemail="39515850404c571741505856795b544a175a5654">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">T. G. Murali Dhar</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0738-1021" title="Orcid link">http://orcid.org/0000-0003-0738-1021</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#79140c0b181510571d11180b391b140a571a1614"><span class="__cf_email__" data-cfemail="3b564e495a5752155f535a497b59564815585456">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ning Li</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James J.-W. Duan</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2730-9924" title="Orcid link">http://orcid.org/0000-0003-2730-9924</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bin Jiang</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhonghui Lu</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Khehyong Ngu</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Tino</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa M. Kopcho</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hao Lu</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing Chen</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew J. Tebben</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Sheriff</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">ChiehYing Y. Chang</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Yanchunas</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deepa Calambur</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mian Gao</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Shuster</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vojkan Susulic</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jenny H. Xie</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Victor R. Guarino</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dauh-Rurng Wu</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kurt R. Gregor</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine B. Goldstine</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Hynes</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0490-5179" title="Orcid link">http://orcid.org/0000-0002-0490-5179</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John E. Macor</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luisa Salter-Cid</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James R. Burke</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick J. Shaw</span> - <span class="hlFld-Affiliation affiliation">Research and Early Development, Bristol Myers Squibb, 3551 Lawrenceville Road, Princeton, New Jersey 08540, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43873" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43873" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Mary Ellen Cvijic and Ding Ren Shen for providing us the experimental protocol for the HEK-Blue assay. We also thank Christine Jorge and Linping Wang for help in generating the HRMS and <sup>13</sup>C NMR data for compound <b>42</b>.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">SBDD</td><td class="NLM_def"><p class="first last">structure-based drug design</p></td></tr><tr><td class="NLM_term">TNFα</td><td class="NLM_def"><p class="first last">tumor necrosis factor alpha</p></td></tr><tr><td class="NLM_term">TNFR1</td><td class="NLM_def"><p class="first last">TNF receptor 1</p></td></tr><tr><td class="NLM_term">PK–PD</td><td class="NLM_def"><p class="first last">pharmacokinetic–pharmacodynamic</p></td></tr><tr><td class="NLM_term">CAIA</td><td class="NLM_def"><p class="first last">collagen antibody-induced arthritis</p></td></tr><tr><td class="NLM_term">SEAP</td><td class="NLM_def"><p class="first last">secreted alkaline phosphatase</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time-resolved fluorescence</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">hWB</td><td class="NLM_def"><p class="first last">human whole blood</p></td></tr><tr><td class="NLM_term">IL</td><td class="NLM_def"><p class="first last">interleukin</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">RT</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">DMA</td><td class="NLM_def"><p class="first last">dimethylacetamide</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 11 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Locksley, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Killeen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenardo, M. J.</span></span> <span> </span><span class="NLM_article-title">The TNF and TNF receptor superfamilies: integrating mammalian biology</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1016/s0092-8674(01)00237-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1016%2FS0092-8674%2801%2900237-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=11239407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BD3MXis1KksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=487-501&author=R.+M.+Locksleyauthor=N.+Killeenauthor=M.+J.+Lenardo&title=The+TNF+and+TNF+receptor+superfamilies%3A+integrating+mammalian+biology&doi=10.1016%2Fs0092-8674%2801%2900237-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The TNF and TNF receptor superfamilies: integrating mammalian biology</span></div><div class="casAuthors">Locksley, Richard M.; Killeen, Nigel; Lenardo, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">487-501</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with over 100 refs.  Topics discussed include structure-function relationships of tumor necrosis factor receptors; pivotal modes of signaling; tumor necrosis factor and receptors as cellular organizers in metazoans; role in immunity; cell death; acute inflammation; bone and mammary gland homeostasis; hair follicle and sweat gland development; genetic diseases of tumor necrosis factor receptors; and genomic and sequence relationships of tumor necrosis factor and receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGvXSzzXucDLVg90H21EOLACvtfcHk0lgO_N885-JrDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXis1KksrY%253D&md5=78e12b79221e664c35291f11feb998a0</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900237-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900237-9%26sid%3Dliteratum%253Aachs%26aulast%3DLocksley%26aufirst%3DR.%2BM.%26aulast%3DKilleen%26aufirst%3DN.%26aulast%3DLenardo%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520TNF%2520and%2520TNF%2520receptor%2520superfamilies%253A%2520integrating%2520mammalian%2520biology%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D487%26epage%3D501%26doi%3D10.1016%2Fs0092-8674%2801%2900237-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, B. B.</span></span> <span> </span><span class="NLM_article-title">Signalling pathways of the TNF superfamily: a double-edged sword</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">756</span>, <span class="refDoi"> DOI: 10.1038/nri1184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1038%2Fnri1184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=12949498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVWmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=745-756&author=B.+B.+Aggarwal&title=Signalling+pathways+of+the+TNF+superfamily%3A+a+double-edged+sword&doi=10.1038%2Fnri1184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Signalling pathways of the TNF superfamily: a double-edged sword</span></div><div class="casAuthors">Aggarwal, Bharat B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">745-756</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Two different tumor-necrosis factors (TNFs), first isolated in 1984, were cytotoxic to tumor cells and to induce tumor regression in mice.  Research during the past two decades has shown the existence of a superfamily of TNF proteins consisting of 19 members that signal through 29 receptors.  These ligands, while regulating normal functions such as immune responses, hematopoiesis and morphogenesis, have also been implicated in tumorigenesis, transplant rejection, septic shock, viral replication, bone resorption, rheumatoid arthritis and diabetes; so indicating their role as 'double-edged swords'.  These cytokines either induce cellular proliferation, survival, differentiation or apoptosis.  Blockers of TNF have been approved for human use in treating TNF-linked autoimmune diseases in the United States and other countries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLbPm1fw2He7Vg90H21EOLACvtfcHk0lgO_N885-JrDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVWmtb0%253D&md5=3cf33b638795bd0b2492aded83dbad51</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnri1184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1184%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DSignalling%2520pathways%2520of%2520the%2520TNF%2520superfamily%253A%2520a%2520double-edged%2520sword%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2003%26volume%3D3%26spage%3D745%26epage%3D756%26doi%3D10.1038%2Fnri1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hehlgans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeffer, K.</span></span> <span> </span><span class="NLM_article-title">The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games</span>. <i>Immunology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2567.2005.02143.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1111%2Fj.1365-2567.2005.02143.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=15819693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFaqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=1-20&author=T.+Hehlgansauthor=K.+Pfeffer&title=The+intriguing+biology+of+the+tumour+necrosis+factor%2Ftumour+necrosis+factor+receptor+superfamily%3A+players%2C+rules+and+the+games&doi=10.1111%2Fj.1365-2567.2005.02143.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: Players, rules and the games</span></div><div class="casAuthors">Hehlgans, Thomas; Pfeffer, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-20</span>CODEN:
                <span class="NLM_cas:coden">IMMUAM</span>;
        ISSN:<span class="NLM_cas:issn">0019-2805</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The members of the tumor necrosis factor (TNF)/tumor necrosis factor receptor (TNFR) superfamily are critically involved in the maintenance of homeostasis of the immune system.  The biol. functions of this system encompass beneficial and protective effects in inflammation and host defense as well as a crucial role in organogenesis.  At the same time, members of this superfamily are responsible for host damaging effects in sepsis, cachexia, and autoimmune diseases.  This review summarizes recent progress in the immunbiol. of the TNF/TNFR superfamily focusing on results obtained from animal studies using gene targeted mice.  The different modes of signalling pathways affecting cell proliferation, survival, differentiation, apoptosis, and immune organ development as well as host defense are reviewed.  Mol. and cellular mechanisms that demonstrate a therapeutic potential by targeting individual receptors or ligands for the treatment of chronic inflammatory or autoimmune diseases are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOKlXHDZr0BrVg90H21EOLACvtfcHk0lgO_N885-JrDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFaqtrs%253D&md5=89ac7ee81e26aa711301368bebccb60e</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2567.2005.02143.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2567.2005.02143.x%26sid%3Dliteratum%253Aachs%26aulast%3DHehlgans%26aufirst%3DT.%26aulast%3DPfeffer%26aufirst%3DK.%26atitle%3DThe%2520intriguing%2520biology%2520of%2520the%2520tumour%2520necrosis%2520factor%252Ftumour%2520necrosis%2520factor%2520receptor%2520superfamily%253A%2520players%252C%2520rules%2520and%2520the%2520games%26jtitle%3DImmunology%26date%3D2005%26volume%3D115%26spage%3D1%26epage%3D20%26doi%3D10.1111%2Fj.1365-2567.2005.02143.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bodmer, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, J.</span></span> <span> </span><span class="NLM_article-title">The molecular architecture of the TNF superfamily</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/s0968-0004(01)01995-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1016%2FS0968-0004%2801%2901995-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=11796220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVOmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=19-26&author=J.-L.+Bodmerauthor=P.+Schneiderauthor=J.+Tschopp&title=The+molecular+architecture+of+the+TNF+superfamily&doi=10.1016%2Fs0968-0004%2801%2901995-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular architecture of the TNF superfamily</span></div><div class="casAuthors">Bodmer, Jean-Luc; Schneider, Pascal; Tschopp, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-26</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Ligands of the TNF (tumor necrosis factor) superfamily have pivotal roles in the organization and function of the immune system, and are implicated in the etiol. of several acquired and genetic diseases.  TNF ligands share a common structural motif, the TNF homol. domain (THD), which binds to cysteine-rich domains (CRDs) of TNF receptors.  CRDs are composed of structural modules, whose variation in no. and type confers heterogeneity upon the family.  Protein folds reminiscent of the THD and CRD are also found in other protein families, raising the possibility that the mode of interaction between TNF and TNF receptors might be conserved in other contexts.  Tumor necrosis ligands and receptors have a widespread biol. activity range, yet they display a remarkably conserved structure and mode of interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWfO_ssPYH-LVg90H21EOLACvtfcHk0liMyXNoOpVTmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVOmtw%253D%253D&md5=dd6bfc0ea79a01fc67e1003614c1c2ea</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0968-0004%2801%2901995-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0004%252801%252901995-8%26sid%3Dliteratum%253Aachs%26aulast%3DBodmer%26aufirst%3DJ.-L.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DThe%2520molecular%2520architecture%2520of%2520the%2520TNF%2520superfamily%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2002%26volume%3D27%26spage%3D19%26epage%3D26%26doi%3D10.1016%2Fs0968-0004%2801%2901995-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Regulation of tumour necrosis factor signalling: live or let die</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1038/nri3834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1038%2Fnri3834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=26008591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=362-374&author=D.+Brennerauthor=H.+Blaserauthor=T.+W.+Mak&title=Regulation+of+tumour+necrosis+factor+signalling%3A+live+or+let+die&doi=10.1038%2Fnri3834"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of tumour necrosis factor signalling: live or let die</span></div><div class="casAuthors">Brenner, Dirk; Blaser, Heiko; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">362-374</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor necrosis factor (TNF) is a pro-inflammatory cytokine that has important roles in mammalian immunity and cellular homeostasis.  Deregulation of TNF receptor (TNFR) signalling is assocd. with many inflammatory disorders, including various types of arthritis and inflammatory bowel disease, and targeting TNF has been an effective therapeutic strategy in these diseases.  This Review focuses on the recent advances that have been made in understanding TNFR signalling and the consequences of its deregulation for cellular survival, apoptosis and regulated necrosis.  We discuss how TNF-induced survival signals are distinguished from those that lead to cell death.  Finally, we provide a brief overview of the role of TNF in inflammatory and autoimmune diseases, and we discuss up-to-date and future treatment strategies for these disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwd5YDL8raprVg90H21EOLACvtfcHk0liMyXNoOpVTmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7jJ&md5=adc251b8af3f6e4d5fc04262c597f67f</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fnri3834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3834%26sid%3Dliteratum%253Aachs%26aulast%3DBrenner%26aufirst%3DD.%26aulast%3DBlaser%26aufirst%3DH.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DRegulation%2520of%2520tumour%2520necrosis%2520factor%2520signalling%253A%2520live%2520or%2520let%2520die%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2015%26volume%3D15%26spage%3D362%26epage%3D374%26doi%3D10.1038%2Fnri3834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dostert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grusdat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letellier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D.</span></span> <span> </span><span class="NLM_article-title">The TNF family of ligands and receptors: communication modules in the immune system and beyond</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1152/physrev.00045.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1152%2Fphysrev.00045.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=30354964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsF2kt77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2019&pages=115-160&author=C.+Dostertauthor=M.+Grusdatauthor=E.+Letellierauthor=D.+Brenner&title=The+TNF+family+of+ligands+and+receptors%3A+communication+modules+in+the+immune+system+and+beyond&doi=10.1152%2Fphysrev.00045.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The TNF family of ligands and receptors: communication modules in the immune system and beyond</span></div><div class="casAuthors">Dostert, Catherine; Grusdat, Melanie; Letellier, Elisabeth; Brenner, Dirk</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-160</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">1522-1210</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The tumor necrosis factor (TNF) and TNF receptor (TNFR) superfamilies (TNFSF/TNFRSF) include 19 ligands and 29 receptors that play important roles in the modulation of cellular functions.  The communication pathways mediated by TNFSF/ TNFRSF are essential for numerous developmental, homeostatic, and stimulus-responsive processes in vivo.  TNFSF/TNFRSF members regulate cellular differentiation, survival, and programmed death, but their most crit. functions pertain to the immune system.  Both innate and adaptive immune cells are controlled by TNFSF/TNFRSF members in a manner that is crucial for the coordination of various mechanisms driving either co-stimulation or co-inhibition of the immune response.  Dysregulation of these same signaling pathways has been implicated in inflammatory and autoimmune diseases, highlighting the importance of their tight regulation.  Investigation of the control of TNFSF/TNFRSF activities has led to the development of therapeutics with the potential to reduce chronic inflammation or promote anti-tumor immunity.  The study of TNFSF/TNFRSF proteins has exploded over the last 30 yr, but there remains a need to better understand the fundamental mechanisms underlying the mol. pathways they mediate to design more effective anti-inflammatory and anti-cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvm0w9gyONO7Vg90H21EOLACvtfcHk0liMyXNoOpVTmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsF2kt77N&md5=283e0d7e025be7dc4f9bfebff8dca55e</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00045.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00045.2017%26sid%3Dliteratum%253Aachs%26aulast%3DDostert%26aufirst%3DC.%26aulast%3DGrusdat%26aufirst%3DM.%26aulast%3DLetellier%26aufirst%3DE.%26aulast%3DBrenner%26aufirst%3DD.%26atitle%3DThe%2520TNF%2520family%2520of%2520ligands%2520and%2520receptors%253A%2520communication%2520modules%2520in%2520the%2520immune%2520system%2520and%2520beyond%26jtitle%3DPhysiol.%2520Rev.%26date%3D2019%26volume%3D99%26spage%3D115%26epage%3D160%26doi%3D10.1152%2Fphysrev.00045.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cessak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuzawińska, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojnar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirowska-Guzel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bałkowiec-Iskra, E.</span></span> <span> </span><span class="NLM_article-title">TNF inhibitors—mechanisms of action, approved and off-label indications</span>. <i>Pharmacol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">836</span>– <span class="NLM_lpage">844</span>, <span class="refDoi"> DOI: 10.1016/j.pharep.2014.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1016%2Fj.pharep.2014.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=25149988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmt1Shtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=836-844&author=G.+Cessakauthor=O.+Kuzawi%C5%84skaauthor=A.+Burdaauthor=K.+Lisauthor=M.+Wojnarauthor=D.+Mirowska-Guzelauthor=E.+Ba%C5%82kowiec-Iskra&title=TNF+inhibitors%E2%80%94mechanisms+of+action%2C+approved+and+off-label+indications&doi=10.1016%2Fj.pharep.2014.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">TNF inhibitors - Mechanisms of action, approved and off-label indications</span></div><div class="casAuthors">Cessak, Grzegorz; Kuzawinska, Olga; Burda, Agnieszka; Lis, Krzysztof; Wojnar, Marcin; Mirowska-Guzel, Dagmara; Balkowiec-Iskra, Ewa</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">836-844</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">2299-5684</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tumor necrosis factor inhibitors (TNFi) belong to the group of biol. drugs, holding presently top positions on lists of most profitable products for pharmaceutical companies.  Although current indications for TNFi include only selected diseases with an established role of immune dysfunction in their pathogenesis, studies on new indications are being carried out all over the world.  The most important aspect of TNFi therapy is a targeted therapeutic approach, allowing to avoid a wide range of side effects assocd. with treatment with nonspecific immunosuppressive agents.  Results of the trials on TNFi in the approved indications are widely accessible and analyzed elsewhere, both in primary publications as well as in systematic reviews and meta-analyses.  Here we aim to discuss their mechanisms of action, and approved, as well as off-label indications of TNFi.  In addn., we present comprehensive evidence on TNFi in treatment of rheumatoid arthritis (RA); the first authorized and probably most extensively developed indication for the majority of TNFi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa12p20fRqLLVg90H21EOLACvtfcHk0lg-gEQhUllJ5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmt1Shtbo%253D&md5=6b10db2e8aac8727c6c9a1a999021e38</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pharep.2014.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharep.2014.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DCessak%26aufirst%3DG.%26aulast%3DKuzawi%25C5%2584ska%26aufirst%3DO.%26aulast%3DBurda%26aufirst%3DA.%26aulast%3DLis%26aufirst%3DK.%26aulast%3DWojnar%26aufirst%3DM.%26aulast%3DMirowska-Guzel%26aufirst%3DD.%26aulast%3DBa%25C5%2582kowiec-Iskra%26aufirst%3DE.%26atitle%3DTNF%2520inhibitors%25E2%2580%2594mechanisms%2520of%2520action%252C%2520approved%2520and%2520off-label%2520indications%26jtitle%3DPharmacol.%2520Rep.%26date%3D2014%26volume%3D66%26spage%3D836%26epage%3D844%26doi%3D10.1016%2Fj.pharep.2014.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">He, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oslob, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braisted, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cancilla, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wamg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugovskoy, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoburn, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrington, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldredge, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cachero, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choong, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, B. C.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibition of TNF-alpha</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>310</i></span>,  <span class="NLM_fpage">1022</span>– <span class="NLM_lpage">1025</span>, <span class="refDoi"> DOI: 10.1126/science.1116304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1126%2Fscience.1116304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=16284179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2is7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2005&pages=1022-1025&author=M.+M.+Heauthor=A.+S.+Smithauthor=J.+D.+Oslobauthor=W.+M.+Flanaganauthor=A.+C.+Braistedauthor=A.+Whittyauthor=M.+T.+Cancillaauthor=J.+Wamgauthor=A.+A.+Lugovskoyauthor=J.+C.+Yoburnauthor=A.+D.+Fungauthor=G.+Farringtonauthor=J.+K.+Eldredgeauthor=E.+S.+Dayauthor=L.+A.+Cruzauthor=T.+G.+Cacheroauthor=S.+K.+Millerauthor=J.+E.+Friedmanauthor=I.+C.+Choongauthor=B.+C.+Cunningham&title=Small-molecule+inhibition+of+TNF-alpha&doi=10.1126%2Fscience.1116304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Inhibition of TNF-α</span></div><div class="casAuthors">He, Molly M.; Smith, Annemarie Stroustrup; Oslob, Johan D.; Flanagan, William M.; Braisted, Andrew C.; Whitty, Adrian; Cancilla, Mark T.; Wang, Jun; Lugovskoy, Alexey A.; Yoburn, Josh C.; Fung, Amy D.; Farrington, Graham; Eldredge, John K.; Day, Eric S.; Cruz, Leslie A.; Cachero, Teresa G.; Miller, Stephan K.; Friedman, Jessica E.; Choong, Ingrid C.; Cunningham, Brian C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">5750</span>),
    <span class="NLM_cas:pages">1022-1025</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have identified a small-mol. inhibitor of tumor necrosis factor α (TNF-α) that promotes subunit disassembly of this trimeric cytokine family member.  The compd. inhibits TNF-α activity in biochem. and cell-based assays with median inhibitory concns. of 22 and 4.6 micromolar, resp.  Formation of an intermediate complex between the compd. and the intact trimer results in a 600-fold accelerated subunit dissocn. rate that leads to trimer dissocn.  A structure solved by x-ray crystallog. reveals that a single compd. mol. displaces a subunit of the trimer to form a complex with a dimer of TNF-α subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvbBjoYzi8XbVg90H21EOLACvtfcHk0lg-gEQhUllJ5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2is7nJ&md5=3747a5ad9afb75e9da5d878b73903bf4</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1116304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1116304%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DM.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BS.%26aulast%3DOslob%26aufirst%3DJ.%2BD.%26aulast%3DFlanagan%26aufirst%3DW.%2BM.%26aulast%3DBraisted%26aufirst%3DA.%2BC.%26aulast%3DWhitty%26aufirst%3DA.%26aulast%3DCancilla%26aufirst%3DM.%2BT.%26aulast%3DWamg%26aufirst%3DJ.%26aulast%3DLugovskoy%26aufirst%3DA.%2BA.%26aulast%3DYoburn%26aufirst%3DJ.%2BC.%26aulast%3DFung%26aufirst%3DA.%2BD.%26aulast%3DFarrington%26aufirst%3DG.%26aulast%3DEldredge%26aufirst%3DJ.%2BK.%26aulast%3DDay%26aufirst%3DE.%2BS.%26aulast%3DCruz%26aufirst%3DL.%2BA.%26aulast%3DCachero%26aufirst%3DT.%2BG.%26aulast%3DMiller%26aufirst%3DS.%2BK.%26aulast%3DFriedman%26aufirst%3DJ.%2BE.%26aulast%3DChoong%26aufirst%3DI.%2BC.%26aulast%3DCunningham%26aufirst%3DB.%2BC.%26atitle%3DSmall-molecule%2520inhibition%2520of%2520TNF-alpha%26jtitle%3DScience%26date%3D2005%26volume%3D310%26spage%3D1022%26epage%3D1025%26doi%3D10.1126%2Fscience.1116304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Japonicone A antagonizes the activity of TNF-alpha by directly targeting this cytokine and selectively disrupting its interaction with TNF receptor-1</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1482</span>– <span class="NLM_lpage">1491</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2012.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1016%2Fj.bcp.2012.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=22981364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlKrs7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=1482-1491&author=Z.+Huauthor=J.+Qinauthor=H.+Zhangauthor=D.+Wangauthor=Y.+Huaauthor=J.+Dingauthor=L.+Shanauthor=H.+Jinauthor=J.+Zhangauthor=W.+Zhang&title=Japonicone+A+antagonizes+the+activity+of+TNF-alpha+by+directly+targeting+this+cytokine+and+selectively+disrupting+its+interaction+with+TNF+receptor-1&doi=10.1016%2Fj.bcp.2012.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Japonicone A antagonizes the activity of TNF-α by directly targeting this cytokine and selectively disrupting its interaction with TNF receptor-1</span></div><div class="casAuthors">Hu, Zhenlin; Qin, Jiangjiang; Zhang, Huahua; Wang, Dan; Hua, Yaping; Ding, Jieping; Shan, Lei; Jin, Huizi; Zhang, Junping; Zhang, Weidong</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1482-1491</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Anti-TNF biologics are effective therapies for various inflammatory diseases.  Unfortunately, their clin. use is assocd. with an increased risk of infections.  Selectively inhibiting TNF receptor-1 (TNFR1)-mediated signaling while preserving TNFR2 signaling may reduce inflammation yet maintain host immune response to pathogens.  However, few small mols. that selectively target the TNF/TNFR system have been discovered.  In the present study, we identified Japonicone A (Jap A), a nature compd. derived from Inula japonica Thunb, as a novel TNF-α antagonist, as it reduced the TNF-α-mediated cytotoxicity on L929 cells and inhibited the binding of 125I-labeled TNF-α to L929 cell surface.  Furthermore, Jap A could directly bind to TNF-α rather than TNFR1 as detd. by surface plasmon resonance.  More importantly, Jap A could effectively inhibit the binding of TNF-α to TNFR1, while displaying only marginal inhibitory effects on that to TNFR2.  Jap A also could block TNFR1-mediated signaling as it inhibited TNF-α-induced NF-κB activation in 293 cells.  In addn., Jap A suppressed TNF-α-induced expressions of adhesion mols. (ICAM-1, VCAM-1) and chemokine (MCP-1) in the endothelial cells by blocking TNF-α-triggered multiple signaling pathways.  Data from in vivo expts. demonstrated that Jap A protected mice from acute hepatitis induced by TNF-α/d-galactosamine, but did not compromise host antiviral immunity in adenovirus-infected mice.  These results indicate that Jap A can directly target TNF-α, selectively disrupt its interaction with TNFR1, and antagonize its pro-inflammatory activities without compromising host defense against virus, thus emphasizing the potential of Jap A as an interesting lead compd. for development of new anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLXQAd_eTohLVg90H21EOLACvtfcHk0lg-gEQhUllJ5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlKrs7jM&md5=17868374003fe8b1d1b2224575f873a3</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DHua%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DShan%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DJaponicone%2520A%2520antagonizes%2520the%2520activity%2520of%2520TNF-alpha%2520by%2520directly%2520targeting%2520this%2520cytokine%2520and%2520selectively%2520disrupting%2520its%2520interaction%2520with%2520TNF%2520receptor-1%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D1482%26epage%3D1491%26doi%3D10.1016%2Fj.bcp.2012.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Luzi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadler, L. K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaysburd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holliger, P.</span></span> <span> </span><span class="NLM_article-title">Subunit disassembly and inhibition of TNFα by a semi-synthetic bicyclic peptide</span>. <i>Protein Eng., Des. Sel.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1093/protein/gzu055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1093%2Fprotein%2Fgzu055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=25614525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVOgt7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=45-52&author=S.+Luziauthor=Y.+Kondoauthor=E.+Bernardauthor=L.+K.+J.+Stadlerauthor=M.+Vaysburdauthor=G.+Winterauthor=P.+Holliger&title=Subunit+disassembly+and+inhibition+of+TNF%CE%B1+by+a+semi-synthetic+bicyclic+peptide&doi=10.1093%2Fprotein%2Fgzu055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Subunit disassembly and inhibition of TNF α by a semi-synthetic bicyclic peptide</span></div><div class="casAuthors">Luzi, Stefan; Kondo, Yasushi; Bernard, Elise; Stadler, Lukas K. J.; Vaysburd, Marina; Winter, Greg; Holliger, Philipp</div><div class="citationInfo"><span class="NLM_cas:title">Protein Engineering, Design & Selection</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">45-52</span>CODEN:
                <span class="NLM_cas:coden">PEDSBR</span>;
        ISSN:<span class="NLM_cas:issn">1741-0126</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Macrocyclic peptides are potentially a source of powerful drugs, but theirde novo discovery remains challenging.  Here we describe the discovery of a high-affinity (Kd = 10 nM) peptide macrocycle (M21) against human tumor necrosis factor-alpha (hTNFα), a key drug target in the treatment of inflammatory disorders, directly from diverse semi-synthetic phage peptide repertoires.  The bicyclic peptide M21 (ACPPCLWQVLC) comprises two loops covalently anchored to a 2,4,6-trimethyl-mesitylene core and upon binding induces disassembly of the trimeric TNFα cytokine into dimers and monomers.  A 2.9 Å crystal structure of the M21/hTNF̂I± complex reveals the peptide bound to a hTNFα dimer at a normally buried epitope in the trimer interface overlapping the binding site of a previously discovered small mol. ligand (SPD304), which also induces TNF trimer dissocn. and synergizes with M21 in the inhibition of TNFα cytotoxicity.  The discovery of M21 underlines the potential of semi-synthetic bicyclic peptides as ligands for the discovery of cryptic epitopes, some of which are poorly accessible to antibodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobgFV5_7SRTbVg90H21EOLACvtfcHk0lgiEFTRKf0Wtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVOgt7fJ&md5=35574bfdcf3ec6d8e1db89933a58d640</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1093%2Fprotein%2Fgzu055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fprotein%252Fgzu055%26sid%3Dliteratum%253Aachs%26aulast%3DLuzi%26aufirst%3DS.%26aulast%3DKondo%26aufirst%3DY.%26aulast%3DBernard%26aufirst%3DE.%26aulast%3DStadler%26aufirst%3DL.%2BK.%2BJ.%26aulast%3DVaysburd%26aufirst%3DM.%26aulast%3DWinter%26aufirst%3DG.%26aulast%3DHolliger%26aufirst%3DP.%26atitle%3DSubunit%2520disassembly%2520and%2520inhibition%2520of%2520TNF%25CE%25B1%2520by%2520a%2520semi-synthetic%2520bicyclic%2520peptide%26jtitle%3DProtein%2520Eng.%252C%2520Des.%2520Sel.%26date%3D2015%26volume%3D28%26spage%3D45%26epage%3D52%26doi%3D10.1093%2Fprotein%2Fgzu055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Papaneophytou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexiou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papakyriakou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ntougkos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsiliouka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liepouri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strongilos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mettou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couladouros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliopoulos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollias, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontopidis, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of potential small molecule inhibitors of tumor necrosis factor</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1196</span>– <span class="NLM_lpage">1209</span>, <span class="refDoi"> DOI: 10.1039/c5md00023h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1039%2FC5MD00023H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFOhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1196-1209&author=C.+Papaneophytouauthor=P.+Alexiouauthor=A.+Papakyriakouauthor=E.+Ntougkosauthor=K.+Tsilioukaauthor=A.+Marantiauthor=F.+Liepouriauthor=A.+Strongilosauthor=A.+Mettouauthor=E.+Couladourosauthor=E.+Eliopoulosauthor=E.+Douniauthor=G.+Kolliasauthor=G.+Kontopidis&title=Synthesis+and+biological+evaluation+of+potential+small+molecule+inhibitors+of+tumor+necrosis+factor&doi=10.1039%2Fc5md00023h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of potential small molecule inhibitors of tumor necrosis factor</span></div><div class="casAuthors">Papaneophytou, Christos; Alexiou, Polyxeni; Papakyriakou, Athanasios; Ntougkos, Evangelos; Tsiliouka, Katerina; Maranti, Anna; Liepouri, Fotini; Strongilos, Alexandros; Mettou, Anthi; Couladouros, Elias; Eliopoulos, Elias; Douni, Eleni; Kollias, George; Kontopidis, George</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1196-1209</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Inhibition of tumor necrosis factor (TNF) prodn. or function by small mols. has become a major focus in the pharmaceutical industry for the treatment of rheumatoid arthritis.  In this study, a series of 39 novel SPD-304 analogs were designed, synthesized and evaluated as TNF inhibitors.  Our results show that small structural changes produce ligands with similar binding affinities (Kd) for TNF, but significantly different potencies in a L929 cell-based assay.  In addn., contrary to the high affinity of compds. 4e, 8c and 10e for TNF in vitro, the potency of these compds. was detd. to be low.  We propose that these differences can partly be explained by the physicochem. characteristics of the synthesized SPD-304 analogs.  Our findings were supplemented by mol. docking studies on the TNF dimer.  These synthesized analogs may serve as a starting point for developing novel TNF inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtytnPovIwybVg90H21EOLACvtfcHk0lgiEFTRKf0Wtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFOhsLo%253D&md5=fcaf98943d905165678cddd3c3348aac</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1039%2FC5MD00023H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00023H%26sid%3Dliteratum%253Aachs%26aulast%3DPapaneophytou%26aufirst%3DC.%26aulast%3DAlexiou%26aufirst%3DP.%26aulast%3DPapakyriakou%26aufirst%3DA.%26aulast%3DNtougkos%26aufirst%3DE.%26aulast%3DTsiliouka%26aufirst%3DK.%26aulast%3DMaranti%26aufirst%3DA.%26aulast%3DLiepouri%26aufirst%3DF.%26aulast%3DStrongilos%26aufirst%3DA.%26aulast%3DMettou%26aufirst%3DA.%26aulast%3DCouladouros%26aufirst%3DE.%26aulast%3DEliopoulos%26aufirst%3DE.%26aulast%3DDouni%26aufirst%3DE.%26aulast%3DKollias%26aufirst%3DG.%26aulast%3DKontopidis%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520potential%2520small%2520molecule%2520inhibitors%2520of%2520tumor%2520necrosis%2520factor%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1196%26epage%3D1209%26doi%3D10.1039%2Fc5md00023h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mouhsine, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemain, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourati, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerrouki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desallais, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gizzi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Nasr, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratsimandresy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadoni, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">England, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagury, J.-F.</span></span> <span> </span><span class="NLM_article-title">Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3424</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-03427-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1038%2Fs41598-017-03427-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=28611375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A280%3ADC%252BC1cnnvF2jsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=3424&author=H.+Mouhsineauthor=H.+Guillemainauthor=G.+Moreauauthor=N.+Fouratiauthor=C.+Zerroukiauthor=B.+Baronauthor=L.+Desallaisauthor=P.+Gizziauthor=N.+Ben+Nasrauthor=J.+Perrierauthor=R.+Ratsimandresyauthor=J.-L.+Spadoniauthor=H.+Doauthor=P.+Englandauthor=M.+Montesauthor=J.-F.+Zagury&title=Identification+of+an+in+vivo+orally+active+dual-binding+protein-protein+interaction+inhibitor+targeting+TNF%CE%B1+through+combined+in+silico%2Fin+vitro%2Fin+vivo+screening&doi=10.1038%2Fs41598-017-03427-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening</span></div><div class="casAuthors">Mouhsine Hadley; Guillemain Helene; Moreau Gabriel; Desallais Lucille; Ben Nasr Nesrine; Perrier Julie; Ratsimandresy Rojo; Spadoni Jean-Louis; Do Herve; Montes Matthieu; Zagury Jean-Francois; Mouhsine Hadley; Guillemain Helene; Moreau Gabriel; Desallais Lucille; Do Herve; Fourati Najla; Zerrouki Chouki; Baron Bruno; England Patrick; Gizzi Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3424</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">TNFα is a homotrimeric pro-inflammatory cytokine, whose direct targeting by protein biotherapies has been an undeniable success for the treatment of chronic inflammatory diseases.  Despite many efforts, no orally active drug targeting TNFα has been identified so far.  In the present work, we identified through combined in silico/in vitro/in vivo approaches a TNFα direct inhibitor, compound 1, displaying nanomolar and micromolar range bindings to TNFα.  Compound 1 inhibits the binding of TNFα with both its receptors TNFRI and TNFRII.  Compound 1 inhibits the TNFα induced apoptosis on L929 cells and the TNFα induced NF-κB activation in HEK cells.  In vivo, oral administration of compound 1 displays a significant protection in a murine TNFα-dependent hepatic shock model.  This work illustrates the ability of low-cost combined in silico/in vitro/in vivo screening approaches to identify orally available small-molecules targeting challenging protein-protein interactions such as homotrimeric TNFα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRUkSBKybTdi6qcneEtCi92fW6udTcc2eZD6p_xAKPgUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnnvF2jsg%253D%253D&md5=06b2bdec45070ee7c7865e01ceba9c59</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-03427-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-03427-z%26sid%3Dliteratum%253Aachs%26aulast%3DMouhsine%26aufirst%3DH.%26aulast%3DGuillemain%26aufirst%3DH.%26aulast%3DMoreau%26aufirst%3DG.%26aulast%3DFourati%26aufirst%3DN.%26aulast%3DZerrouki%26aufirst%3DC.%26aulast%3DBaron%26aufirst%3DB.%26aulast%3DDesallais%26aufirst%3DL.%26aulast%3DGizzi%26aufirst%3DP.%26aulast%3DBen%2BNasr%26aufirst%3DN.%26aulast%3DPerrier%26aufirst%3DJ.%26aulast%3DRatsimandresy%26aufirst%3DR.%26aulast%3DSpadoni%26aufirst%3DJ.-L.%26aulast%3DDo%26aufirst%3DH.%26aulast%3DEngland%26aufirst%3DP.%26aulast%3DMontes%26aufirst%3DM.%26aulast%3DZagury%26aufirst%3DJ.-F.%26atitle%3DIdentification%2520of%2520an%2520in%2520vivo%2520orally%2520active%2520dual-binding%2520protein-protein%2520interaction%2520inhibitor%2520targeting%2520TNF%25CE%25B1%2520through%2520combined%2520in%2520silico%252Fin%2520vitro%252Fin%2520vivo%2520screening%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D3424%26doi%3D10.1038%2Fs41598-017-03427-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Blevitt, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hack, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krawczuk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebsack, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirzadegan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelen, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milla, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lumb, K. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of small-molecule aggregate induced inhibition of a protein–protein interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3511</span>– <span class="NLM_lpage">3517</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01836</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01836" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktlSrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3511-3517&author=J.+M.+Blevittauthor=M.+D.+Hackauthor=K.+L.+Hermanauthor=P.+F.+Jacksonauthor=P.+J.+Krawczukauthor=A.+D.+Lebsackauthor=A.+X.+Liuauthor=T.+Mirzadeganauthor=M.+I.+Nelenauthor=A.+N.+Patrickauthor=S.+Steinbacherauthor=M.+E.+Millaauthor=K.+J.+Lumb&title=Structural+basis+of+small-molecule+aggregate+induced+inhibition+of+a+protein%E2%80%93protein+interaction&doi=10.1021%2Facs.jmedchem.6b01836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5fR"><div class="casContent"><span class="casTitleNuber">5f</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Small-Molecule Aggregate Induced Inhibition of a Protein-Protein Interaction</span></div><div class="casAuthors">Blevitt, Jonathan M.; Hack, Michael D.; Herman, Krystal L.; Jackson, Paul F.; Krawczuk, Paul J.; Lebsack, Alec D.; Liu, Annie X.; Mirzadegan, Taraneh; Nelen, Marina I.; Patrick, Aaron N.; Steinbacher, Stefan; Milla, Marcos E.; Lumb, Kevin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3511-3517</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A prevalent observation in high-throughput screening and drug discovery programs is the inhibition of protein function by small-mol. compd. aggregation.  Here, the authors present the x-ray structural description of aggregation-based inhibition of a protein-protein interaction involving tumor necrosis factor α (TNFα).  An ordered conglomerate of an aggregating small-mol. inhibitor (JNJ525) induces a quaternary structure switch of TNFα that inhibits the protein-protein interaction between TNFα and TNFα receptors.  SPD-304 may employ a similar mechanism of inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbIRn5NHx_ibVg90H21EOLACvtfcHk0ljwRcO8T9gKkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktlSrtr4%253D&md5=d1a750585d50de5089786d3780638d99</span></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01836%26sid%3Dliteratum%253Aachs%26aulast%3DBlevitt%26aufirst%3DJ.%2BM.%26aulast%3DHack%26aufirst%3DM.%2BD.%26aulast%3DHerman%26aufirst%3DK.%2BL.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26aulast%3DKrawczuk%26aufirst%3DP.%2BJ.%26aulast%3DLebsack%26aufirst%3DA.%2BD.%26aulast%3DLiu%26aufirst%3DA.%2BX.%26aulast%3DMirzadegan%26aufirst%3DT.%26aulast%3DNelen%26aufirst%3DM.%2BI.%26aulast%3DPatrick%26aufirst%3DA.%2BN.%26aulast%3DSteinbacher%26aufirst%3DS.%26aulast%3DMilla%26aufirst%3DM.%2BE.%26aulast%3DLumb%26aufirst%3DK.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520small-molecule%2520aggregate%2520induced%2520inhibition%2520of%2520a%2520protein%25E2%2580%2593protein%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3511%26epage%3D3517%26doi%3D10.1021%2Facs.jmedchem.6b01836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Saddala, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span> <span> </span><span class="NLM_article-title">Identifcation of novel inhibitors for TNFα, TNFR1 and TNFα-TNFR1 complex using pharmacophore-based approaches</span>. <i>J. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">215</span>, <span class="refDoi"> DOI: 10.1186/s12967-019-1965-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1186%2Fs12967-019-1965-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=31266509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A280%3ADC%252BB3MzjsVKiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=215&author=M.+S.+Saddalaauthor=H.+Huang&title=Identifcation+of+novel+inhibitors+for+TNF%CE%B1%2C+TNFR1+and+TNF%CE%B1-TNFR1+complex+using+pharmacophore-based+approaches&doi=10.1186%2Fs12967-019-1965-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5gR"><div class="casContent"><span class="casTitleNuber">5g</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel inhibitors for TNFα, TNFR1 and TNFα-TNFR1 complex using pharmacophore-based approaches</span></div><div class="casAuthors">Saddala Madhu Sudhana; Huang Hu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of translational medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">215</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Tumor necrosis factor α (TNFα) is a multifunctional cytokine with a potent pro-inflammatory effect.  It is a validated therapeutic target molecule for several disorders related to autoimmunity and inflammation.  TNFα-TNF receptor-1 (TNFR1) signaling contributes to the pathological processes of these disorders.  The current study is focused on finding novel small molecules that can directly bind to TNFα and/or TNFR1, preventing the interaction between TNFα or TNFR1, and regulating downstream signaling pathways.  METHODS:  Cheminformatics pipeline (pharmacophore modeling, virtual screening, molecular docking and in silico ADMET analysis) was used to screen for novel TNFα and TNFR1 inhibitors in the Zinc database.  The pharmacophore-based models were generated to screen for the best drug like compounds in the Zinc database.  RESULTS:  The 39, 37 and 45 best hit molecules were mapped with the core pharmacophore features of TNFα, TNFR1, and the TNFα-TNFR1 complex respectively.  They were further evaluated by molecular docking, protein-ligand interactions and in silico ADMET studies.  The molecular docking analysis revealed the binding energies of TNFα, TNFR1 and the TNFα-TNFR1 complex, the basis of which was used to select the top five best binding energy compounds.  Furthermore, in silico ADMET studies clearly revealed that all 15 compounds (ZINC09609430, ZINC49467549, ZINC13113075, ZINC39907639, ZINC25251930, ZINC02968981, ZINC09544246, ZINC58047088, ZINC72021182, ZINC08704414, ZINC05462670, ZINC35681945, ZINC23553920, ZINC05328058, and ZINC17206695) satisfied the Lipinski rule of five and had no toxicity.  CONCLUSIONS:  The new selective TNFα, TNFR1 and TNFα-TNFR1 complex inhibitors can serve as anti-inflammatory agents and are promising candidates for further research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-iLTdWoHMA1f1XRtfYM0dfW6udTcc2eYiYZheegF4Ebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzjsVKiuw%253D%253D&md5=3440357e5b7717cc3f677fbaa877c944</span></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=10.1186%2Fs12967-019-1965-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12967-019-1965-5%26sid%3Dliteratum%253Aachs%26aulast%3DSaddala%26aufirst%3DM.%2BS.%26aulast%3DHuang%26aufirst%3DH.%26atitle%3DIdentifcation%2520of%2520novel%2520inhibitors%2520for%2520TNF%25CE%25B1%252C%2520TNFR1%2520and%2520TNF%25CE%25B1-TNFR1%2520complex%2520using%2520pharmacophore-based%2520approaches%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2019%26volume%3D17%26spage%3D215%26doi%3D10.1186%2Fs12967-019-1965-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally active small-molecule tumor necrosis factor-α inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">8146</span>– <span class="NLM_lpage">8156</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00377</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00377" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtl2rs73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=8146-8156&author=W.+Sunauthor=Y.+Wuauthor=M.+Zhengauthor=Y.+Yangauthor=Y.+Liuauthor=C.+Wuauthor=Y.+Zhouauthor=Y.+Zhangauthor=L.+Chenauthor=H.+Li&title=Discovery+of+an+orally+active+small-molecule+tumor+necrosis+factor-%CE%B1+inhibitor&doi=10.1021%2Facs.jmedchem.0c00377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5hR"><div class="casContent"><span class="casTitleNuber">5h</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Orally Active Small-Molecule Tumor Necrosis Factor-α Inhibitor</span></div><div class="casAuthors">Sun, Weiguang; Wu, Yanli; Zheng, Mengzhu; Yang, Yueying; Liu, Yang; Wu, Canrong; Zhou, Yirong; Zhang, Yonghui; Chen, Lixia; Li, Hua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8146-8156</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tumor necrosis factor α (TNF-α) is an important therapeutic target for rheumatoid arthritis, inflammatory bowel disease, and septic hepatitis.  In this study, structure-based virtual ligand screening combined with in vitro and in vivo assays were applied.  A lead compd., benpyrine, could directly bind to TNF-α and block TNF-α-trigged signaling activation.  Furthermore, the endotoxemic murine model showed that benpyrine could attenuate TNF-α-induced inflammation, thereby reducing liver and lung injury.  Meanwhile, administration of benpyrine by gavage significantly relieved the symptoms of collagen-induced arthritis and imiquimod-induced psoriasis form inflammation in mice.  Thus, our study discovered a novel, highly specific, and orally active small-mol. TNF-α inhibitor that is potentially useful for treating TNF-α-mediated inflammatory and autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL4_essrgDzrVg90H21EOLACvtfcHk0liSvUh-kSOj9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtl2rs73M&md5=4b1e2381348304ac8b9852065b52fd6a</span></div><a href="/servlet/linkout?suffix=cit5h&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00377%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520active%2520small-molecule%2520tumor%2520necrosis%2520factor-%25CE%25B1%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D8146%26epage%3D8156%26doi%3D10.1021%2Facs.jmedchem.0c00377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colangelo, J.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of the interaction between TNF and TNFR</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.4155%2Ffmc.12.192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=23256814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKgsLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=69-79&author=J.+M.+Davisauthor=J.+Colangelo&title=Small-molecule+inhibitors+of+the+interaction+between+TNF+and+TNFR&doi=10.4155%2Ffmc.12.192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of the interaction between TNF and TNFR</span></div><div class="casAuthors">Davis, Jessica M.; Colangelo, Julie</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-79</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The overexpression of TNF has been implicated in a variety of disease conditions including rheumatoid arthritis, Crohn's disease, HIV and cancer.  It is presently a therapeutic target for inflammatory diseases.  Many of the therapeutics currently used are biologics designed to sequester TNF, preventing it from binding with its receptors.  Recent research has been focused on finding small mols. that alter the prodn. of TNF, modulate its signal transduction pathways, or directly inhibit the binding to its receptors.  Modulation of a protein-protein interaction with small mols. is an interesting and nontrivial approach.  The various strategies used in obtaining small-mol., nonpeptide, inhibitors of the TNF-TNF receptor interaction through disruption of the TNF trimer or direct inhibition of the TNF-TNF receptor interaction are presented here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsUFCqKwJFfbVg90H21EOLACvtfcHk0liSvUh-kSOj9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKgsLbK&md5=40d35324b2e496468743c54f128b1777</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.192%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DJ.%2BM.%26aulast%3DColangelo%26aufirst%3DJ.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520interaction%2520between%2520TNF%2520and%2520TNFR%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D69%26epage%3D79%26doi%3D10.4155%2Ffmc.12.192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueno, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alche, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, J.</span></span> <span> </span><span class="NLM_article-title">Small Molecules as anti-TNF Drugs</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2920</span>– <span class="NLM_lpage">2942</span>, <span class="refDoi"> DOI: 10.2174/0929867322666150729115553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.2174%2F0929867322666150729115553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=26219390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKktbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=2920-2942&author=V.+Richmondauthor=F.+Micheliniauthor=C.+Buenoauthor=L.+Alcheauthor=J.+Ramirez&title=Small+Molecules+as+anti-TNF+Drugs&doi=10.2174%2F0929867322666150729115553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecules as Anti-TNF Drugs</span></div><div class="casAuthors">Richmond, Victoria; Michelini, Flavia M.; Bueno, Carlos A.; Alche, Laura E.; Ramirez, Javier A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2920-2942</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Tumor necrosis factor (TNF, TNF-α, cachectin) is a pleiotropic, proinflammatory cytokine with multiple biol. effects, many of which are not yet fully understood.  Although TNF was initially described as an anti-tumor agent more than three decades ago, current knowledge places it central to immune system homeostasis.  TNF plays a crit. role in host defense against infection, as well as an inhibitory role in autoimmune disease.  However, TNF overprodn. generates deleterious effects by inducing the transcription of genes involved in acute and chronic inflammatory responses including asthma, rheumatoid arthritis, Crohn's disease, and psoriasis.  Direct inhibition of TNF by biologics, such as monoclonal antibodies and circulating TNF receptor constructs, has produced effective treatments for these disorders and validated the inhibition of this proinflammatory cytokine as an effective therapy.  Unfortunately, these biol. therapies suffer from several drawbacks, including high cost and the induction of autoantibody prodn.  Thus, the development of small mols. able to modulate TNF prodn. or signaling pathways remains a central challenge in Medicinal Chem.  Considerable efforts have been made over the past two decades to develop such inhibitors, which could potentially be administered orally and would presumably be cheaper.  This review is focused on the recent development of compds. that modulate the activity of this cytokine by acting at different levels, such as TNF expression, processing, binding to its receptors and direct inhibition.  These approaches will be compared and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGKPvies5PprVg90H21EOLACvtfcHk0lh3nOzmYvmUgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKktbbI&md5=ea185aed23d392c639f95c359813651e</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.2174%2F0929867322666150729115553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666150729115553%26sid%3Dliteratum%253Aachs%26aulast%3DRichmond%26aufirst%3DV.%26aulast%3DMichelini%26aufirst%3DF.%26aulast%3DBueno%26aufirst%3DC.%26aulast%3DAlche%26aufirst%3DL.%26aulast%3DRamirez%26aufirst%3DJ.%26atitle%3DSmall%2520Molecules%2520as%2520anti-TNF%2520Drugs%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D2920%26epage%3D2942%26doi%3D10.2174%2F0929867322666150729115553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, P.</span></span> <span> </span><span class="NLM_article-title">TNF superfamily protein–protein interactions: feasibility of small-molecule modulation</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.2174/1389450116666150223115628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.2174%2F1389450116666150223115628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=25706111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsF2hsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=393-408&author=Y.+Songauthor=P.+Buchwald&title=TNF+superfamily+protein%E2%80%93protein+interactions%3A+feasibility+of+small-molecule+modulation&doi=10.2174%2F1389450116666150223115628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">TNF Superfamily Protein-Protein Interactions: Feasibility of Small- Molecule Modulation</span></div><div class="casAuthors">Song, Yun; Buchwald, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">393-408</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The tumor necrosis factor (TNF) superfamily (TNFSF) contains about thirty structurally related receptors (TNFSFRs) and about twenty protein ligands that bind to one or more of these receptors.  Almost all of these cell surface protein-protein interactions (PPIs) represent high-value therapeutic targets for inflammatory or immune modulation in autoimmune diseases, transplant recipients, or cancers, and there are several biologics including antibodies and fusion proteins targeting them that are in various phases of clin. development.  Small-mol. inhibitors or activators could represent possible alternatives if the difficulties related to the targeting of protein-protein interactions by small mols. can be addressed.  Compds. proving the feasibility of such approaches have been identified through different drug discovery approaches for a no. of these TNFSFR-TNFSF type PPIs including CD40-CD40L, BAFFR-BAFF, TRAIL-DR5, and OX40-OX40L.  Corresponding structural, signaling, and medicinal chem. aspects are briefly reviewed here.  While none of these small-mol. modulators identified so far seems promising enough to be pursued for clin. development, they provide proof-of-principle evidence that these interactions are susceptible to small-mol. modulation and can serve as starting points toward the identification of more potent and selective candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqK0-qQTLzt7Vg90H21EOLACvtfcHk0lh3nOzmYvmUgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsF2hsLs%253D&md5=c443d967c79488d838eb9d449fc6962b</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.2174%2F1389450116666150223115628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450116666150223115628%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DBuchwald%26aufirst%3DP.%26atitle%3DTNF%2520superfamily%2520protein%25E2%2580%2593protein%2520interactions%253A%2520feasibility%2520of%2520small-molecule%2520modulation%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2015%26volume%3D16%26spage%3D393%26epage%3D408%26doi%3D10.2174%2F1389450116666150223115628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroeplien, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapecki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMillan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arakaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox Iii, D.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceska, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecomte, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vugler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrington, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cossins, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, A.</span></span> <span> </span><span class="NLM_article-title">Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">5795</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-13616-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1038%2Fs41467-019-13616-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=31857588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVyiurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=5795&author=J.+O%E2%80%99Connellauthor=J.+Porterauthor=B.+Kroeplienauthor=T.+Normanauthor=S.+Rapeckiauthor=R.+Davisauthor=D.+McMillanauthor=T.+Arakakiauthor=A.+Burginauthor=D.+Fox+Iiiauthor=T.+Ceskaauthor=F.+Lecomteauthor=A.+Maloneyauthor=A.+Vuglerauthor=B.+Carringtonauthor=B.+P.+Cossinsauthor=T.+Bourneauthor=A.+Lawson&title=Small+molecules+that+inhibit+TNF+signalling+by+stabilising+an+asymmetric+form+of+the+trimer&doi=10.1038%2Fs41467-019-13616-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules that inhibit TNF signalling by stabilising an asymmetric form of trimer</span></div><div class="casAuthors">O'Connell, James; Porter, John; Kroeplien, Boris; Norman, Tim; Rapecki, Stephen; Davis, Rachel; McMillan, David; Arakaki, Tracy; Burgin, Alex; Fox, David, III; Ceska, Tom; Lecomte, Fabien; Maloney, Alison; Vugler, Alex; Carrington, Bruce; Cossins, Benjamin P.; Bourne, Tim; Lawson, Alastair</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5795</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Tumor necrosis factor (TNF) is a cytokine belonging to a family of trimeric proteins; it has been shown to be a key mediator in autoimmune diseases such as rheumatoid arthritis and Crohn's disease.  While TNF is the target of several successful biol. drugs, attempts to design small mol. therapies directed to this cytokine have not led to approved products.  Here we report the discovery of potent small mol. inhibitors of TNF that stabilize an asym. form of the sol. TNF trimer, compromising signalling and inhibiting the functions of TNF in vitro and in vivo.  This discovery paves the way for a class of small mol. drugs capable of modulating TNF function by stabilizing a naturally sampled, receptor-incompetent conformation of TNF.  Furthermore, this approach may prove to be a more general mechanism for inhibiting protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHOWvf7fPE4bVg90H21EOLACvtfcHk0lh3nOzmYvmUgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVyiurjJ&md5=5cb49a89aab05c869f0226a8306d93a4</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-13616-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-13616-1%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DPorter%26aufirst%3DJ.%26aulast%3DKroeplien%26aufirst%3DB.%26aulast%3DNorman%26aufirst%3DT.%26aulast%3DRapecki%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DMcMillan%26aufirst%3DD.%26aulast%3DArakaki%26aufirst%3DT.%26aulast%3DBurgin%26aufirst%3DA.%26aulast%3DFox%2BIii%26aufirst%3DD.%26aulast%3DCeska%26aufirst%3DT.%26aulast%3DLecomte%26aufirst%3DF.%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DVugler%26aufirst%3DA.%26aulast%3DCarrington%26aufirst%3DB.%26aulast%3DCossins%26aufirst%3DB.%2BP.%26aulast%3DBourne%26aufirst%3DT.%26aulast%3DLawson%26aufirst%3DA.%26atitle%3DSmall%2520molecules%2520that%2520inhibit%2520TNF%2520signalling%2520by%2520stabilising%2520an%2520asymmetric%2520form%2520of%2520the%2520trimer%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D5795%26doi%3D10.1038%2Fs41467-019-13616-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brookings, D. C.</span>; <span class="NLM_string-name">Calmiano, M. D.</span>; <span class="NLM_string-name">Galimore, E. O.</span>; <span class="NLM_string-name">Horsley, H. T.</span>; <span class="NLM_string-name">Hutchings, M. C.</span>; <span class="NLM_string-name">Johnson, J. A.</span>; <span class="NLM_string-name">Kroeplien, B.</span>; <span class="NLM_string-name">Lecomte, F. C.</span>; <span class="NLM_string-name">Lowe, M. A.</span>; <span class="NLM_string-name">Norman, T. J.</span>; <span class="NLM_string-name">Porter, J. R.</span>; <span class="NLM_string-name">Quincey, J. R.</span>; <span class="NLM_string-name">Reuberson, J. A.</span>; <span class="NLM_string-name">Selby, M. D.</span>; <span class="NLM_string-name">Shaw, M. A.</span>; <span class="NLM_string-name">Zhu, Z.</span>; <span class="NLM_string-name">Foley, A. M.</span></span> <span> </span><span class="NLM_article-title">TNF-alpha modulating benzimidazoles</span>. <span class="NLM_patent">WO 2013186229 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=D.+C.+Brookings&author=M.+D.+Calmiano&author=E.+O.+Galimore&author=H.+T.+Horsley&author=M.+C.+Hutchings&author=J.+A.+Johnson&author=B.+Kroeplien&author=F.+C.+Lecomte&author=M.+A.+Lowe&author=T.+J.+Norman&author=J.+R.+Porter&author=J.+R.+Quincey&author=J.+A.+Reuberson&author=M.+D.+Selby&author=M.+A.+Shaw&author=Z.+Zhu&author=A.+M.+Foley&title=TNF-alpha+modulating+benzimidazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrookings%26aufirst%3DD.%2BC.%26atitle%3DTNF-alpha%2520modulating%2520benzimidazoles%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="note"><p class="first last">We followed the chain nomenclature of O’Connell<a onclick="showRef(event, 'cit7a'); return false;" href="javascript:void(0);" class="ref cit7a">(7a)</a> where the chain whose orientation is most distorted from symmetrical TNFα trimer, is labeled A. When the trimer is viewed from the side of the C-termini, O’Connell<a onclick="showRef(event, 'cit7a'); return false;" href="javascript:void(0);" class="ref cit7a">(7a)</a> have labeled their chains in counterclockwise order whereas all other TNFα structures when viewed from the same direction are labeled in clockwise order.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="note"><p class="first last">The non-bonded interactions were calculated using the Jaguar hydrogen bond workflow as implemented in Jaguar v 2020-2</p></div><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braden, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">Pseudospectral local second-order Møller–Plesset methods for computation of hydrogen bonding energies of molecular pairs</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1021/ct049880o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct049880o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BD2MXovFSktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=248-254&author=G.+A.+Kaminskiauthor=J.+R.+Mapleauthor=R.+B.+Murphyauthor=D.+A.+Bradenauthor=R.+A.+Friesner&title=Pseudospectral+local+second-order+M%C3%B8ller%E2%80%93Plesset+methods+for+computation+of+hydrogen+bonding+energies+of+molecular+pairs&doi=10.1021%2Fct049880o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Pseudospectral Local Second-Order Moller-Plesset Methods for Computation of Hydrogen Bonding Energies of Molecular Pairs</span></div><div class="casAuthors">Kaminski, George A.; Maple, Jon R.; Murphy, Robert B.; Braden, Dale A.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">248-254</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a methodol. for computing the binding energy of mol. dimers based on extrapolation of pseudospectral local second-order Moller-Plesset (MP2), or PS-LMP2, energies to the basis set limit.  The extrapolation protocol is based on carrying out PS-LMP2 calcns. with the Dunning cc-pVTZ (-f) and cc-pVQZ (-g) basis sets and then using a simple two-parameter function to compute the final basis set limit results.  The function is parametrized to ultralarge basis set MP2 calcns. for 5 mol. pairs taken from the literature and then tested by calcg. results for a set of formamide dimers for which such calcns. have also been carried out.  The results agree to within ca. 0.2 kcal/mol with the conventional MP2 large basis set calcns.  A specialized, but relatively simple, protocol is described for eliminating noise due to overcompleteness of the basis set.  Timing results are presented for the LMP2 calcns., and comparisons are made with the LMP2 methodol. of the QChem program.  CPU time required by each of the methods scales as N3, where N is the no. of the basis functions, with the PS-LMP2 approach displaying a 2- to 3-fold advantage in the prefactor.  We also discuss one set of test cases for which the PS-LMP2 results disagree with those obtained from an alternative type of MP2 calcn., N-Me acetamide (NMA) dimers, and show that the results for liq.-state simulations using polarizable parameters derived by fitting to the PS-LMP2 binding energies appear to produce better results when compared with exptl. data.  The convergence issues assocd. with the alternative MP2 formulation remain to be investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlNpf06OE2CrVg90H21EOLACvtfcHk0ljmTVBW1W9sfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXovFSktA%253D%253D&md5=3c4247bc2e3620b9e25d15822f2fa379</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fct049880o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct049880o%26sid%3Dliteratum%253Aachs%26aulast%3DKaminski%26aufirst%3DG.%2BA.%26aulast%3DMaple%26aufirst%3DJ.%2BR.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DBraden%26aufirst%3DD.%2BA.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DPseudospectral%2520local%2520second-order%2520M%25C3%25B8ller%25E2%2580%2593Plesset%2520methods%2520for%2520computation%2520of%2520hydrogen%2520bonding%2520energies%2520of%2520molecular%2520pairs%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2005%26volume%3D1%26spage%3D248%26epage%3D254%26doi%3D10.1021%2Fct049880o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9"><span> <i>Schrodinger Release 2020-2: Jaguar</i>; <span class="NLM_publisher-name">Schrodinger LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schrodinger+Release+2020-2%3A+Jaguar%3B+Schrodinger+LLC%3A+New+York%2C+NY%2C+2020."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchrodinger%2520Release%25202020-2%253A%2520Jaguar%26pub%3DSchrodinger%2520LLC%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Read, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitley, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Best, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, T.</span></span> <span> </span><span class="NLM_article-title">Tumor necrosis factor α-induced E-selectin expression is activated by the nuclear factor-kB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">2753</span>– <span class="NLM_lpage">2761</span>, <span class="refDoi"> DOI: 10.1074/jbc.272.5.2753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1074%2Fjbc.272.5.2753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=9006914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADyaK2sXpslersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=2753-2761&author=M.+A.+Readauthor=M.+Z.+Whitleyauthor=S.+Guptaauthor=J.+W.+Pierceauthor=J.+Bestauthor=R.+J.+Davisauthor=T.+Collins&title=Tumor+necrosis+factor+%CE%B1-induced+E-selectin+expression+is+activated+by+the+nuclear+factor-kB+and+c-JUN+N-terminal+kinase%2Fp38+mitogen-activated+protein+kinase+pathways&doi=10.1074%2Fjbc.272.5.2753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor necrosis factor α-induced E-selectin expression is activated by the nuclear factor-κB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways</span></div><div class="casAuthors">Read, Margaret A.; Whitley, Maryann Z.; Gupta, Shashi; Pierce, Jacqueline W.; Best, Jennifer; Davis, Roger J.; Collins, Tucker</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2753-2761</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">E-selectin expression by endothelium is crucial for leukocyte recruitment during inflammatory responses.  Transcriptional regulation of the E-selectin promoter by tumor necrosis factor α (TNFα) requires multiple nuclear factor-κB (NF-κB) binding sites and a cAMP-responsive element/activating transcription factor-like binding site designated pos. domain II (PDII).  Here the authors characterize the role of the stress-activated family of mitogen-activated protein (MAP) kinases in induced expression of this adhesion mol.  By UV crosslinking and immunopptn., the authors demonstrated that a heterodimer of transcription factors ATF-2 and c-JUN is constitutively bound to the PDII site.  TNFα stimulation of endothelial cells induces transient phosphorylation of both ATF-2 and c-JUN and induces marked activation of the c-JUN N-terminal kinase (JNK1) and p38 but not extracellular signal-regulated kinase (ERK1).  JNK and p38 are constitutively present in the nucleus, and DNA-bound c-JUN and ATF-2 are stably contacted by JNK and p38, resp.  MAP/ERK kinase kinase 1 (MEEK1), an upstream activator of MAP kinases, increases E-selectin promoter transcription and requires an intact PDII site for maximal induction.  MEKK1 can also activate NF-κB-dependent gene expression.  The effects of dominant interfering forms of the JNK/p38 signaling pathway demonstrate that activation of these kinases is crit. for cytokine-induced E-selectin gene expression.  Thus, TNFα activates 2 signaling pathways, NF-κB and JNK/p38, which are both required for maximal expression of E-selectin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomcbWscJDfcrVg90H21EOLACvtfcHk0ljmTVBW1W9sfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXpslersw%253D%253D&md5=25d8a744712b64f849a71c30b5afd28d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.5.2753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.5.2753%26sid%3Dliteratum%253Aachs%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DWhitley%26aufirst%3DM.%2BZ.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DPierce%26aufirst%3DJ.%2BW.%26aulast%3DBest%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26aulast%3DCollins%26aufirst%3DT.%26atitle%3DTumor%2520necrosis%2520factor%2520%25CE%25B1-induced%2520E-selectin%2520expression%2520is%2520activated%2520by%2520the%2520nuclear%2520factor-kB%2520and%2520c-JUN%2520N-terminal%2520kinase%252Fp38%2520mitogen-activated%2520protein%2520kinase%2520pathways%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D2753%26epage%3D2761%26doi%3D10.1074%2Fjbc.272.5.2753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, H.-Y.</span>; <span class="NLM_string-name">Dhar, T. G. M.</span>; <span class="NLM_string-name">Li, N.</span>; <span class="NLM_string-name">Duan, J.</span>; <span class="NLM_string-name">Jiang, B.</span>; <span class="NLM_string-name">Lu, Z.</span>; <span class="NLM_string-name">Khehyong, N.</span>; <span class="NLM_string-name">Pitts, W. J.</span>; <span class="NLM_string-name">Tino, J.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic compounds useful as modulators of TNF alpha</span>. <span class="NLM_patent">WO 2017023905 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=H.-Y.+Xiao&author=T.+G.+M.+Dhar&author=N.+Li&author=J.+Duan&author=B.+Jiang&author=Z.+Lu&author=N.+Khehyong&author=W.+J.+Pitts&author=J.+Tino&title=Heterocyclic+compounds+useful+as+modulators+of+TNF+alpha"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DH.-Y.%26atitle%3DHeterocyclic%2520compounds%2520useful%2520as%2520modulators%2520of%2520TNF%2520alpha%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c','cit5d','cit5e','cit5f','cit5g','cit5h'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7a','cit7b'],'ref8':[],'ref9':['cit9a','cit9'],'ref10':['cit10'],'ref11':['cit11']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiamin  Zheng</span>, <span class="hlFld-ContribAuthor ">Dongdong  Chen</span>, <span class="hlFld-ContribAuthor ">Jie  Xu</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Yao  Wu</span>, <span class="hlFld-ContribAuthor ">Hong C.  Shen</span>, <span class="hlFld-ContribAuthor ">Xuefei  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule approaches to treat autoimmune and inflammatory diseases (Part III): Targeting cytokines and cytokine receptor complexes. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>48 </em>, 128229. <a href="https://doi.org/10.1016/j.bmcl.2021.128229" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128229%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSmall%252Bmolecule%252Bapproaches%252Bto%252Btreat%252Bautoimmune%252Band%252Binflammatory%252Bdiseases%252B%252528Part%252BIII%252529%25253A%252BTargeting%252Bcytokines%252Band%252Bcytokine%252Breceptor%252Bcomplexes%26aulast%3DZheng%26aufirst%3DJiamin%26date%3D2021%26volume%3D48%26spage%3D128229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Dömling</span>, <span class="hlFld-ContribAuthor ">Xin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">TNF-α: The shape of small molecules to come?. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>138 </em><a href="https://doi.org/10.1016/j.drudis.2021.06.018" title="DOI URL">https://doi.org/10.1016/j.drudis.2021.06.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2021.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2021.06.018%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DTNF-%2525CE%2525B1%25253A%252BThe%252Bshape%252Bof%252Bsmall%252Bmolecules%252Bto%252Bcome%25253F%26aulast%3DD%25C3%25B6mling%26aufirst%3DAlexander%26date%3D2021%26volume%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Scaffold hopping approach to novel inhibitors of TNFα.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 4-Amino-6-substituted Quinolines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) camphor-10-sulfonic acid, 150 °C; (b) R<sup>3</sup>B(OR)<sub>2</sub> (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> for R<sub>3</sub>), K<sub>2</sub>CO<sub>3</sub>, dioxane, PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct, 100 °C (22–81% over two steps).</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray co-crystal structure of compound <b>16</b> with TNFα. Chain A is colored orange, chain B is blue, and chain C is purple. Compound <b>16</b> is shown in yellow. Waters are rendered as red spheres. Hydrogen bonds between compound <b>16</b> and TNF are shown as yellow dashed lines. Omit <i>F</i><sub>o</sub>–<i>F</i><sub>c</sub> electron density was contoured at 3.0 rmsd (gray) (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7JRA">7JRA</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Optimization of <b>39</b><sup>a</sup>. <sup>a</sup>Standard deviation (SD) is provided for means of three or more experiments. Where SD is not provided, values are means of two or more experiments. <sup>b</sup>Metabolic stability in human and mouse liver microsome; values are the percentage of parent remaining after 10 min of incubation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Sedimentation velocity results of TNF (10 μM) and TNFR1 (15 μM) alone and in combination with or without compound <b>42</b> (25 μM). Molecular size, in terms of the sedimentation coefficient, is plotted as a function of relative concentration, in absorbance units, per <i>S</i> value, at the wavelength used for the detection of 280 nm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mouse TNFα-induced PK–PD model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Efficacy of <b>42</b> in a Mouse CAIA model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the 4-Amino-quinoline Analogue <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>43</b>, B<sub>2</sub>pin<sub>2</sub>, PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct, KOAc, dioxane, 80 °C, then <b>4</b>, K<sub>2</sub>CO<sub>3</sub>, 100 °C, 76%; (b) <b>45</b>, camphor-10-sulfonic acid, DMA, 140 °C, 90%; and (c) ChiralPak AS-H (3 × 25 cm, 5 μm), 40% desired enantiomer <b>16</b>.</p></p></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/medium/jm0c01732_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 1,5-Naphthyridine Analogue <b>42</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01732/20201203/images/large/jm0c01732_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01732&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) AcOH and toluene, reflux, 42%; (b) Ph<sub>2</sub>O, 250 °C, 78%; (c) NCS and AcOH, 65 °C, 72%; (d) POCl<sub>3</sub>, 105 °C, 68%; (e) <b>43</b>, B<sub>2</sub>pin<sub>2</sub>, PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct, KOAc, and dioxane, 80 °C, then <b>50</b>, K<sub>2</sub>CO<sub>3</sub>, 100 °C, 44%; (f) <b>52</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, and toluene, 100 °C, 84%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 11 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Locksley, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Killeen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenardo, M. J.</span></span> <span> </span><span class="NLM_article-title">The TNF and TNF receptor superfamilies: integrating mammalian biology</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1016/s0092-8674(01)00237-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1016%2FS0092-8674%2801%2900237-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=11239407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BD3MXis1KksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=487-501&author=R.+M.+Locksleyauthor=N.+Killeenauthor=M.+J.+Lenardo&title=The+TNF+and+TNF+receptor+superfamilies%3A+integrating+mammalian+biology&doi=10.1016%2Fs0092-8674%2801%2900237-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The TNF and TNF receptor superfamilies: integrating mammalian biology</span></div><div class="casAuthors">Locksley, Richard M.; Killeen, Nigel; Lenardo, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">487-501</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with over 100 refs.  Topics discussed include structure-function relationships of tumor necrosis factor receptors; pivotal modes of signaling; tumor necrosis factor and receptors as cellular organizers in metazoans; role in immunity; cell death; acute inflammation; bone and mammary gland homeostasis; hair follicle and sweat gland development; genetic diseases of tumor necrosis factor receptors; and genomic and sequence relationships of tumor necrosis factor and receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGvXSzzXucDLVg90H21EOLACvtfcHk0ljnJwl1ec-Qug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXis1KksrY%253D&md5=78e12b79221e664c35291f11feb998a0</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900237-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900237-9%26sid%3Dliteratum%253Aachs%26aulast%3DLocksley%26aufirst%3DR.%2BM.%26aulast%3DKilleen%26aufirst%3DN.%26aulast%3DLenardo%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520TNF%2520and%2520TNF%2520receptor%2520superfamilies%253A%2520integrating%2520mammalian%2520biology%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D487%26epage%3D501%26doi%3D10.1016%2Fs0092-8674%2801%2900237-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, B. B.</span></span> <span> </span><span class="NLM_article-title">Signalling pathways of the TNF superfamily: a double-edged sword</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">745</span>– <span class="NLM_lpage">756</span>, <span class="refDoi"> DOI: 10.1038/nri1184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1038%2Fnri1184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=12949498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVWmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=745-756&author=B.+B.+Aggarwal&title=Signalling+pathways+of+the+TNF+superfamily%3A+a+double-edged+sword&doi=10.1038%2Fnri1184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Signalling pathways of the TNF superfamily: a double-edged sword</span></div><div class="casAuthors">Aggarwal, Bharat B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">745-756</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Two different tumor-necrosis factors (TNFs), first isolated in 1984, were cytotoxic to tumor cells and to induce tumor regression in mice.  Research during the past two decades has shown the existence of a superfamily of TNF proteins consisting of 19 members that signal through 29 receptors.  These ligands, while regulating normal functions such as immune responses, hematopoiesis and morphogenesis, have also been implicated in tumorigenesis, transplant rejection, septic shock, viral replication, bone resorption, rheumatoid arthritis and diabetes; so indicating their role as 'double-edged swords'.  These cytokines either induce cellular proliferation, survival, differentiation or apoptosis.  Blockers of TNF have been approved for human use in treating TNF-linked autoimmune diseases in the United States and other countries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLbPm1fw2He7Vg90H21EOLACvtfcHk0lj22BsGt9fRKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVWmtb0%253D&md5=3cf33b638795bd0b2492aded83dbad51</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnri1184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1184%26sid%3Dliteratum%253Aachs%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DSignalling%2520pathways%2520of%2520the%2520TNF%2520superfamily%253A%2520a%2520double-edged%2520sword%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2003%26volume%3D3%26spage%3D745%26epage%3D756%26doi%3D10.1038%2Fnri1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hehlgans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeffer, K.</span></span> <span> </span><span class="NLM_article-title">The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games</span>. <i>Immunology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2567.2005.02143.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1111%2Fj.1365-2567.2005.02143.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=15819693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFaqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=1-20&author=T.+Hehlgansauthor=K.+Pfeffer&title=The+intriguing+biology+of+the+tumour+necrosis+factor%2Ftumour+necrosis+factor+receptor+superfamily%3A+players%2C+rules+and+the+games&doi=10.1111%2Fj.1365-2567.2005.02143.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: Players, rules and the games</span></div><div class="casAuthors">Hehlgans, Thomas; Pfeffer, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-20</span>CODEN:
                <span class="NLM_cas:coden">IMMUAM</span>;
        ISSN:<span class="NLM_cas:issn">0019-2805</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The members of the tumor necrosis factor (TNF)/tumor necrosis factor receptor (TNFR) superfamily are critically involved in the maintenance of homeostasis of the immune system.  The biol. functions of this system encompass beneficial and protective effects in inflammation and host defense as well as a crucial role in organogenesis.  At the same time, members of this superfamily are responsible for host damaging effects in sepsis, cachexia, and autoimmune diseases.  This review summarizes recent progress in the immunbiol. of the TNF/TNFR superfamily focusing on results obtained from animal studies using gene targeted mice.  The different modes of signalling pathways affecting cell proliferation, survival, differentiation, apoptosis, and immune organ development as well as host defense are reviewed.  Mol. and cellular mechanisms that demonstrate a therapeutic potential by targeting individual receptors or ligands for the treatment of chronic inflammatory or autoimmune diseases are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOKlXHDZr0BrVg90H21EOLACvtfcHk0lj22BsGt9fRKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFaqtrs%253D&md5=89ac7ee81e26aa711301368bebccb60e</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2567.2005.02143.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2567.2005.02143.x%26sid%3Dliteratum%253Aachs%26aulast%3DHehlgans%26aufirst%3DT.%26aulast%3DPfeffer%26aufirst%3DK.%26atitle%3DThe%2520intriguing%2520biology%2520of%2520the%2520tumour%2520necrosis%2520factor%252Ftumour%2520necrosis%2520factor%2520receptor%2520superfamily%253A%2520players%252C%2520rules%2520and%2520the%2520games%26jtitle%3DImmunology%26date%3D2005%26volume%3D115%26spage%3D1%26epage%3D20%26doi%3D10.1111%2Fj.1365-2567.2005.02143.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bodmer, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, J.</span></span> <span> </span><span class="NLM_article-title">The molecular architecture of the TNF superfamily</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/s0968-0004(01)01995-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1016%2FS0968-0004%2801%2901995-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=11796220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVOmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=19-26&author=J.-L.+Bodmerauthor=P.+Schneiderauthor=J.+Tschopp&title=The+molecular+architecture+of+the+TNF+superfamily&doi=10.1016%2Fs0968-0004%2801%2901995-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular architecture of the TNF superfamily</span></div><div class="casAuthors">Bodmer, Jean-Luc; Schneider, Pascal; Tschopp, Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-26</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Ligands of the TNF (tumor necrosis factor) superfamily have pivotal roles in the organization and function of the immune system, and are implicated in the etiol. of several acquired and genetic diseases.  TNF ligands share a common structural motif, the TNF homol. domain (THD), which binds to cysteine-rich domains (CRDs) of TNF receptors.  CRDs are composed of structural modules, whose variation in no. and type confers heterogeneity upon the family.  Protein folds reminiscent of the THD and CRD are also found in other protein families, raising the possibility that the mode of interaction between TNF and TNF receptors might be conserved in other contexts.  Tumor necrosis ligands and receptors have a widespread biol. activity range, yet they display a remarkably conserved structure and mode of interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWfO_ssPYH-LVg90H21EOLACvtfcHk0lj22BsGt9fRKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVOmtw%253D%253D&md5=dd6bfc0ea79a01fc67e1003614c1c2ea</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0968-0004%2801%2901995-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0004%252801%252901995-8%26sid%3Dliteratum%253Aachs%26aulast%3DBodmer%26aufirst%3DJ.-L.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DThe%2520molecular%2520architecture%2520of%2520the%2520TNF%2520superfamily%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2002%26volume%3D27%26spage%3D19%26epage%3D26%26doi%3D10.1016%2Fs0968-0004%2801%2901995-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Regulation of tumour necrosis factor signalling: live or let die</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1038/nri3834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1038%2Fnri3834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=26008591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=362-374&author=D.+Brennerauthor=H.+Blaserauthor=T.+W.+Mak&title=Regulation+of+tumour+necrosis+factor+signalling%3A+live+or+let+die&doi=10.1038%2Fnri3834"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of tumour necrosis factor signalling: live or let die</span></div><div class="casAuthors">Brenner, Dirk; Blaser, Heiko; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">362-374</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor necrosis factor (TNF) is a pro-inflammatory cytokine that has important roles in mammalian immunity and cellular homeostasis.  Deregulation of TNF receptor (TNFR) signalling is assocd. with many inflammatory disorders, including various types of arthritis and inflammatory bowel disease, and targeting TNF has been an effective therapeutic strategy in these diseases.  This Review focuses on the recent advances that have been made in understanding TNFR signalling and the consequences of its deregulation for cellular survival, apoptosis and regulated necrosis.  We discuss how TNF-induced survival signals are distinguished from those that lead to cell death.  Finally, we provide a brief overview of the role of TNF in inflammatory and autoimmune diseases, and we discuss up-to-date and future treatment strategies for these disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwd5YDL8raprVg90H21EOLACvtfcHk0lg5vLxJaW__1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeit7jJ&md5=adc251b8af3f6e4d5fc04262c597f67f</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fnri3834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3834%26sid%3Dliteratum%253Aachs%26aulast%3DBrenner%26aufirst%3DD.%26aulast%3DBlaser%26aufirst%3DH.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DRegulation%2520of%2520tumour%2520necrosis%2520factor%2520signalling%253A%2520live%2520or%2520let%2520die%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2015%26volume%3D15%26spage%3D362%26epage%3D374%26doi%3D10.1038%2Fnri3834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dostert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grusdat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letellier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D.</span></span> <span> </span><span class="NLM_article-title">The TNF family of ligands and receptors: communication modules in the immune system and beyond</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1152/physrev.00045.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1152%2Fphysrev.00045.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=30354964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsF2kt77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2019&pages=115-160&author=C.+Dostertauthor=M.+Grusdatauthor=E.+Letellierauthor=D.+Brenner&title=The+TNF+family+of+ligands+and+receptors%3A+communication+modules+in+the+immune+system+and+beyond&doi=10.1152%2Fphysrev.00045.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The TNF family of ligands and receptors: communication modules in the immune system and beyond</span></div><div class="casAuthors">Dostert, Catherine; Grusdat, Melanie; Letellier, Elisabeth; Brenner, Dirk</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-160</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">1522-1210</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The tumor necrosis factor (TNF) and TNF receptor (TNFR) superfamilies (TNFSF/TNFRSF) include 19 ligands and 29 receptors that play important roles in the modulation of cellular functions.  The communication pathways mediated by TNFSF/ TNFRSF are essential for numerous developmental, homeostatic, and stimulus-responsive processes in vivo.  TNFSF/TNFRSF members regulate cellular differentiation, survival, and programmed death, but their most crit. functions pertain to the immune system.  Both innate and adaptive immune cells are controlled by TNFSF/TNFRSF members in a manner that is crucial for the coordination of various mechanisms driving either co-stimulation or co-inhibition of the immune response.  Dysregulation of these same signaling pathways has been implicated in inflammatory and autoimmune diseases, highlighting the importance of their tight regulation.  Investigation of the control of TNFSF/TNFRSF activities has led to the development of therapeutics with the potential to reduce chronic inflammation or promote anti-tumor immunity.  The study of TNFSF/TNFRSF proteins has exploded over the last 30 yr, but there remains a need to better understand the fundamental mechanisms underlying the mol. pathways they mediate to design more effective anti-inflammatory and anti-cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvm0w9gyONO7Vg90H21EOLACvtfcHk0lg5vLxJaW__1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsF2kt77N&md5=283e0d7e025be7dc4f9bfebff8dca55e</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00045.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00045.2017%26sid%3Dliteratum%253Aachs%26aulast%3DDostert%26aufirst%3DC.%26aulast%3DGrusdat%26aufirst%3DM.%26aulast%3DLetellier%26aufirst%3DE.%26aulast%3DBrenner%26aufirst%3DD.%26atitle%3DThe%2520TNF%2520family%2520of%2520ligands%2520and%2520receptors%253A%2520communication%2520modules%2520in%2520the%2520immune%2520system%2520and%2520beyond%26jtitle%3DPhysiol.%2520Rev.%26date%3D2019%26volume%3D99%26spage%3D115%26epage%3D160%26doi%3D10.1152%2Fphysrev.00045.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cessak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuzawińska, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojnar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirowska-Guzel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bałkowiec-Iskra, E.</span></span> <span> </span><span class="NLM_article-title">TNF inhibitors—mechanisms of action, approved and off-label indications</span>. <i>Pharmacol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">836</span>– <span class="NLM_lpage">844</span>, <span class="refDoi"> DOI: 10.1016/j.pharep.2014.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1016%2Fj.pharep.2014.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=25149988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmt1Shtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=836-844&author=G.+Cessakauthor=O.+Kuzawi%C5%84skaauthor=A.+Burdaauthor=K.+Lisauthor=M.+Wojnarauthor=D.+Mirowska-Guzelauthor=E.+Ba%C5%82kowiec-Iskra&title=TNF+inhibitors%E2%80%94mechanisms+of+action%2C+approved+and+off-label+indications&doi=10.1016%2Fj.pharep.2014.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">TNF inhibitors - Mechanisms of action, approved and off-label indications</span></div><div class="casAuthors">Cessak, Grzegorz; Kuzawinska, Olga; Burda, Agnieszka; Lis, Krzysztof; Wojnar, Marcin; Mirowska-Guzel, Dagmara; Balkowiec-Iskra, Ewa</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">836-844</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">2299-5684</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tumor necrosis factor inhibitors (TNFi) belong to the group of biol. drugs, holding presently top positions on lists of most profitable products for pharmaceutical companies.  Although current indications for TNFi include only selected diseases with an established role of immune dysfunction in their pathogenesis, studies on new indications are being carried out all over the world.  The most important aspect of TNFi therapy is a targeted therapeutic approach, allowing to avoid a wide range of side effects assocd. with treatment with nonspecific immunosuppressive agents.  Results of the trials on TNFi in the approved indications are widely accessible and analyzed elsewhere, both in primary publications as well as in systematic reviews and meta-analyses.  Here we aim to discuss their mechanisms of action, and approved, as well as off-label indications of TNFi.  In addn., we present comprehensive evidence on TNFi in treatment of rheumatoid arthritis (RA); the first authorized and probably most extensively developed indication for the majority of TNFi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa12p20fRqLLVg90H21EOLACvtfcHk0lg5vLxJaW__1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmt1Shtbo%253D&md5=6b10db2e8aac8727c6c9a1a999021e38</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pharep.2014.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharep.2014.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DCessak%26aufirst%3DG.%26aulast%3DKuzawi%25C5%2584ska%26aufirst%3DO.%26aulast%3DBurda%26aufirst%3DA.%26aulast%3DLis%26aufirst%3DK.%26aulast%3DWojnar%26aufirst%3DM.%26aulast%3DMirowska-Guzel%26aufirst%3DD.%26aulast%3DBa%25C5%2582kowiec-Iskra%26aufirst%3DE.%26atitle%3DTNF%2520inhibitors%25E2%2580%2594mechanisms%2520of%2520action%252C%2520approved%2520and%2520off-label%2520indications%26jtitle%3DPharmacol.%2520Rep.%26date%3D2014%26volume%3D66%26spage%3D836%26epage%3D844%26doi%3D10.1016%2Fj.pharep.2014.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">He, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oslob, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braisted, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cancilla, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wamg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugovskoy, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoburn, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrington, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldredge, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruz, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cachero, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choong, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, B. C.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibition of TNF-alpha</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>310</i></span>,  <span class="NLM_fpage">1022</span>– <span class="NLM_lpage">1025</span>, <span class="refDoi"> DOI: 10.1126/science.1116304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1126%2Fscience.1116304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=16284179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2is7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2005&pages=1022-1025&author=M.+M.+Heauthor=A.+S.+Smithauthor=J.+D.+Oslobauthor=W.+M.+Flanaganauthor=A.+C.+Braistedauthor=A.+Whittyauthor=M.+T.+Cancillaauthor=J.+Wamgauthor=A.+A.+Lugovskoyauthor=J.+C.+Yoburnauthor=A.+D.+Fungauthor=G.+Farringtonauthor=J.+K.+Eldredgeauthor=E.+S.+Dayauthor=L.+A.+Cruzauthor=T.+G.+Cacheroauthor=S.+K.+Millerauthor=J.+E.+Friedmanauthor=I.+C.+Choongauthor=B.+C.+Cunningham&title=Small-molecule+inhibition+of+TNF-alpha&doi=10.1126%2Fscience.1116304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Inhibition of TNF-α</span></div><div class="casAuthors">He, Molly M.; Smith, Annemarie Stroustrup; Oslob, Johan D.; Flanagan, William M.; Braisted, Andrew C.; Whitty, Adrian; Cancilla, Mark T.; Wang, Jun; Lugovskoy, Alexey A.; Yoburn, Josh C.; Fung, Amy D.; Farrington, Graham; Eldredge, John K.; Day, Eric S.; Cruz, Leslie A.; Cachero, Teresa G.; Miller, Stephan K.; Friedman, Jessica E.; Choong, Ingrid C.; Cunningham, Brian C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">5750</span>),
    <span class="NLM_cas:pages">1022-1025</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have identified a small-mol. inhibitor of tumor necrosis factor α (TNF-α) that promotes subunit disassembly of this trimeric cytokine family member.  The compd. inhibits TNF-α activity in biochem. and cell-based assays with median inhibitory concns. of 22 and 4.6 micromolar, resp.  Formation of an intermediate complex between the compd. and the intact trimer results in a 600-fold accelerated subunit dissocn. rate that leads to trimer dissocn.  A structure solved by x-ray crystallog. reveals that a single compd. mol. displaces a subunit of the trimer to form a complex with a dimer of TNF-α subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvbBjoYzi8XbVg90H21EOLACvtfcHk0lgUBDVxaYNrOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2is7nJ&md5=3747a5ad9afb75e9da5d878b73903bf4</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1116304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1116304%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DM.%2BM.%26aulast%3DSmith%26aufirst%3DA.%2BS.%26aulast%3DOslob%26aufirst%3DJ.%2BD.%26aulast%3DFlanagan%26aufirst%3DW.%2BM.%26aulast%3DBraisted%26aufirst%3DA.%2BC.%26aulast%3DWhitty%26aufirst%3DA.%26aulast%3DCancilla%26aufirst%3DM.%2BT.%26aulast%3DWamg%26aufirst%3DJ.%26aulast%3DLugovskoy%26aufirst%3DA.%2BA.%26aulast%3DYoburn%26aufirst%3DJ.%2BC.%26aulast%3DFung%26aufirst%3DA.%2BD.%26aulast%3DFarrington%26aufirst%3DG.%26aulast%3DEldredge%26aufirst%3DJ.%2BK.%26aulast%3DDay%26aufirst%3DE.%2BS.%26aulast%3DCruz%26aufirst%3DL.%2BA.%26aulast%3DCachero%26aufirst%3DT.%2BG.%26aulast%3DMiller%26aufirst%3DS.%2BK.%26aulast%3DFriedman%26aufirst%3DJ.%2BE.%26aulast%3DChoong%26aufirst%3DI.%2BC.%26aulast%3DCunningham%26aufirst%3DB.%2BC.%26atitle%3DSmall-molecule%2520inhibition%2520of%2520TNF-alpha%26jtitle%3DScience%26date%3D2005%26volume%3D310%26spage%3D1022%26epage%3D1025%26doi%3D10.1126%2Fscience.1116304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Japonicone A antagonizes the activity of TNF-alpha by directly targeting this cytokine and selectively disrupting its interaction with TNF receptor-1</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1482</span>– <span class="NLM_lpage">1491</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2012.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1016%2Fj.bcp.2012.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=22981364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlKrs7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=1482-1491&author=Z.+Huauthor=J.+Qinauthor=H.+Zhangauthor=D.+Wangauthor=Y.+Huaauthor=J.+Dingauthor=L.+Shanauthor=H.+Jinauthor=J.+Zhangauthor=W.+Zhang&title=Japonicone+A+antagonizes+the+activity+of+TNF-alpha+by+directly+targeting+this+cytokine+and+selectively+disrupting+its+interaction+with+TNF+receptor-1&doi=10.1016%2Fj.bcp.2012.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Japonicone A antagonizes the activity of TNF-α by directly targeting this cytokine and selectively disrupting its interaction with TNF receptor-1</span></div><div class="casAuthors">Hu, Zhenlin; Qin, Jiangjiang; Zhang, Huahua; Wang, Dan; Hua, Yaping; Ding, Jieping; Shan, Lei; Jin, Huizi; Zhang, Junping; Zhang, Weidong</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1482-1491</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Anti-TNF biologics are effective therapies for various inflammatory diseases.  Unfortunately, their clin. use is assocd. with an increased risk of infections.  Selectively inhibiting TNF receptor-1 (TNFR1)-mediated signaling while preserving TNFR2 signaling may reduce inflammation yet maintain host immune response to pathogens.  However, few small mols. that selectively target the TNF/TNFR system have been discovered.  In the present study, we identified Japonicone A (Jap A), a nature compd. derived from Inula japonica Thunb, as a novel TNF-α antagonist, as it reduced the TNF-α-mediated cytotoxicity on L929 cells and inhibited the binding of 125I-labeled TNF-α to L929 cell surface.  Furthermore, Jap A could directly bind to TNF-α rather than TNFR1 as detd. by surface plasmon resonance.  More importantly, Jap A could effectively inhibit the binding of TNF-α to TNFR1, while displaying only marginal inhibitory effects on that to TNFR2.  Jap A also could block TNFR1-mediated signaling as it inhibited TNF-α-induced NF-κB activation in 293 cells.  In addn., Jap A suppressed TNF-α-induced expressions of adhesion mols. (ICAM-1, VCAM-1) and chemokine (MCP-1) in the endothelial cells by blocking TNF-α-triggered multiple signaling pathways.  Data from in vivo expts. demonstrated that Jap A protected mice from acute hepatitis induced by TNF-α/d-galactosamine, but did not compromise host antiviral immunity in adenovirus-infected mice.  These results indicate that Jap A can directly target TNF-α, selectively disrupt its interaction with TNFR1, and antagonize its pro-inflammatory activities without compromising host defense against virus, thus emphasizing the potential of Jap A as an interesting lead compd. for development of new anti-inflammatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLXQAd_eTohLVg90H21EOLACvtfcHk0lgUBDVxaYNrOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlKrs7jM&md5=17868374003fe8b1d1b2224575f873a3</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DHua%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DShan%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DJaponicone%2520A%2520antagonizes%2520the%2520activity%2520of%2520TNF-alpha%2520by%2520directly%2520targeting%2520this%2520cytokine%2520and%2520selectively%2520disrupting%2520its%2520interaction%2520with%2520TNF%2520receptor-1%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D1482%26epage%3D1491%26doi%3D10.1016%2Fj.bcp.2012.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Luzi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadler, L. K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaysburd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holliger, P.</span></span> <span> </span><span class="NLM_article-title">Subunit disassembly and inhibition of TNFα by a semi-synthetic bicyclic peptide</span>. <i>Protein Eng., Des. Sel.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1093/protein/gzu055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1093%2Fprotein%2Fgzu055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=25614525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVOgt7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=45-52&author=S.+Luziauthor=Y.+Kondoauthor=E.+Bernardauthor=L.+K.+J.+Stadlerauthor=M.+Vaysburdauthor=G.+Winterauthor=P.+Holliger&title=Subunit+disassembly+and+inhibition+of+TNF%CE%B1+by+a+semi-synthetic+bicyclic+peptide&doi=10.1093%2Fprotein%2Fgzu055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Subunit disassembly and inhibition of TNF α by a semi-synthetic bicyclic peptide</span></div><div class="casAuthors">Luzi, Stefan; Kondo, Yasushi; Bernard, Elise; Stadler, Lukas K. J.; Vaysburd, Marina; Winter, Greg; Holliger, Philipp</div><div class="citationInfo"><span class="NLM_cas:title">Protein Engineering, Design & Selection</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">45-52</span>CODEN:
                <span class="NLM_cas:coden">PEDSBR</span>;
        ISSN:<span class="NLM_cas:issn">1741-0126</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Macrocyclic peptides are potentially a source of powerful drugs, but theirde novo discovery remains challenging.  Here we describe the discovery of a high-affinity (Kd = 10 nM) peptide macrocycle (M21) against human tumor necrosis factor-alpha (hTNFα), a key drug target in the treatment of inflammatory disorders, directly from diverse semi-synthetic phage peptide repertoires.  The bicyclic peptide M21 (ACPPCLWQVLC) comprises two loops covalently anchored to a 2,4,6-trimethyl-mesitylene core and upon binding induces disassembly of the trimeric TNFα cytokine into dimers and monomers.  A 2.9 Å crystal structure of the M21/hTNF̂I± complex reveals the peptide bound to a hTNFα dimer at a normally buried epitope in the trimer interface overlapping the binding site of a previously discovered small mol. ligand (SPD304), which also induces TNF trimer dissocn. and synergizes with M21 in the inhibition of TNFα cytotoxicity.  The discovery of M21 underlines the potential of semi-synthetic bicyclic peptides as ligands for the discovery of cryptic epitopes, some of which are poorly accessible to antibodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobgFV5_7SRTbVg90H21EOLACvtfcHk0lgUBDVxaYNrOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVOgt7fJ&md5=35574bfdcf3ec6d8e1db89933a58d640</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1093%2Fprotein%2Fgzu055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fprotein%252Fgzu055%26sid%3Dliteratum%253Aachs%26aulast%3DLuzi%26aufirst%3DS.%26aulast%3DKondo%26aufirst%3DY.%26aulast%3DBernard%26aufirst%3DE.%26aulast%3DStadler%26aufirst%3DL.%2BK.%2BJ.%26aulast%3DVaysburd%26aufirst%3DM.%26aulast%3DWinter%26aufirst%3DG.%26aulast%3DHolliger%26aufirst%3DP.%26atitle%3DSubunit%2520disassembly%2520and%2520inhibition%2520of%2520TNF%25CE%25B1%2520by%2520a%2520semi-synthetic%2520bicyclic%2520peptide%26jtitle%3DProtein%2520Eng.%252C%2520Des.%2520Sel.%26date%3D2015%26volume%3D28%26spage%3D45%26epage%3D52%26doi%3D10.1093%2Fprotein%2Fgzu055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Papaneophytou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexiou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papakyriakou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ntougkos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsiliouka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maranti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liepouri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strongilos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mettou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couladouros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eliopoulos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollias, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontopidis, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of potential small molecule inhibitors of tumor necrosis factor</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1196</span>– <span class="NLM_lpage">1209</span>, <span class="refDoi"> DOI: 10.1039/c5md00023h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1039%2FC5MD00023H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFOhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1196-1209&author=C.+Papaneophytouauthor=P.+Alexiouauthor=A.+Papakyriakouauthor=E.+Ntougkosauthor=K.+Tsilioukaauthor=A.+Marantiauthor=F.+Liepouriauthor=A.+Strongilosauthor=A.+Mettouauthor=E.+Couladourosauthor=E.+Eliopoulosauthor=E.+Douniauthor=G.+Kolliasauthor=G.+Kontopidis&title=Synthesis+and+biological+evaluation+of+potential+small+molecule+inhibitors+of+tumor+necrosis+factor&doi=10.1039%2Fc5md00023h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of potential small molecule inhibitors of tumor necrosis factor</span></div><div class="casAuthors">Papaneophytou, Christos; Alexiou, Polyxeni; Papakyriakou, Athanasios; Ntougkos, Evangelos; Tsiliouka, Katerina; Maranti, Anna; Liepouri, Fotini; Strongilos, Alexandros; Mettou, Anthi; Couladouros, Elias; Eliopoulos, Elias; Douni, Eleni; Kollias, George; Kontopidis, George</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1196-1209</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Inhibition of tumor necrosis factor (TNF) prodn. or function by small mols. has become a major focus in the pharmaceutical industry for the treatment of rheumatoid arthritis.  In this study, a series of 39 novel SPD-304 analogs were designed, synthesized and evaluated as TNF inhibitors.  Our results show that small structural changes produce ligands with similar binding affinities (Kd) for TNF, but significantly different potencies in a L929 cell-based assay.  In addn., contrary to the high affinity of compds. 4e, 8c and 10e for TNF in vitro, the potency of these compds. was detd. to be low.  We propose that these differences can partly be explained by the physicochem. characteristics of the synthesized SPD-304 analogs.  Our findings were supplemented by mol. docking studies on the TNF dimer.  These synthesized analogs may serve as a starting point for developing novel TNF inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtytnPovIwybVg90H21EOLACvtfcHk0lio-BKqJ2Nw8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFOhsLo%253D&md5=fcaf98943d905165678cddd3c3348aac</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1039%2FC5MD00023H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00023H%26sid%3Dliteratum%253Aachs%26aulast%3DPapaneophytou%26aufirst%3DC.%26aulast%3DAlexiou%26aufirst%3DP.%26aulast%3DPapakyriakou%26aufirst%3DA.%26aulast%3DNtougkos%26aufirst%3DE.%26aulast%3DTsiliouka%26aufirst%3DK.%26aulast%3DMaranti%26aufirst%3DA.%26aulast%3DLiepouri%26aufirst%3DF.%26aulast%3DStrongilos%26aufirst%3DA.%26aulast%3DMettou%26aufirst%3DA.%26aulast%3DCouladouros%26aufirst%3DE.%26aulast%3DEliopoulos%26aufirst%3DE.%26aulast%3DDouni%26aufirst%3DE.%26aulast%3DKollias%26aufirst%3DG.%26aulast%3DKontopidis%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520potential%2520small%2520molecule%2520inhibitors%2520of%2520tumor%2520necrosis%2520factor%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1196%26epage%3D1209%26doi%3D10.1039%2Fc5md00023h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mouhsine, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemain, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourati, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerrouki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desallais, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gizzi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Nasr, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratsimandresy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadoni, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">England, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagury, J.-F.</span></span> <span> </span><span class="NLM_article-title">Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3424</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-03427-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1038%2Fs41598-017-03427-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=28611375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A280%3ADC%252BC1cnnvF2jsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=3424&author=H.+Mouhsineauthor=H.+Guillemainauthor=G.+Moreauauthor=N.+Fouratiauthor=C.+Zerroukiauthor=B.+Baronauthor=L.+Desallaisauthor=P.+Gizziauthor=N.+Ben+Nasrauthor=J.+Perrierauthor=R.+Ratsimandresyauthor=J.-L.+Spadoniauthor=H.+Doauthor=P.+Englandauthor=M.+Montesauthor=J.-F.+Zagury&title=Identification+of+an+in+vivo+orally+active+dual-binding+protein-protein+interaction+inhibitor+targeting+TNF%CE%B1+through+combined+in+silico%2Fin+vitro%2Fin+vivo+screening&doi=10.1038%2Fs41598-017-03427-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening</span></div><div class="casAuthors">Mouhsine Hadley; Guillemain Helene; Moreau Gabriel; Desallais Lucille; Ben Nasr Nesrine; Perrier Julie; Ratsimandresy Rojo; Spadoni Jean-Louis; Do Herve; Montes Matthieu; Zagury Jean-Francois; Mouhsine Hadley; Guillemain Helene; Moreau Gabriel; Desallais Lucille; Do Herve; Fourati Najla; Zerrouki Chouki; Baron Bruno; England Patrick; Gizzi Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3424</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">TNFα is a homotrimeric pro-inflammatory cytokine, whose direct targeting by protein biotherapies has been an undeniable success for the treatment of chronic inflammatory diseases.  Despite many efforts, no orally active drug targeting TNFα has been identified so far.  In the present work, we identified through combined in silico/in vitro/in vivo approaches a TNFα direct inhibitor, compound 1, displaying nanomolar and micromolar range bindings to TNFα.  Compound 1 inhibits the binding of TNFα with both its receptors TNFRI and TNFRII.  Compound 1 inhibits the TNFα induced apoptosis on L929 cells and the TNFα induced NF-κB activation in HEK cells.  In vivo, oral administration of compound 1 displays a significant protection in a murine TNFα-dependent hepatic shock model.  This work illustrates the ability of low-cost combined in silico/in vitro/in vivo screening approaches to identify orally available small-molecules targeting challenging protein-protein interactions such as homotrimeric TNFα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRUkSBKybTdi6qcneEtCi92fW6udTcc2eYIuoFeduphKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnnvF2jsg%253D%253D&md5=06b2bdec45070ee7c7865e01ceba9c59</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-03427-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-03427-z%26sid%3Dliteratum%253Aachs%26aulast%3DMouhsine%26aufirst%3DH.%26aulast%3DGuillemain%26aufirst%3DH.%26aulast%3DMoreau%26aufirst%3DG.%26aulast%3DFourati%26aufirst%3DN.%26aulast%3DZerrouki%26aufirst%3DC.%26aulast%3DBaron%26aufirst%3DB.%26aulast%3DDesallais%26aufirst%3DL.%26aulast%3DGizzi%26aufirst%3DP.%26aulast%3DBen%2BNasr%26aufirst%3DN.%26aulast%3DPerrier%26aufirst%3DJ.%26aulast%3DRatsimandresy%26aufirst%3DR.%26aulast%3DSpadoni%26aufirst%3DJ.-L.%26aulast%3DDo%26aufirst%3DH.%26aulast%3DEngland%26aufirst%3DP.%26aulast%3DMontes%26aufirst%3DM.%26aulast%3DZagury%26aufirst%3DJ.-F.%26atitle%3DIdentification%2520of%2520an%2520in%2520vivo%2520orally%2520active%2520dual-binding%2520protein-protein%2520interaction%2520inhibitor%2520targeting%2520TNF%25CE%25B1%2520through%2520combined%2520in%2520silico%252Fin%2520vitro%252Fin%2520vivo%2520screening%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D3424%26doi%3D10.1038%2Fs41598-017-03427-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Blevitt, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hack, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krawczuk, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebsack, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, A. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirzadegan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelen, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milla, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lumb, K. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of small-molecule aggregate induced inhibition of a protein–protein interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3511</span>– <span class="NLM_lpage">3517</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01836</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01836" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktlSrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3511-3517&author=J.+M.+Blevittauthor=M.+D.+Hackauthor=K.+L.+Hermanauthor=P.+F.+Jacksonauthor=P.+J.+Krawczukauthor=A.+D.+Lebsackauthor=A.+X.+Liuauthor=T.+Mirzadeganauthor=M.+I.+Nelenauthor=A.+N.+Patrickauthor=S.+Steinbacherauthor=M.+E.+Millaauthor=K.+J.+Lumb&title=Structural+basis+of+small-molecule+aggregate+induced+inhibition+of+a+protein%E2%80%93protein+interaction&doi=10.1021%2Facs.jmedchem.6b01836"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5fR"><div class="casContent"><span class="casTitleNuber">5f</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis of Small-Molecule Aggregate Induced Inhibition of a Protein-Protein Interaction</span></div><div class="casAuthors">Blevitt, Jonathan M.; Hack, Michael D.; Herman, Krystal L.; Jackson, Paul F.; Krawczuk, Paul J.; Lebsack, Alec D.; Liu, Annie X.; Mirzadegan, Taraneh; Nelen, Marina I.; Patrick, Aaron N.; Steinbacher, Stefan; Milla, Marcos E.; Lumb, Kevin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3511-3517</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A prevalent observation in high-throughput screening and drug discovery programs is the inhibition of protein function by small-mol. compd. aggregation.  Here, the authors present the x-ray structural description of aggregation-based inhibition of a protein-protein interaction involving tumor necrosis factor α (TNFα).  An ordered conglomerate of an aggregating small-mol. inhibitor (JNJ525) induces a quaternary structure switch of TNFα that inhibits the protein-protein interaction between TNFα and TNFα receptors.  SPD-304 may employ a similar mechanism of inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbIRn5NHx_ibVg90H21EOLACvtfcHk0li9e81rohhpVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktlSrtr4%253D&md5=d1a750585d50de5089786d3780638d99</span></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01836%26sid%3Dliteratum%253Aachs%26aulast%3DBlevitt%26aufirst%3DJ.%2BM.%26aulast%3DHack%26aufirst%3DM.%2BD.%26aulast%3DHerman%26aufirst%3DK.%2BL.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26aulast%3DKrawczuk%26aufirst%3DP.%2BJ.%26aulast%3DLebsack%26aufirst%3DA.%2BD.%26aulast%3DLiu%26aufirst%3DA.%2BX.%26aulast%3DMirzadegan%26aufirst%3DT.%26aulast%3DNelen%26aufirst%3DM.%2BI.%26aulast%3DPatrick%26aufirst%3DA.%2BN.%26aulast%3DSteinbacher%26aufirst%3DS.%26aulast%3DMilla%26aufirst%3DM.%2BE.%26aulast%3DLumb%26aufirst%3DK.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520small-molecule%2520aggregate%2520induced%2520inhibition%2520of%2520a%2520protein%25E2%2580%2593protein%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3511%26epage%3D3517%26doi%3D10.1021%2Facs.jmedchem.6b01836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Saddala, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span> <span> </span><span class="NLM_article-title">Identifcation of novel inhibitors for TNFα, TNFR1 and TNFα-TNFR1 complex using pharmacophore-based approaches</span>. <i>J. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">215</span>, <span class="refDoi"> DOI: 10.1186/s12967-019-1965-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1186%2Fs12967-019-1965-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=31266509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A280%3ADC%252BB3MzjsVKiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=215&author=M.+S.+Saddalaauthor=H.+Huang&title=Identifcation+of+novel+inhibitors+for+TNF%CE%B1%2C+TNFR1+and+TNF%CE%B1-TNFR1+complex+using+pharmacophore-based+approaches&doi=10.1186%2Fs12967-019-1965-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5gR"><div class="casContent"><span class="casTitleNuber">5g</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel inhibitors for TNFα, TNFR1 and TNFα-TNFR1 complex using pharmacophore-based approaches</span></div><div class="casAuthors">Saddala Madhu Sudhana; Huang Hu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of translational medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">215</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Tumor necrosis factor α (TNFα) is a multifunctional cytokine with a potent pro-inflammatory effect.  It is a validated therapeutic target molecule for several disorders related to autoimmunity and inflammation.  TNFα-TNF receptor-1 (TNFR1) signaling contributes to the pathological processes of these disorders.  The current study is focused on finding novel small molecules that can directly bind to TNFα and/or TNFR1, preventing the interaction between TNFα or TNFR1, and regulating downstream signaling pathways.  METHODS:  Cheminformatics pipeline (pharmacophore modeling, virtual screening, molecular docking and in silico ADMET analysis) was used to screen for novel TNFα and TNFR1 inhibitors in the Zinc database.  The pharmacophore-based models were generated to screen for the best drug like compounds in the Zinc database.  RESULTS:  The 39, 37 and 45 best hit molecules were mapped with the core pharmacophore features of TNFα, TNFR1, and the TNFα-TNFR1 complex respectively.  They were further evaluated by molecular docking, protein-ligand interactions and in silico ADMET studies.  The molecular docking analysis revealed the binding energies of TNFα, TNFR1 and the TNFα-TNFR1 complex, the basis of which was used to select the top five best binding energy compounds.  Furthermore, in silico ADMET studies clearly revealed that all 15 compounds (ZINC09609430, ZINC49467549, ZINC13113075, ZINC39907639, ZINC25251930, ZINC02968981, ZINC09544246, ZINC58047088, ZINC72021182, ZINC08704414, ZINC05462670, ZINC35681945, ZINC23553920, ZINC05328058, and ZINC17206695) satisfied the Lipinski rule of five and had no toxicity.  CONCLUSIONS:  The new selective TNFα, TNFR1 and TNFα-TNFR1 complex inhibitors can serve as anti-inflammatory agents and are promising candidates for further research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-iLTdWoHMA1f1XRtfYM0dfW6udTcc2ebMZytyFSOsT7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzjsVKiuw%253D%253D&md5=3440357e5b7717cc3f677fbaa877c944</span></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=10.1186%2Fs12967-019-1965-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12967-019-1965-5%26sid%3Dliteratum%253Aachs%26aulast%3DSaddala%26aufirst%3DM.%2BS.%26aulast%3DHuang%26aufirst%3DH.%26atitle%3DIdentifcation%2520of%2520novel%2520inhibitors%2520for%2520TNF%25CE%25B1%252C%2520TNFR1%2520and%2520TNF%25CE%25B1-TNFR1%2520complex%2520using%2520pharmacophore-based%2520approaches%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2019%26volume%3D17%26spage%3D215%26doi%3D10.1186%2Fs12967-019-1965-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally active small-molecule tumor necrosis factor-α inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">8146</span>– <span class="NLM_lpage">8156</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00377</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00377" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtl2rs73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=8146-8156&author=W.+Sunauthor=Y.+Wuauthor=M.+Zhengauthor=Y.+Yangauthor=Y.+Liuauthor=C.+Wuauthor=Y.+Zhouauthor=Y.+Zhangauthor=L.+Chenauthor=H.+Li&title=Discovery+of+an+orally+active+small-molecule+tumor+necrosis+factor-%CE%B1+inhibitor&doi=10.1021%2Facs.jmedchem.0c00377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5hR"><div class="casContent"><span class="casTitleNuber">5h</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Orally Active Small-Molecule Tumor Necrosis Factor-α Inhibitor</span></div><div class="casAuthors">Sun, Weiguang; Wu, Yanli; Zheng, Mengzhu; Yang, Yueying; Liu, Yang; Wu, Canrong; Zhou, Yirong; Zhang, Yonghui; Chen, Lixia; Li, Hua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8146-8156</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tumor necrosis factor α (TNF-α) is an important therapeutic target for rheumatoid arthritis, inflammatory bowel disease, and septic hepatitis.  In this study, structure-based virtual ligand screening combined with in vitro and in vivo assays were applied.  A lead compd., benpyrine, could directly bind to TNF-α and block TNF-α-trigged signaling activation.  Furthermore, the endotoxemic murine model showed that benpyrine could attenuate TNF-α-induced inflammation, thereby reducing liver and lung injury.  Meanwhile, administration of benpyrine by gavage significantly relieved the symptoms of collagen-induced arthritis and imiquimod-induced psoriasis form inflammation in mice.  Thus, our study discovered a novel, highly specific, and orally active small-mol. TNF-α inhibitor that is potentially useful for treating TNF-α-mediated inflammatory and autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL4_essrgDzrVg90H21EOLACvtfcHk0lgjn1TUMcwirA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtl2rs73M&md5=4b1e2381348304ac8b9852065b52fd6a</span></div><a href="/servlet/linkout?suffix=cit5h&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00377%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520active%2520small-molecule%2520tumor%2520necrosis%2520factor-%25CE%25B1%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D8146%26epage%3D8156%26doi%3D10.1021%2Facs.jmedchem.0c00377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colangelo, J.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of the interaction between TNF and TNFR</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.4155%2Ffmc.12.192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=23256814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKgsLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=69-79&author=J.+M.+Davisauthor=J.+Colangelo&title=Small-molecule+inhibitors+of+the+interaction+between+TNF+and+TNFR&doi=10.4155%2Ffmc.12.192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of the interaction between TNF and TNFR</span></div><div class="casAuthors">Davis, Jessica M.; Colangelo, Julie</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-79</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The overexpression of TNF has been implicated in a variety of disease conditions including rheumatoid arthritis, Crohn's disease, HIV and cancer.  It is presently a therapeutic target for inflammatory diseases.  Many of the therapeutics currently used are biologics designed to sequester TNF, preventing it from binding with its receptors.  Recent research has been focused on finding small mols. that alter the prodn. of TNF, modulate its signal transduction pathways, or directly inhibit the binding to its receptors.  Modulation of a protein-protein interaction with small mols. is an interesting and nontrivial approach.  The various strategies used in obtaining small-mol., nonpeptide, inhibitors of the TNF-TNF receptor interaction through disruption of the TNF trimer or direct inhibition of the TNF-TNF receptor interaction are presented here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsUFCqKwJFfbVg90H21EOLACvtfcHk0lgjn1TUMcwirA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKgsLbK&md5=40d35324b2e496468743c54f128b1777</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.192%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DJ.%2BM.%26aulast%3DColangelo%26aufirst%3DJ.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520interaction%2520between%2520TNF%2520and%2520TNFR%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D69%26epage%3D79%26doi%3D10.4155%2Ffmc.12.192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueno, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alche, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, J.</span></span> <span> </span><span class="NLM_article-title">Small Molecules as anti-TNF Drugs</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2920</span>– <span class="NLM_lpage">2942</span>, <span class="refDoi"> DOI: 10.2174/0929867322666150729115553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.2174%2F0929867322666150729115553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=26219390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKktbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=2920-2942&author=V.+Richmondauthor=F.+Micheliniauthor=C.+Buenoauthor=L.+Alcheauthor=J.+Ramirez&title=Small+Molecules+as+anti-TNF+Drugs&doi=10.2174%2F0929867322666150729115553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecules as Anti-TNF Drugs</span></div><div class="casAuthors">Richmond, Victoria; Michelini, Flavia M.; Bueno, Carlos A.; Alche, Laura E.; Ramirez, Javier A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2920-2942</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Tumor necrosis factor (TNF, TNF-α, cachectin) is a pleiotropic, proinflammatory cytokine with multiple biol. effects, many of which are not yet fully understood.  Although TNF was initially described as an anti-tumor agent more than three decades ago, current knowledge places it central to immune system homeostasis.  TNF plays a crit. role in host defense against infection, as well as an inhibitory role in autoimmune disease.  However, TNF overprodn. generates deleterious effects by inducing the transcription of genes involved in acute and chronic inflammatory responses including asthma, rheumatoid arthritis, Crohn's disease, and psoriasis.  Direct inhibition of TNF by biologics, such as monoclonal antibodies and circulating TNF receptor constructs, has produced effective treatments for these disorders and validated the inhibition of this proinflammatory cytokine as an effective therapy.  Unfortunately, these biol. therapies suffer from several drawbacks, including high cost and the induction of autoantibody prodn.  Thus, the development of small mols. able to modulate TNF prodn. or signaling pathways remains a central challenge in Medicinal Chem.  Considerable efforts have been made over the past two decades to develop such inhibitors, which could potentially be administered orally and would presumably be cheaper.  This review is focused on the recent development of compds. that modulate the activity of this cytokine by acting at different levels, such as TNF expression, processing, binding to its receptors and direct inhibition.  These approaches will be compared and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGKPvies5PprVg90H21EOLACvtfcHk0lgjn1TUMcwirA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKktbbI&md5=ea185aed23d392c639f95c359813651e</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.2174%2F0929867322666150729115553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666150729115553%26sid%3Dliteratum%253Aachs%26aulast%3DRichmond%26aufirst%3DV.%26aulast%3DMichelini%26aufirst%3DF.%26aulast%3DBueno%26aufirst%3DC.%26aulast%3DAlche%26aufirst%3DL.%26aulast%3DRamirez%26aufirst%3DJ.%26atitle%3DSmall%2520Molecules%2520as%2520anti-TNF%2520Drugs%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D2920%26epage%3D2942%26doi%3D10.2174%2F0929867322666150729115553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, P.</span></span> <span> </span><span class="NLM_article-title">TNF superfamily protein–protein interactions: feasibility of small-molecule modulation</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.2174/1389450116666150223115628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.2174%2F1389450116666150223115628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=25706111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsF2hsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=393-408&author=Y.+Songauthor=P.+Buchwald&title=TNF+superfamily+protein%E2%80%93protein+interactions%3A+feasibility+of+small-molecule+modulation&doi=10.2174%2F1389450116666150223115628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">TNF Superfamily Protein-Protein Interactions: Feasibility of Small- Molecule Modulation</span></div><div class="casAuthors">Song, Yun; Buchwald, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">393-408</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The tumor necrosis factor (TNF) superfamily (TNFSF) contains about thirty structurally related receptors (TNFSFRs) and about twenty protein ligands that bind to one or more of these receptors.  Almost all of these cell surface protein-protein interactions (PPIs) represent high-value therapeutic targets for inflammatory or immune modulation in autoimmune diseases, transplant recipients, or cancers, and there are several biologics including antibodies and fusion proteins targeting them that are in various phases of clin. development.  Small-mol. inhibitors or activators could represent possible alternatives if the difficulties related to the targeting of protein-protein interactions by small mols. can be addressed.  Compds. proving the feasibility of such approaches have been identified through different drug discovery approaches for a no. of these TNFSFR-TNFSF type PPIs including CD40-CD40L, BAFFR-BAFF, TRAIL-DR5, and OX40-OX40L.  Corresponding structural, signaling, and medicinal chem. aspects are briefly reviewed here.  While none of these small-mol. modulators identified so far seems promising enough to be pursued for clin. development, they provide proof-of-principle evidence that these interactions are susceptible to small-mol. modulation and can serve as starting points toward the identification of more potent and selective candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqK0-qQTLzt7Vg90H21EOLACvtfcHk0li8sKAHoVEZBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsF2hsLs%253D&md5=c443d967c79488d838eb9d449fc6962b</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.2174%2F1389450116666150223115628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450116666150223115628%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DBuchwald%26aufirst%3DP.%26atitle%3DTNF%2520superfamily%2520protein%25E2%2580%2593protein%2520interactions%253A%2520feasibility%2520of%2520small-molecule%2520modulation%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2015%26volume%3D16%26spage%3D393%26epage%3D408%26doi%3D10.2174%2F1389450116666150223115628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroeplien, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapecki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMillan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arakaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox Iii, D.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceska, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecomte, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vugler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrington, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cossins, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, A.</span></span> <span> </span><span class="NLM_article-title">Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">5795</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-13616-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1038%2Fs41467-019-13616-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=31857588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVyiurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=5795&author=J.+O%E2%80%99Connellauthor=J.+Porterauthor=B.+Kroeplienauthor=T.+Normanauthor=S.+Rapeckiauthor=R.+Davisauthor=D.+McMillanauthor=T.+Arakakiauthor=A.+Burginauthor=D.+Fox+Iiiauthor=T.+Ceskaauthor=F.+Lecomteauthor=A.+Maloneyauthor=A.+Vuglerauthor=B.+Carringtonauthor=B.+P.+Cossinsauthor=T.+Bourneauthor=A.+Lawson&title=Small+molecules+that+inhibit+TNF+signalling+by+stabilising+an+asymmetric+form+of+the+trimer&doi=10.1038%2Fs41467-019-13616-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules that inhibit TNF signalling by stabilising an asymmetric form of trimer</span></div><div class="casAuthors">O'Connell, James; Porter, John; Kroeplien, Boris; Norman, Tim; Rapecki, Stephen; Davis, Rachel; McMillan, David; Arakaki, Tracy; Burgin, Alex; Fox, David, III; Ceska, Tom; Lecomte, Fabien; Maloney, Alison; Vugler, Alex; Carrington, Bruce; Cossins, Benjamin P.; Bourne, Tim; Lawson, Alastair</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5795</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Tumor necrosis factor (TNF) is a cytokine belonging to a family of trimeric proteins; it has been shown to be a key mediator in autoimmune diseases such as rheumatoid arthritis and Crohn's disease.  While TNF is the target of several successful biol. drugs, attempts to design small mol. therapies directed to this cytokine have not led to approved products.  Here we report the discovery of potent small mol. inhibitors of TNF that stabilize an asym. form of the sol. TNF trimer, compromising signalling and inhibiting the functions of TNF in vitro and in vivo.  This discovery paves the way for a class of small mol. drugs capable of modulating TNF function by stabilizing a naturally sampled, receptor-incompetent conformation of TNF.  Furthermore, this approach may prove to be a more general mechanism for inhibiting protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHOWvf7fPE4bVg90H21EOLACvtfcHk0li8sKAHoVEZBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVyiurjJ&md5=5cb49a89aab05c869f0226a8306d93a4</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-13616-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-13616-1%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DPorter%26aufirst%3DJ.%26aulast%3DKroeplien%26aufirst%3DB.%26aulast%3DNorman%26aufirst%3DT.%26aulast%3DRapecki%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DMcMillan%26aufirst%3DD.%26aulast%3DArakaki%26aufirst%3DT.%26aulast%3DBurgin%26aufirst%3DA.%26aulast%3DFox%2BIii%26aufirst%3DD.%26aulast%3DCeska%26aufirst%3DT.%26aulast%3DLecomte%26aufirst%3DF.%26aulast%3DMaloney%26aufirst%3DA.%26aulast%3DVugler%26aufirst%3DA.%26aulast%3DCarrington%26aufirst%3DB.%26aulast%3DCossins%26aufirst%3DB.%2BP.%26aulast%3DBourne%26aufirst%3DT.%26aulast%3DLawson%26aufirst%3DA.%26atitle%3DSmall%2520molecules%2520that%2520inhibit%2520TNF%2520signalling%2520by%2520stabilising%2520an%2520asymmetric%2520form%2520of%2520the%2520trimer%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D5795%26doi%3D10.1038%2Fs41467-019-13616-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Brookings, D. C.</span>; <span class="NLM_string-name">Calmiano, M. D.</span>; <span class="NLM_string-name">Galimore, E. O.</span>; <span class="NLM_string-name">Horsley, H. T.</span>; <span class="NLM_string-name">Hutchings, M. C.</span>; <span class="NLM_string-name">Johnson, J. A.</span>; <span class="NLM_string-name">Kroeplien, B.</span>; <span class="NLM_string-name">Lecomte, F. C.</span>; <span class="NLM_string-name">Lowe, M. A.</span>; <span class="NLM_string-name">Norman, T. J.</span>; <span class="NLM_string-name">Porter, J. R.</span>; <span class="NLM_string-name">Quincey, J. R.</span>; <span class="NLM_string-name">Reuberson, J. A.</span>; <span class="NLM_string-name">Selby, M. D.</span>; <span class="NLM_string-name">Shaw, M. A.</span>; <span class="NLM_string-name">Zhu, Z.</span>; <span class="NLM_string-name">Foley, A. M.</span></span> <span> </span><span class="NLM_article-title">TNF-alpha modulating benzimidazoles</span>. <span class="NLM_patent">WO 2013186229 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=D.+C.+Brookings&author=M.+D.+Calmiano&author=E.+O.+Galimore&author=H.+T.+Horsley&author=M.+C.+Hutchings&author=J.+A.+Johnson&author=B.+Kroeplien&author=F.+C.+Lecomte&author=M.+A.+Lowe&author=T.+J.+Norman&author=J.+R.+Porter&author=J.+R.+Quincey&author=J.+A.+Reuberson&author=M.+D.+Selby&author=M.+A.+Shaw&author=Z.+Zhu&author=A.+M.+Foley&title=TNF-alpha+modulating+benzimidazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrookings%26aufirst%3DD.%2BC.%26atitle%3DTNF-alpha%2520modulating%2520benzimidazoles%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="note"><p class="first last">We followed the chain nomenclature of O’Connell<a onclick="showRef(event, 'cit7a'); return false;" href="javascript:void(0);" class="ref cit7a">(7a)</a> where the chain whose orientation is most distorted from symmetrical TNFα trimer, is labeled A. When the trimer is viewed from the side of the C-termini, O’Connell<a onclick="showRef(event, 'cit7a'); return false;" href="javascript:void(0);" class="ref cit7a">(7a)</a> have labeled their chains in counterclockwise order whereas all other TNFα structures when viewed from the same direction are labeled in clockwise order.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="note"><p class="first last">The non-bonded interactions were calculated using the Jaguar hydrogen bond workflow as implemented in Jaguar v 2020-2</p></div><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braden, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">Pseudospectral local second-order Møller–Plesset methods for computation of hydrogen bonding energies of molecular pairs</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1021/ct049880o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct049880o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADC%252BD2MXovFSktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=248-254&author=G.+A.+Kaminskiauthor=J.+R.+Mapleauthor=R.+B.+Murphyauthor=D.+A.+Bradenauthor=R.+A.+Friesner&title=Pseudospectral+local+second-order+M%C3%B8ller%E2%80%93Plesset+methods+for+computation+of+hydrogen+bonding+energies+of+molecular+pairs&doi=10.1021%2Fct049880o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Pseudospectral Local Second-Order Moller-Plesset Methods for Computation of Hydrogen Bonding Energies of Molecular Pairs</span></div><div class="casAuthors">Kaminski, George A.; Maple, Jon R.; Murphy, Robert B.; Braden, Dale A.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">248-254</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a methodol. for computing the binding energy of mol. dimers based on extrapolation of pseudospectral local second-order Moller-Plesset (MP2), or PS-LMP2, energies to the basis set limit.  The extrapolation protocol is based on carrying out PS-LMP2 calcns. with the Dunning cc-pVTZ (-f) and cc-pVQZ (-g) basis sets and then using a simple two-parameter function to compute the final basis set limit results.  The function is parametrized to ultralarge basis set MP2 calcns. for 5 mol. pairs taken from the literature and then tested by calcg. results for a set of formamide dimers for which such calcns. have also been carried out.  The results agree to within ca. 0.2 kcal/mol with the conventional MP2 large basis set calcns.  A specialized, but relatively simple, protocol is described for eliminating noise due to overcompleteness of the basis set.  Timing results are presented for the LMP2 calcns., and comparisons are made with the LMP2 methodol. of the QChem program.  CPU time required by each of the methods scales as N3, where N is the no. of the basis functions, with the PS-LMP2 approach displaying a 2- to 3-fold advantage in the prefactor.  We also discuss one set of test cases for which the PS-LMP2 results disagree with those obtained from an alternative type of MP2 calcn., N-Me acetamide (NMA) dimers, and show that the results for liq.-state simulations using polarizable parameters derived by fitting to the PS-LMP2 binding energies appear to produce better results when compared with exptl. data.  The convergence issues assocd. with the alternative MP2 formulation remain to be investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlNpf06OE2CrVg90H21EOLACvtfcHk0li8sKAHoVEZBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXovFSktA%253D%253D&md5=3c4247bc2e3620b9e25d15822f2fa379</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fct049880o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct049880o%26sid%3Dliteratum%253Aachs%26aulast%3DKaminski%26aufirst%3DG.%2BA.%26aulast%3DMaple%26aufirst%3DJ.%2BR.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DBraden%26aufirst%3DD.%2BA.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DPseudospectral%2520local%2520second-order%2520M%25C3%25B8ller%25E2%2580%2593Plesset%2520methods%2520for%2520computation%2520of%2520hydrogen%2520bonding%2520energies%2520of%2520molecular%2520pairs%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2005%26volume%3D1%26spage%3D248%26epage%3D254%26doi%3D10.1021%2Fct049880o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9"><span> <i>Schrodinger Release 2020-2: Jaguar</i>; <span class="NLM_publisher-name">Schrodinger LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schrodinger+Release+2020-2%3A+Jaguar%3B+Schrodinger+LLC%3A+New+York%2C+NY%2C+2020."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchrodinger%2520Release%25202020-2%253A%2520Jaguar%26pub%3DSchrodinger%2520LLC%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Read, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitley, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Best, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, T.</span></span> <span> </span><span class="NLM_article-title">Tumor necrosis factor α-induced E-selectin expression is activated by the nuclear factor-kB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">2753</span>– <span class="NLM_lpage">2761</span>, <span class="refDoi"> DOI: 10.1074/jbc.272.5.2753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=10.1074%2Fjbc.272.5.2753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=9006914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;key=1%3ACAS%3A528%3ADyaK2sXpslersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=2753-2761&author=M.+A.+Readauthor=M.+Z.+Whitleyauthor=S.+Guptaauthor=J.+W.+Pierceauthor=J.+Bestauthor=R.+J.+Davisauthor=T.+Collins&title=Tumor+necrosis+factor+%CE%B1-induced+E-selectin+expression+is+activated+by+the+nuclear+factor-kB+and+c-JUN+N-terminal+kinase%2Fp38+mitogen-activated+protein+kinase+pathways&doi=10.1074%2Fjbc.272.5.2753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor necrosis factor α-induced E-selectin expression is activated by the nuclear factor-κB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways</span></div><div class="casAuthors">Read, Margaret A.; Whitley, Maryann Z.; Gupta, Shashi; Pierce, Jacqueline W.; Best, Jennifer; Davis, Roger J.; Collins, Tucker</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2753-2761</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">E-selectin expression by endothelium is crucial for leukocyte recruitment during inflammatory responses.  Transcriptional regulation of the E-selectin promoter by tumor necrosis factor α (TNFα) requires multiple nuclear factor-κB (NF-κB) binding sites and a cAMP-responsive element/activating transcription factor-like binding site designated pos. domain II (PDII).  Here the authors characterize the role of the stress-activated family of mitogen-activated protein (MAP) kinases in induced expression of this adhesion mol.  By UV crosslinking and immunopptn., the authors demonstrated that a heterodimer of transcription factors ATF-2 and c-JUN is constitutively bound to the PDII site.  TNFα stimulation of endothelial cells induces transient phosphorylation of both ATF-2 and c-JUN and induces marked activation of the c-JUN N-terminal kinase (JNK1) and p38 but not extracellular signal-regulated kinase (ERK1).  JNK and p38 are constitutively present in the nucleus, and DNA-bound c-JUN and ATF-2 are stably contacted by JNK and p38, resp.  MAP/ERK kinase kinase 1 (MEEK1), an upstream activator of MAP kinases, increases E-selectin promoter transcription and requires an intact PDII site for maximal induction.  MEKK1 can also activate NF-κB-dependent gene expression.  The effects of dominant interfering forms of the JNK/p38 signaling pathway demonstrate that activation of these kinases is crit. for cytokine-induced E-selectin gene expression.  Thus, TNFα activates 2 signaling pathways, NF-κB and JNK/p38, which are both required for maximal expression of E-selectin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomcbWscJDfcrVg90H21EOLACvtfcHk0likjxixLDYZSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXpslersw%253D%253D&md5=25d8a744712b64f849a71c30b5afd28d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.5.2753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.5.2753%26sid%3Dliteratum%253Aachs%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DWhitley%26aufirst%3DM.%2BZ.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DPierce%26aufirst%3DJ.%2BW.%26aulast%3DBest%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26aulast%3DCollins%26aufirst%3DT.%26atitle%3DTumor%2520necrosis%2520factor%2520%25CE%25B1-induced%2520E-selectin%2520expression%2520is%2520activated%2520by%2520the%2520nuclear%2520factor-kB%2520and%2520c-JUN%2520N-terminal%2520kinase%252Fp38%2520mitogen-activated%2520protein%2520kinase%2520pathways%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D2753%26epage%3D2761%26doi%3D10.1074%2Fjbc.272.5.2753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, H.-Y.</span>; <span class="NLM_string-name">Dhar, T. G. M.</span>; <span class="NLM_string-name">Li, N.</span>; <span class="NLM_string-name">Duan, J.</span>; <span class="NLM_string-name">Jiang, B.</span>; <span class="NLM_string-name">Lu, Z.</span>; <span class="NLM_string-name">Khehyong, N.</span>; <span class="NLM_string-name">Pitts, W. J.</span>; <span class="NLM_string-name">Tino, J.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic compounds useful as modulators of TNF alpha</span>. <span class="NLM_patent">WO 2017023905 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=H.-Y.+Xiao&author=T.+G.+M.+Dhar&author=N.+Li&author=J.+Duan&author=B.+Jiang&author=Z.+Lu&author=N.+Khehyong&author=W.+J.+Pitts&author=J.+Tino&title=Heterocyclic+compounds+useful+as+modulators+of+TNF+alpha"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DH.-Y.%26atitle%3DHeterocyclic%2520compounds%2520useful%2520as%2520modulators%2520of%2520TNF%2520alpha%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7JRA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7JRA','PDB','7JRA'); return false;">PDB: 7JRA</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i70"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01732">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_78560"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01732?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01732</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Description of mouse TNFα induced PK–PD model, CAIA model, protein expression, purification and crystallization, X-ray crystal structure data collection and structure refinement and analytical data for representative compounds, and SMILES representation of compounds with key data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01732/suppl_file/jm0c01732_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01732/suppl_file/jm0c01732_si_002.xlsx">XLSX</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01732/suppl_file/jm0c01732_si_001.pdf">jm0c01732_si_001.pdf (742.63 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01732/suppl_file/jm0c01732_si_002.xlsx">jm0c01732_si_002.xlsx (51.1 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01732&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-23%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01732" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01732" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799151aeab63da0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
